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Abstract 
 
Total Synthesis                                                                                     Marianne Fouché 
of Cruentaren A 
 
Cruentaren A, a highly cytotoxic metabolite, which also inhibits F-ATPase, was 
synthesized using our recently developed methodology on resorcylic acid lactones 
natural products. 
 
 
 
Alcohol A was prepared on a multigram scale in 13 steps starting from (S)-Roche 
ester and using highly stereoselective reactions such as Evans aldol reaction and 
asymmetric propargylation. 
 
 
 
Key fragment B was synthesized in 11 steps from 1,3-propanediol. The 
1,2-anti-configuration was installed with a Brown crotylation. Diketo-dioxinone D 
was generated from C-acylation between Weinreb amide B and keto-dioxinone C. 
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Ketene generation by thermolysis followed by trapping with alcohol A and 
aromatization afforded resorcylate derivative E. 
 
 
 
Finally after a sequence consisting of the following key steps: ring closing alkyne 
metathesis, coupling between amine G and acid H and Lindlar hydrogenation, 
cruentaren A was obtained. 
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1 Introduction 
1.1 General introduction to resorcylic acid lactones (RALs) 
1.1.1 Structure and biological properties 
 
RALs are a large family of natural products isolated from different fungal strains. 
They commonly contain a 12- or 14-membered ring lactone adjoined to an aromatic 
unit, more precisely the 6-alkyl-2,4-dihydroxybenzoic acid unit (Figure 1, highlighted 
in red).1 Despite being known for 60 years, with the isolation of radicicol (4) in 1953,2 
the increased interest of organic chemists in this class of natural products is very 
recent. In the early 1990s, the kinase inhibition properties of radicicol were first 
reported. Initially, Kwon et al. believed that radicicol was a Src kinase inhibitor,3 
however it was later proved that radicicol is in fact a potent and selective inhibitor of 
90-kD heat shock protein (HSP90)4. Since then, many RALs have displayed 
promising biologically active compounds with a wide and diverse spectrum of action. 
Zearalenone (1) is a powerful estrogen agonist used as a bovine growth stimulant. 
Hypothemycin (2) has been reported to irreversibly inhibits mitogen activated 
proteins (MAP) kinases and structurally related LL-7783,277 (3) has been identified 
as a mitogen-activated protein/extracellular signal regulated kinase kinase (MEK) 
inhibitor. 15G256b (7) exhibits antibiotic properties and it has been discovered that 
aigialomycin D (5) has antimalarial activity.1 Finally, recently isolated cruentaren A 
(6) proved to be highly cytotoxic (IC50 = 1.2 ng mL-1) and inhibits mitochondrial 
F1F0-ATPase (F-ATPase).5 
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Figure 1 - Examples of RAL natural products 
 
1.1.2 Biosynthesis 
 
It is proposed and widely known that aromatic units in all RALs have a polyketide 
biosynthetic origin. In the 1950s, Birch developed a theory for the biosynthesis of 
polyketides.6 The pathway begins with the condensation of coenzyme A esters 8, with 
malonyl coenzyme A ester 9 to produce β-ketothioester 10. These can then undergo 
further Claisen-type condensation with malonyl coenzyme A ester 9 to give thioesters 
of 3,5-diketoacids 11. Repeating this process gives thioesters of 3,5,7-triketoacids 12 
and so forth (Scheme 1). 
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Scheme 1 - Biosynthesis of polyketides 
 
For the biosynthesis of zearalenone (Scheme 2), it is believed that two polyketide 
synthases (PKS) are involved. First, the assembly of five acetate units take place with 
further manipulations to obtain the right oxidation state for each carbon. The second 
PKS is responsible for three more condensations, which are not followed by carbonyl 
reduction. The product 15 obtained contains highly reactive ketones, which undergo a 
cyclisation/aromatization. It is worth noting that the numerous functionalities present 
in the RALs family are due to different combinatorial arrangements during the first 
five condensations.7,1 
 
 
Scheme 2 - Biosynthesis of zearalenone 
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1.1.3 Common strategies for syntheses of RALs 
 
Biomimetic strategies for the synthesis of resorcylate natural products have not been 
extensively developed until now, mainly because harsh conditions such as very basic 
or acidic media were necessary for the aromatization step. Therefore the use of the 
resorcylate unit as a starting point followed by its derivatization has been the principal 
method used. 
 
Zearalenone 
The first total synthesis of zearalenone (1) was achieved in 1968.8 The key 
disconnections were a Wittig reaction between aromatic building block 16 and ylide 
17, corresponding to the aliphatic part, and a macrolactonization to close the ring. The 
methoxy groups were cleaved using boron tribromide (Scheme 3). 
 
 
Scheme 3 - Key disconnections for zearalenone (1) 
 
Radicicol 
In 1992, Lett and co-workers achieved the first total synthesis of radicicol (4).9 
Starting from resorcylate derivative 18, a Stille coupling was performed with tin 
derivative 19 and afforded 20 in good yield. The subsequent sequence, 
diisobutylaluminium hydride (DIBAL-H) reduction then oxidation, followed by a 
Mitsunobu reaction led to macrolactone 21 in 39% yield. It is worth noting that the 
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Mitsunobu reaction proceeded more efficiently if the o-phenol was unprotected. The 
ketone and conjugated diene were only revealed at a late stage, with the 
methoxymethyl ether (MOM) elimination. This strategy allowed Lett to overcome the 
main challenging aspect of radicicol: the allylic epoxide and the ketone functionality 
at the benzylic position. Finally the chlorine atom was introduced using calcium 
hypochlorite and subsequent deprotection afforded radicicol (4) (Scheme 4). 
 
 
Scheme 4 - Key disconnections and synthesis of radicicol (4) by Lett and co-workers 
 
Aigialomycin D 
The first total synthesis of aigialomycin D was reported by Danishefsky et al. in 
2004.10 In 2006, Winssinger et al. published a new strategy, which allowed access to 
various analogues (Scheme 5).11 Starting from orsellinic acid (24), a Mitsunobu 
reaction with alcohol 24 followed by phenol protection and alkylation with diphenyl 
diselenide, led to 22 in good yield. Alkylation with bromide 23 and subsequent ring 
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closing metathesis (RCM) afforded protected resorcylate 26 in 68% yield. Finally, 
selenium oxidation followed by in situ elimination and phenol deprotection produced 
aigialomycin D (5) in 82% yield. 
 
 
Scheme 5 - Key disconnections and synthesis of aigialomycin D (5) by Winssinger 
and co-workers 
 
The previous examples show that, until recently, the strategies for the synthesis of 
resorcylate natural products were limited: aromatic ring as building-block followed by 
stepwise derivatization (palladium based coupling and stabilization of benzylic 
carbanion) and esterification/macrolactonization. Furthermore, the macrolactonization 
is generally a difficult and low yielding step because the carbonyl group involved is 
sterically hindered and deactivated by the phenol ring. 
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1.2 Cruentaren A 
1.2.1 Isolation, structure and biological properties 
 
Myxobacteria are a particulary rich source of bioactive secondary metabolites and 
have therefore attracted attention over the last 25 years. Cruentaren A (6), was 
isolated in 2006 by Höfle et al. from the myxobacterium Byssovorax cruenta.5 Its 
structure was elucidated by detailed NMR spectroscopic analysis revealing, a 
12-membered lactone with a (Z)-double bond and an N-acylallylamine side chain 
(Figure 2).12 More precisely, as mentioned earlier, cruentaren A is part of the 
resorcylic acid lactone natural product. A minor and inactive co-metabolite, 
cruentaren B (27), was also isolated and identified as a 6-membered lactone isomer of 
cruentaren A.13 
 
 
Figure 2 - Cruentaren A (6), B (27) and structurally related apicularen A (28) 
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This new compound 6 strongly inhibited the growth of yeast and filamentous fungi 
and showed high cytotoxicity against L929 mouse fibroblast cell with an half 
maximal inhibitory concentration (IC50) value of 1.2 ng mL-1. Despite its structural 
similarity with apicularen A (28) (Figure 2), which targets vacuolar-H+ATPase 
(V-ATPase), further studies revealed that cruentaren A (6) selectively inhibits 
F-ATPase.5 In recent years, it became more evident that adenosine triphosphtatases 
(ATPases) play a crucial role in numerous diseases including cancer. Therefore a total 
synthesis would be beneficial to evaluate the full potential of cruentaren A and 
potentially provide access to analogues. Since the project started in late 2007, two 
research groups have reported the total synthesis of cruentaren A. 
 
1.2.2 Published syntheses 
 
The first total synthesis was published by Maier et al.14 closely followed by Fürstner 
et al. in 2007.15 The two syntheses beautifully showcase the use of ring-closing 
alkyne metathesis (RCAM) in total syntheses of natural products and present other 
similarities.  
 
1.2.2.1 Maier’s synthesis 
 
In the Maier approach, the final step was the Lindlar reduction of both triple bonds 
(Scheme 6). With the triple bond in place, the macrolactone is highly strained, 
therefore translactonisation with 9-OH bearing a triisopropylsilyl (TIPS) protecting 
group is impossible. The construction of the side chain was based on the coupling 
between amine 29 and the ß-hydroxy acid 30 and on a Seyferth-Gilbert reaction in 
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order to introduce the alkyne moiety, which was later reduced to a (Z)-alkene. The 
macrolactone ring was formed using an esterification followed by a RCAM. Acid 33, 
used for the key esterification, was derived from resorcylic acid derivative 34 and its 
two stereocenters were created by Evans aldol reaction. The key steps for the 
synthesis of alkynol 32 were a Marshall-Tamaru reaction followed by hydroboration. 
The homopropargylic alcohol moiety was obtained by nucleophilic attack of an 
epoxide, derived from the corresponding vicinal diol, with trimethylsilyl 
(TMS)-acetylene.14 
 
 
Scheme 6 - Key disconnections for Maier’s synthesis of cruentaren A (6) 
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Synthesis of acid 33 started with dimethoxybenzoic acid (34) (Scheme 7). First 34 
was allylated at C-7 after treatment with s-butyllithium and converted to the 
corresponding methyl ester in 51% yield. Oxidative cleavage of terminal alkene 35 
was achieved using an osmium tetroxide-catalysed periodate oxidation and afforded 
the corresponding aldehyde derivative, which was engaged in an Evans aldol reaction 
with pentynyloxazolidinone 36 to yield the “Evans syn” product 37 in 68% yield over 
two steps. TIPS-protection and reductive cleavage of the chiral auxiliary afforded 38. 
In order to obtain the desired methyl group at C-10 primary alcohol 38 was converted 
into its tosylate derivative and treated with sodium iodide and zinc to give 
intermediate 39 in 92% yield. This reductive removal of the tosylate group was first 
reported in 1976 by Fujimoto et al.16 and takes place in two steps with first 
conversion of the tosylate into its iodide derivative, then reduction with zinc powder. 
After saponification of ester 39, terminal alkyne was methylated and the desired key 
fragment 33 was obtained in 10 steps and 26% overall yield. 
 
 
Scheme 7 - Synthesis of key fragment 33 
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The synthesis of key alcohol 32 (Scheme 8) started from literature known triol 43 
which was prepared in three steps from the procedure described by Kuwajima et al.17 
This procedure involved the formation of an Evans syn aldol aduct, acetonide 
protection and reductive removal of the chiral auxiliary. After oxidation of primary 
alcohol 43 to the corresponding aldehyde, a Marshall-Tamaru reaction,18 featuring 
(S)-propargyl mesylate 44, afforded compound 45 with high diastereoselectivity 
(dr = 22:1) and 70% yield over two steps. At this stage, the four stereocenters of key 
alcohol 32 were in place. After protection of the secondary alcohol, the terminal 
alkyne was hydroborated using dicyclohexyl borane to give aldehyde 46 which was 
then reduced to the corresponding alcohol and protected with a 3,4-dimethoxybenzyl 
(DMB) group. The acetonide moiety was then cleaved using a mild method to afford 
diol 47.19 In order to introduce the alkyne moiety, 47 was converted to the 
corresponding epoxide 49 using a one-pot procedure with sodium hydride and 
tosylimidazole 48.20 Epoxide 49 was then successfully opened with lithiated 
TMS-acetylene to give homopropargylic alcohol 50 in 82% yield. After temporary 
protection of the secondary alcohol, 50 was methylated. Finally, 
tert-butyldimethysilyl (TBS) cleavage of both secondary alcohols afforded the desired 
key fragment 32 (15 steps, 30% overall yield). 
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Scheme 8 - Synthesis of key fragment 32 
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catalyst 5224 and afforded the desired macrolactone 31. Unfortunately Lindlar 
reduction of the alkyne moiety, followed by the cleavage of the silyl protecting 
groups with hydrogen fluoride in pyridine only resulted in the formation of the 
δ-lactone. Therefore Maier et al. decided to employ the reduction as the final step in 
order to prevent the translactonisation. Starting from macrocyclic 31, DMB cleavage 
with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) followed by oxidation of the 
primary alcohol to the corresponding aldehyde and subsequent Seyferth-Gilbert 
reaction with diazophosphonate 53 afforded terminal alkyne 54 in 91% yield over 
three steps. The subsequent carbon homologation was performed by treating 54 with 
tert-butyllithium and paraformaldehyde affording alcohol 55 in 85% yield. In order to 
convert 55 into the corresponding amine, the usual method involving azide formation 
with a Mitsunobu conditions followed by a Staudinger reduction was used and 
afforded 29 in good overall yield. The coupling with acid 30 (obtained in three steps 
using Evans aldol chemistry) was then carried out with 1-hydroxybenzotriazole 
(HOBt) and O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluroniumhexafluorophosphate 
(HBTU) as coupling agents and amide 56 was obtained. At this stage the full skeleton 
of cruentaren A was secured. The demethylation at C-3 was achieved using boron 
trichloride at -80 ºC. Boron trichloride selectively demethylates the methoxy group 
which is ortho to a carbonyl group because of the coordination of the boron atom with 
the two oxygen atoms.25 Silyl group cleavage was achieved with hydrogen fluoride in 
pyridine and no δ-lactone was observed, indicating that the triple bond was effective 
in preventing translactonisation. Finally Lindlar reduction of both alkyne moieties 
afforded cruentaren A in 91% yield over three steps. Cruentaren A was obtained in 28 
steps for the longest linear sequence and 8% overall yield. 
 
 29 
 
Scheme 9 - Synthesis of cruentaren A (6) 
 
Following this strategy, Maier and co-workers managed to synthesize various 
analogues of cruentaren A.26 Unfortunately, none of them showed any biological 
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even before the deprotection steps. However, by using a stable tert-butyldiphenylsilyl 
(TBDPS) protecting group for 9-OH, no translactonisation was observed during the 
synthesis and the final silyl deprotection proceeded smoothly without formation of the 
δ-lactone. Synthesis of the key acid 60 is based as well on the derivatization of the 
aromatic building block and was achieved in five steps from orsellinic acid (24) using 
Evans alkylation and Corey-Bakshi-Shibata (CBS) reduction to install the two 
stereocenters. Key polyketide 59 was generated using highly stereoselective reactions 
including the Soderquist asymmetric propargylation. 
 
 
Scheme 10 - Key disconnections for Fürstner’s synthesis of cruentaren A (6) 
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moiety, deprotonation with lithium diisopropylamide (LDA) followed by acylation 
with Weinreb amid derivative 62 (obtained via Evans chemistry) afforded ketone 63 
in 68% yield. CBS reduction of the carbonyl group with the required 
(R)-oxazaborolidine 64 afforded 65 with good diastereoselectivity and in 95% yield.27 
Subsequent protection of the secondary alcohol with a robust TBDPS group in order 
to avoid possible subsequent translactonisation was followed by selective cleavage of 
the TMS group with tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF) 
to afford key fragment 60 in 83% yield over two steps. With six steps for the longest 
linear sequence (54% overall yield), Fürstner’s strategy for the synthesis of 60 is 
much efficient and convergent than the one described by Maier. 
 
 
Scheme 11 - Synthesis of key fragment 60 
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aldolisation with (S)-oxazolidinone ent-42 led to the syn Evans product which was 
obtained with excellent diastereoselectivity. Subsequent TBS-protection of the 
secondary alcohol afforded 69 in 72% yield over two steps. Reductive cleavage of the 
auxiliary followed by Dess-Martin oxidation in pyridine in order to avoid 
epimerization, afforded primary alcohol 70. In order to introduce the propargyl 
moiety and to set the last stereocenter, Fürstner and co-workers decided to perform an 
asymmetric propargylation. Asymmetric propargylation reactions have been widely 
studied over the past decades resulting in important progress in terms of yield and 
enantioselectivity. The addition reaction of propargyl or allenyl metal reagent onto a 
carbonyl compound is the most common type. Recently Soderquist developed a 
powerful asymmetric allenylboration leading to homopropargylic alcohols in good 
yield and high enantioselectivity.30 It involves the treatment of chiral 
borabicyclodecanes with propargyl bromide through Grignard conditions to form 71 
that then reacts with the aldehyde to provide the desired homopropargylic alcohol. 
Fürstner and co-workers applied this methodology. Aldehyde 70 was treated with 71 
and underwent propargylation to afford the desired alcohol 72 in high 
diastereoselectivity (dr = 97:3) and good yield. Temporary protection of the created 
secondary alcohol followed by methylation of the terminal alkyne and cleavage of the 
TES group gave access to the 59 in 65% yield over three steps. Key alcohol 59 was 
obtained in 12 steps and 15% yield. 
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Scheme 12 - Synthesis of key fragment 59 
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the use of the Schrock catalyst 52 for the RCAM of alkyne 58 was only responsible 
for the cleavage of the  tetrahydropyranyl (THP) protecting group. The Schrock 
catalyst is indeed well known to be incompatible with numerous functional groups.24 
On the contrary, they showed that the use of their own catalyst 74 afforded the desired 
macrolactone. They later explored other catalytic system33,34 for the synthesis of 
analogues of 635 and all were successful. Despite the greater risk of translactonisation, 
the alkyne moiety of the macrolactone was then reduced using Lindlar catalyst to 
yield (Z)-olefin 75. After deprotection of 22-OH, the primary alcohol was converted 
into the corresponding azide derivative using the Mitsunobu conditions. Subsequent 
Staudinger reduction afforded the corresponding amine 57 in 55% yield over three 
steps. 57 was then coupled with acid 30 using conventional coupling agents to afford 
amide 76 in 64% yield. At this stage the fully protected skeleton of cruentaren A was 
obtained. Demethylation at C-3 was unsurprisingly performed with boron trichloride25 
and the TBS group at C-25 was also cleaved during this step (the sterically hindered 
TBS group at C-17 was left untouched). Finally the conditions for the final silyl 
deprotection were investigated. Various fluoride sources, such as 
tetra-n-butylammonium fluoride (TBAF), TASF, hydrogen fluoride in pyridine, were 
unsuccessful. Only the use of aqueous hydrogen fluoride met with success and 
afforded cruentaren A (6) with no trace of cruentaren B, the product of 
translactonisation. Cruentaren A was obtained in 22 steps and 3% yield for the longest 
linear sequence. 
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Scheme 13 - Synthesis of cruentaren A (6) 
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Figure 3 - Cytotoxicity of cruentaren A (6) and analogues synthesized by 
Fürstner et al. against L-929 mouse fibroblast cells 
 
These two syntheses of cruentaren A are following the usual route used for the 
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converting the acid to the imidazolidine derivative. However, Fürstner and co-
workers found this approach low yielding and hardly scalable. Instead, they showed 
that by converting the acid to the corresponding acid fluoride, the desired 
esterification could be carried out in high and reproducible yield with no trace of the 
δ-lactone. Although the difficulties caused by the esterification could be successfully 
solved in this case, a general limitation of these strategies is obvious.  
 
1.3 Alkyne metathesis 
 
The RCAM/Lindlar reduction system seemed to be the obvious choice for the 
synthesis of cruentaren A. However, despite being known for several decades, alkyne 
metathesis is not yet as widely used as alkene metathesis (Scheme 14). It is only 
recently that its full potential is used for the synthesis of natural products, especially 
as a RCAM combined with Lindlar reduction to give stereoselectively access to 
(Z)-cycloalkenes. On the contrary, RCM (ring closing metathesis) do not allow to 
predict or to control the stereochemistry, which depends on the ring strain. Several 
reasons might explain why alkyne metathesis has been under used by organic 
chemists for a long time: 
-While several catalysts for the olefin metathesis are commercially available and easy 
to handle, many catalysts for the alkyne metathesis are highly sensitive to air and 
various functional groups and require harsh reaction conditions.  
-The RCM can give access to ring size ≥ 5, whereas RCAM can only be used to 
synthesize ring size ≥ 12. 
-Finally, terminal alkynes are not compatible with most catalytic systems. 
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Scheme 14 - Alkyne metathesis 
 
Until recently three main systems were available for the alkyne metathesis. The first 
homogeneous system was reported by Mortreux et al. in 197436 and consists of 
molybdenum hexacarbonyl and phenol additives (Scheme 15). Despite being user 
friendly (cheap and commercially available reagents), the rather harsh conditions and 
the low functional groups tolerability has limited its application. 
 
 
Scheme 15 - Mortreux’s system 
 
The exact catalytic mechanism and the active species of alkyne metathesis still remain 
unknown, however Katz et al. proposed a mechanism in 1975 involving a metal 
carbene in a [2+2] cycloaddition and cycloreversion steps (Scheme 16).37 
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Scheme 16 - Katz’s mechanism of alkyne metathesis 
 
This mechanism was later investigated and proved by Schrock and co-workers when 
they developed a new catalytic system. The Schrock type catalysts include high 
oxidation state molybdenum and tungsten alkylidyne complexes, the most commonly 
used being the tungsten neopentylidyne complex 52, which forms 
metallocyclobutadienes (refer to Katz mechanism) when treated with internal 
alkynes.24,38 In 1998, Fürstner was the first to report the use of this catalyst to convert 
functionalized diynes into the corresponding macrocycles (Figure 4, Table 1).39 
 
 
Figure 4 - Schrock catalyst 52 
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This class of catalysts offered a broader application than the Mortreux system because 
of its milder reaction conditions. However its air and moisture sensitivity and 
appreciable Lewis acidity lowered its tolerance towards numerous functional groups 
and limited the development of alkyne metathesis. 
 
Later Fürstner and co-workers developed a new catalytic system based on sterically 
hindered trisamido molybdenum(III) complexes of the general type 
[Mo{(tBu)(Ar)N}3] activated by dichloromethane (Scheme 17).40 The role of 
dichloromethane was investigated and it was found that the active species was in fact 
[ClMo{(tBu)(Ar)N}3] 94. During this investigation, the presence of another complex, 
[HCMo{(tBu)(Ar)N}3] (95), was detected. However results showed that this terminal 
alkylidyne complex was only active for one turn-over.  
 
 
Scheme 17 - Catalyst 74 and its activation by CH2Cl2 
 
This catalytic system was successfully tested for RCAM and ring sizes ≥ 12 were 
formed in high yields. The full potential of catalyst 74 was particularly tested towards 
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catalyst suffers from air and moisture sensitivity and can even activates molecular 
nitrogen. 
 
Entry Product Yield 
a 
 
91% 
b 
 
60% 
c 
 
80% 
Table 2 - Examples of RCAM using 74 (10 mol %) in PhMe/CH2Cl2 at 80 ºC42 
 
With hope to develop new user-friendly catalysts in order to expand the use of alkyne 
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of triphenylsilanol. Another possibility is the complexation of the active specie 99 
with pyridine or phenanthroline, which affords air stable complexes, 100 and 101 
respectively. The pyridine adduct is reported to be robust enough to be weighed in air 
whereas the phenanthroline adduct seems to be indefinitely air stable. The catalytic 
O
O O
O
92
96
O
O
O
O
O
S
N
O OR
OR
97 (R = TBS)
precursor of epothilone C
 42 
activity is then restored upon heat for 100 and upon exposure to manganese dichloride 
for 101 (Scheme 18). 
 
 
Scheme 18 - Molybdenum nitride complexes with silanolate ligands 
 
For the alkylidyne complexes (Scheme 19), the active specie 103 can be obtained 
from molybdenum hexacarbonyl (102) following an adapted synthesis route leading 
to Shrock alkylidyne. Again this complex 103 can be isolated as phenanthroline 
adduct 104 to obtain a better stability towards air.  
 
 
Scheme 19 - Molybdenum alkylidyne complexes with silanolate ligands 
 
Since catalyst 103 is superbly active, the alkyne metathesis reaction can be performed 
even at room temperature.34 While this is a great improvement for sensitive substrate, 
it does create a new difficulty, which involves the accumulation of but-2-yne. The 
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addition of 5 Å molecular sieves resolved successfully this problem. In addition to 
their remarkable air stability, these catalysts show an excellent functional group 
tolerance as well as high catalytic performance. Fürstner and co-workers have already 
shown their strong potential use towards the synthesis of several natural products, 
including cruentaren A (Table 3). 
 
Yield 
Entry Product 
a98 b100 c101 d103 e104 
a 
 
83% 42% 91% 73% 78% 
b 
 
42% - - 91% - 
c 
 
81% - - 
82% 
(at 80 ºC) 
- 
Table 3 - a 98 (20 mol %), Ph3SiOH in PhMe at 80 ºC. b 100 (20 mol %) in PhMe at 
80 ºC. c 101 (10 mol %), MnCl2 in PhMe at 80 ºC. d 103 (2 mol %), MS 5 Å in PhMe 
at rt. e 105 (5 mol %), MnCl2, MS 5 Å in PhMe at 80 ºC then rt.34,35 
 
The new catalysts developed by Fürstner and co-workers show high catalyst 
properties and stability which greatly open access to the use of alkyne metathesis in 
organic chemistry. These user-friendly complexes should allow the development of 
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the RCAM combined with the Lindlar reduction. The last obstacle for the complete 
development of the alkyne metathesis is the fact that terminal alkyne are not 
compatible with most catalysts. 
 
1.4 New biomimetic inspired strategy 
 
As illustrated by the previous syntheses of RALs, including cruentaren A, described 
earlier, the strategy for the synthesis of this class of natural product is limited. 
Because the resorcylate unit is a privileged pharmacophore and the RALs contain 
highly promising biologically active compounds there was need for the development 
of much more flexible strategies. The Barrett group decided therefore to develop a 
new biomimetic inspired strategy based on the construction of the aromatic unit from 
triketo-ester compounds (Scheme 20). 
 
 
Scheme 20 - Construction of the resorcylate unit from polyketides 
 
1.4.1 Aromatization of polyketides by Harris 
 
In the late 1970s, Harris reported that polyketide chains and more specifically 
3,5,7-triketoester 109 could be obtained by self condensation of methyl acetoacetate 
units 108 under basic conditions (Scheme 21).43 
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Scheme 21 - Formation of 3,5,7-triketoester 109 
 
More importantly, Harris established that under specific conditions, simple 
polycarbonyl chains could undergo the same cyclisation reactions as in nature without 
enzyme catalysis. He showed that starting from 3,5,7-triketoester 109, four different 
products could be obtained (Scheme 22). If treated with a strong base, 109 led to 
resorcylate ester 110. Using strong basic aqueous media, acetophenone 111 was 
obtained through Claisen condensation. Finally under acidic conditions two different 
ring closures took place leading to 4-pyrone 112 and 4-hydroxy-2-pyrone 113.  
 
 
Scheme 22 - Synthesis of aromatic products from polyketides 
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Inspired by this discovery, Barrett and Barton in 1980 showed that the aromatization 
of simple polyketide chains could occur under mild basic conditions using pH 9.2 
buffer to form resorcylate 110.44 This discovery paved the way to our new strategy. 
 
1.4.2 Dioxinone as a masked carbonyl group 
 
A mild method, allowing various functionalities, to form 3,5,7-triketoesters was 
necessary to validate the new strategy. In 1984, Hyatt showed that dioxinone 114 
could undergo retro Diels-Alder reaction to form the highly reactive ketene 
intermediate 115 which could then be trapped in situ with various nucleophiles 
(Scheme 23).45  
 
 
Scheme 23 - Formation of ketene 115 by thermolysis 
 
Based on this discovery, Boeckman developed a macrolactonization method in 1989 
through the thermolysis of dioxinone 116 and intramolecular trapping of the 
corresponding ketene to form lactone 118 (Scheme 24).46 
 
 
 
Scheme 24 - Macrolactonisation based of the thermolysis of dioxinone 116 
O O
O
O
O
•
115114
O O
HO
O
PhMe 
reflux
HO
O
O
O
OO
116 117 118
 47 
1.4.3 Barrett group strategy 
 
The aromatization of polyketides developed by Harris and the use of a dioxinone as a 
masked carbonyl group for the esterification step were the grounds of our new 
biomimetically inspired strategy. These two discoveries led us to consider a late stage 
aromatization as the key step for the synthesis of RAL natural products (Scheme 25). 
Therefore polyketide 106 could be a precursor of resorcylate 105 via aldol 
condensation followed by dehydration. Furthermore 106 could be obtained from 
alcohol 120 and diketo-dioxinone 119 by thermolysis followed by ketene trapping. 
This last step represents a mild method for the synthesis of triketo-ester derivatives. 
 
 
Scheme 25 - Barrett group strategy for the biomimetic synthesis of RALs 
 
1.4.4 Synthesis of keto-dioxinone 
 
The new strategy developed by the Barrett group for the synthesis of RAL natural 
products would imply the synthesis of keto-dioxinone and diketo-dioxinone 
derivatives. Keto-dioxinone derivatives were first reported in 1991 by Kaneko and 
co-workers who discovered that keto-dioxinone 123 could be prepared by 
deprotonation of dioxinone 114 with LDA in presence of hexamethylphosphoramide 
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(HMPA) followed by addition of acid chloride 122.47 Keto-dioxinone 123 was 
selectively formed via C-acylation (Scheme 26). The O-acylation, which was a 
competitive reaction, could be prevented by using 0.5 equivalent of electrophile 122. 
 
 
Scheme 26 - Synthesis of keto-dioxinone 123 by Kaneko and co-workers 
 
In 2005, Katritzky et al. optimised and showed that C-acylation of lithium enolate of 
dioxinone could be performed by using an acylbenzotriazol derivatives, which are 
easier to handle and more tolerant towards several functional groups than acid 
chloride derivatives (Scheme 27).48  
 
 
Scheme 27 - Synthesis of keto-dioxinone 125 by Katritzky and co-workers 
 
In 2003, Tadano and co-workers developed a novel two-step methodology for the 
synthesis of keto-dioxinone through the succesful synthesis of (+)-macquarimicin A. 
This strategy involved a Mukaiyama type aldolisation with sililanol ether of 
dioxinone 126, which reacted with aldehyde 127 to give a secondary alcohol 
derivative, which was then oxidised to yield keto-dioxinone 128 (Scheme 28).49 
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Scheme 28 - Synthesis of keto-dioxinone 128 by Tadano and co-workers 
 
Those examples list the most common method used for the synthesis of 
keto-dioxinone derivatives. Keto- and diketo-dioxinone derivatives are key fragments 
for the synthesis of RALs in the methodology developed by the Barrett group. 
Therefore, extensive studies, which will be presented later, have been carried out to 
find efficient syntheses of keto- and diketo-dioxinone derivatives.  
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1.5 Objectives of this project 
 
Cruentaren A was a perfect candidate to validate the new biomimetic inspired strategy 
with late stage aromatization developed in the Barrett group for the synthesis of RAL 
natural products. This novel methodology should allow us to circumvent the 
difficulties met by Maier and Fürstner during the esterification step. Our 
retrosynthetic plan is outlined in Scheme 29. The (Z)-configuration of the alkene 
moiety incorporated in the macrolactone ring as well as the high probability of 
translactonisation featuring 9-OH prove that the use of a RCAM is almost compulsory 
as demonstrated by Maier and Fürstner. With this in mind, it is clear that the last key 
step of the synthesis should be a Lindlar reduction of the alkyne functionality within 
the macrolactone ring, which should afford cruentaren A (6) with high E:Z selectivity. 
The RCAM could be envisaged as the next key step on precursor 130, which will be 
required to be fully protected, as alkyne metathesis catalysts do not tolerate hydroxy- 
and amino-functional groups. The aromatic ring could be installed using our novel 
methodology. Therefore resorcylate 130 could come from the reaction between 
alcohol 132 and diketo-dioxinone 131 via ketene trapping and aromatization. Finally 
key fragment 132 could result from the coupling between amine 133 and acid 134. It 
was unclear at the start of this project whether amide 132 would be a suitable partner 
for the ketene trapping/aromatization sequence or if it would be more judicious to 
carry out the amide formation at the end of the synthesis and work instead with the 
amine or the corresponding alcohol. All key fragments contain at least 2 chiral 
centers. We assumed that the syn configuration of acid 134 could be obtained via 
Evans aldol reaction, however the construction of key fragment 131 and 133 would 
require more investigation, which will be discussed later. To conclude, it should be 
 51 
outlined that 133 was a key fragment of Fürstner’s synthesis too and that the 
RCAM/hydrogenation strategy is similar to Maier’s and Fürstner’s strategies. 
However their syntheses were not published at the start of this project and their work 
unknown to us at that time. 
 
 
Scheme 29 - Key disconnections for the synthesis of cruentaren A (6) utilizing late 
stage aromatization 
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2 Results and discussion  
2.1 Synthesis of diketo-dioxinone 215 (similar to key fragment 131)* 
 
The first key fragment to prepare was diketo-dioxinone derivative 131 (Figure 5). 
Since this class of compound had never been described, members of the Barrett group 
carried out extensive researches to find general efficient methods for their synthesis.  
 
 
Figure 5 - Key fragment diketo-dioxinone 131 
 
2.1.1 Studies towards the preparation of diketo-dioxinone derivatives 
 
Based on successful syntheses of keto-dioxinone derivatives reported in the literature 
(Sub-section 1.4.4), it was believed that C-acylations and aldol reactions would be 
appropriate in preparing diketo-dioxinone derivatives.  
 
 
 
 
                                                
* The term “similar to” refers to the fact that the compounds share the same structure 
but have different protecting groups (PG) or substituents (R). 
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2.1.1.1 Preparation of diketo-dioxinone derivatives based on a Claisen-type 
condensation 
 
The first method was developed by Navarro and Barrett in 2008 for the synthesis of 
15G256.50 Diketo-ester 139 was synthesized via sequential double C-acylation of 
dioxinone 135 with acid chloride 136 and 138. Magnesium chloride was used to 
prevent O-acylation over C-acylation. Subsequent palladium-catalyzed 
deallylation-decarboxylation provided the key diketo-dioxinone 140, which was 
obtained in 74% yield from key allyl ester 137 (Scheme 30). 
 
 
Scheme 30 - Synthesis of diketo-dioxinone 140 by C-acylation  
 
This procedure was used by Calo and Barrett towards the synthesis of aygialomycin D 
(5) and allowed the synthesis of diketo-dioxinone 144 in three steps and good yield 
from acid 141 (Scheme 31).51 
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Scheme 31 - Synthesis of diketo-dioxinone 144 by C-acylation  
 
2.1.1.2 Preparation of diketo-dioxinone derivatives using a Mukaiyama aldol 
reaction 
 
At the same time, Basset and Barrett reported a new method based on a 
Mukaiyama-aldol reaction towards the synthesis of (S)-(–)-zearalenone.50 Addition of 
the silyl-enolate of dioxinone 135 to aldehyde 145, catalyzed by trifluoroboron 
etherate, provided intermediate 146. Dess-Martin oxidation followed by TBS group 
cleavage and Dess-Martin oxidation gave access to the desired diketo-dioxinone 148 
(Scheme 32). 
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Scheme 32 - Synthesis of diketo-dioxinone 148 using a Mukaiyama aldol reaction 
 
2.1.1.3 Preparation of diketo-dioxinone derivatives using Weinreb amides 
 
In 2009, Pöverlein and Barrett developed a straightforward method for the 
functionalization of dioxinone 114, which was used for the synthesis of ent-W1278A 
(153).52 Dioxinone 114, after treatment with lithium hexamethyldisilazide (LiHMDS) 
followed by zinc chloride, reacted with imidazole derivative 149 to form keto-
dioxinone 150. Enolate dianion derived from 150 was formed using 2 equivalents of 
LDA and reacted with Weinreb amide 151 to give diketo-dioxinone derivative 152 
(Scheme 33). They reported that Weinreb amide derivatives were, in this case, useful 
electrophiles to minimize competitive double C- and O-acylation.  
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Scheme 33 - Synthesis of diketo-dioxinone 152 using Weinreb amides 
 
Later, Patel and Barrett investigated the addition of diethylzinc during the C-acylation 
step as low yields were obtained when highly functionalized Weinreb amides were 
used (Scheme 34).53 They showed that transmetalation of the lithium enolate of 150 
with zinc (II) could lead to higher yield most likely by suppressing unwanted side 
reaction54 (double C-acylation and O-acylation) and by inducing full consumption of 
the Weinreb amide derivatives. 
 
 
Scheme 34 - Synthesis of diketo-dioxinone 155 using Weinreb amides 
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Noyori and co-workers reported in 1989 that the use of organozinc in the reaction of 
lithium enolates with electrophiles was effective to suppress undesired ?-proton 
exhange and increase the yield, through the reversible formation of a lithium 
alkoxydialkylzincate (Scheme 35).54 
 
 
Scheme 35 - Formation of a lithium alkoxydialkylzincate 
 
2.1.1.4 Preparation of diketo-dioxinone derivatives using benzotriazole 
derivatives 
 
In 2010, Basset and Barrett reported the synthesis of (+)-montagnetol and 
(+)-erythrin.55 Thermolysis of dioxinone 114 produced acyl-ketene 115 (via 
retro-Diels-Alder reaction), which was trapped with benzotriazole 159 to form amide 
160. Subsequent C-acylation between 160 and the lithium enolate of 114 afforded 
diketo-dioxinone 161 (Scheme 36). 
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Scheme 36 - Synthesis of diketo-dioxinone 161 using benzotriazole derivatives 
 
Miyatake-Ondozobal and Barrett later used a similar method to prepare compound 
166 (Scheme 37), a key intermediate towards the synthesis of (S)-(–)-zearalenone.56 
 
 
Scheme 37 - Synthesis of 166 using benzotriazole derivatives 
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2.1.2 Synthesis of acid 201 (similar to key fragment 168) 
 
Based on these discoveries, we believed that diketo-dioxinone 131 could be obtained 
by C-acylation between keto-dioxinone 150 and a suitable electrophile derived from 
acid 168 (Scheme 38).  
 
Scheme 38 - Key disconnections for diketo-dioxinone 131 
 
2.1.2.1 Towards the synthesis of acid 168 using an ozonolysis  
 
This route is mainly inspired by the synthesis of spirastrellolide A published by 
Fürstner et al.57 Acid 168 could be obtained after selective deprotection followed by 
oxidation of primary alcohol 169. The acetylene moiety could be introduced by 
nucleophilic substitution with propyne or its derivatives on 170 after conversion of 
the primary alcohol to a good leaving group. The preparation of 170 could be 
envisaged with the ozonolysis of the corresponding alkene 171.58 Finally, the 
anti-configuration of 171 could be introduced using an asymmetric crotylation on 
aldehyde 172 (Scheme 39). 
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Scheme 39 - Key disconnections for acid 168 
 
2.1.2.1.1 Preparation of fragment 187 (similar to key fragment 170) 
 
The synthesis of 170 started with preparation of aldehyde 172. TBS-mono-protection 
on 1,3-propanediol (173) afforded the corresponding mono-protected alcohol in 86% 
yield. Dess-Martin oxidation was then attempted to obtain 172. However after silica 
flash chromatography, the desired aldehyde was isolated in low yield. Since Swern 
oxidation does not require further purifications, this method was chosen and afforded 
172 in good yield (Scheme 40).59 
 
 
Scheme 40 - Synthesis of aldehyde 172 
 
The next step was an asymmetric crotylation reaction. Several methods have been 
developed for the synthesis of chiral homoallylic alcohols, crotyl boron reagents 
being commonly used. The Brown crotylation60 refers to the use of chiral 
crotylboranes derived from terpenes (most often ?–pinene), while the Roush 
crotylation61 is based on chiral crotylboronates derived from tartrates. The main 
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difference between these two reactions is the stability of the reagents: crotylboronates 
are stable at room temperature and tolerant to exposure to air and moisture (Figure 6). 
In our case, we decided to perform a Brown crotylation to obtain 171. 
 
 
Figure 6 - Crotyl boron reagents for asymmetric crotylation 
 
During a Brown crotylation, two stereocenters are created therefore this reaction is 
associated with two stereochemical aspects. The diastereoselection is controlled by 
the stereochemistry of the butene: trans-butene leads to the formation of 
anti-diastereoisomers, while cis-butene leads to syn-diastereoisomers (Scheme 41).60 
 
 
Scheme 41 - Diastereoselection of the Brown crotylation 
 
On the other hand, the enantioselection is controlled by the stereochemistry of the 
isopinocamphenylgroup. The crotylation of aldehydes proceed through a chair-like 
transition state and the aldehyde’s facial selectivity derives from minimization of 
steric hindrance. The four models (Figure 7) show the preferred transition states 
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depending on the stereochemistry of the alkene and on the geometry of the 
asymmetric isopinocampheyl group.60 
 
 
Figure 7 - Transition state of the Brown crotylation 
 
The crotylborane is formed in situ: butene is metalated with a mixture of 
n-butyllithium and potassium tert-butoxide (Schlosser super base).62 A particular 
attention should be given to this step as trans-butene can isomerise above -50 °C. 
Then the resulting crotylpotassium 183 is treated with 
(+/-)-methoxydiisopinocampheylborane [(Ipc)2BOMe] to form the “ate” complex 
184. After treatment with boron trifluoride etherate and decomplexation of 
methoxide, the crotylborane is treated with the desired aldehyde. Finally an oxidative 
work-up affords the desired product (E)-174 (Scheme 42).60 
 
 
Scheme 42 - Synthesis of the crotyl boron reagent (E)-174 
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Since desired compound 171 exhibited an anti-configuration, the Brown crotylation 
was carried out with trans-butene. Furthermore, in order to obtain the desired 
stereochemistry, (–)-(Ipc)2BOMe, derived from (+)-?-pinene, was used. Following 
the procedure described by Brown,60 the first attempts led to an inseparable mixture 
of desired compound 171 and aldehyde 172. In order to obtain full consumption of 
aldehyde 172, crotyl borane reagent 174 was used in large excess (Scheme 43). This 
attempt was successful and homoallylic alcohol 171 was obtained in 72% yield. The 
1H NMR spectrum of the crude material showed that 171 was obtained as a single 
diastereoisomer (dr ≥ 97:3). 
 
 
Scheme 43 - Synthesis of 171 
 
Before performing the ozonolysis of the terminal alkene moiety, it was necessary to 
protect secondary alcohol 171. Instead of using two different protecting groups for 
7-OH and 9-OH, we believed that acetonide protection of the 1,3-diol function might 
be suitable. After TBS-cleavage using TBAF, the resulting diol was treated with 
dimethoxypropane and camphor sulfonic acid (CSA) in acetone (Scheme 44).63 
However despite full conversion of the diol observed by thin layer chromatography 
(TLC) analysis, desired compound 185 could not be isolated. Because of its low 
molecular weight, we believe 185 was too volatile and therefore lost during the 
concentration under reduced pressure of the solvent after the work-up. 
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Scheme 44 - Attempted synthesis of 185 
 
Secondary alcohol 171 was eventually protected with a TIPS group. The different 
reactivity of these silyl ethers (TBS (1) < TIPS (35))64 will allow a selective 
deprotection of the primary alcohol over the secondary one. The ozonolysis, carried 
out in a mixture of dichloromethane/methanol at -78 ºC, was followed by a reductive 
work-up with sodium borohydride to yield alcohol 187 (Scheme 45). When isolation 
of the aldehyde is required, dimethylsulfide or triphenylphosphine are usually added 
at the end of the ozonolysis in order to quench the ozonide derivative formed during 
this reaction.  
 
 
Scheme 45 - Synthesis of alcohol 187 via ozonolysis 
 
2.1.2.1.2 Attempted synthesis of 193 (similar to key fragment 169) 
 
In order to introduce the propyne moiety, terminal alcohol 187 was converted into a 
good leaving group. Appel reaction conditions afforded iodide and bromide 
derivatives 188 and 189 respectively in 63% and 51% yield (Scheme 46).  
 
7
TBSO
9
OH
171
1. TBAF, THF
    0 °C
2. (CH3)2C(OMe)2, CSA
    Acetone, 4A MS
O O
185
TBSO OH TBSO
OH
OTIPS
1. O3, CH2Cl2/MeOH,
    -78 °CTIPSOTf, 2,6-lutidine
TBSO OTIPS
CH2Cl2, 0 °C
97%
2. NaBH4
    65%
171 186 187
 65 
 
Scheme 46 - Synthesis of halides 188 and 189 
 
The next step was the coupling of alkyl halides 188 and 189 with propyne (190) or its 
derivatives 191, 192. This type of reaction was generally carried out with liquid 
ammonia despite solubility problems.65 However since its introduction, HMPA as a 
co-solvent with tetrahydrofuran is the most popular choice.66 The reaction proceeds 
generally in two steps, first deprotonation of the acetylene derivative with the 
appropriate lithiated base in a mixture of tetrahydrofuran/HMPA at low temperature, 
then addition of the electrophile (Scheme 47). Following this procedure, different 
conditions were tried and are reported Table 4. We noticed that only elimination 
product 195 was isolated when the deprotonation was carried out at -78 ºC and the 
addition of propyne (190) at 0 ºC (Table 4, Entry a). When the deprotonation and 
addition of 190 were carried out at 0 ºC, the 1H NMR spectrum of the crude mixture 
indicated the presence of 195 and desired product 193 in a 9:1 ratio (Table 4, Entry 
b). However 193 could not be isolated. It was then decided to use TMS-acetylene 191, 
which is much easier to handle than propyne (boiling point = -20 ºC). Using previous 
conditions, no desired product was isolated (Table 4, Entry c). Furthermore, a similar 
attempt with bromide derivative 189 was unsuccessful (Table 4, Entry d). Finally, 
bromopropene (192) was used as a source of propyne (2 equivalents of n-butyllithium 
were necessary). However no formation of desired product 193 was observed. Instead 
bromide derivative 189 was isolated, indicating that a halide exchange occurred 
(Table 4, Entry e). 
 
TBSO
OH
OTIPS TBSO OTIPS
I2, PPh3
imidazole, THF
188 (X = I)
189 (X = Br)
63%
X
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Scheme 47 - Synthesis of 193 and 194 
 
Entry 
Acetylene 
derivative 
Halide  Conditions 
Products 
(yield) 
a 
 
188 
-Deprotonation at -78 ºC 
-Addition of 188 at 0 ºC 
195 
b 
 
188 
-Deprotonation at 0 ºC 
-Addition of 188 at 0 ºC 
195/193 
(9:1) 
c 
 
188 
-Deprotonation at 0 ºC 
-Addition of 188 at 0 ºC 
No reaction 
d 
 
189 
-Deprotonation at 0 ºC 
-Addition of 189 at 0 ºC 
No reaction 
d 
 
188 
-Deprotonation at -78 ºC 
-Addition of 188 at 0 ºC 
189 
Table 4 – Different conditions for the synthesis of 193 and 194 
 
Since the use of HMPA to promote this coupling was unsuccessful, it was decided to 
explore other conditions. To date, there are no examples of Sonogashira couplings 
with non-activated alkyl halides and terminal alkynes in the presence of phosphine 
ligands.67 Furthermore this reaction is known to proceed only in moderate yields in 
the presence of N-heterocyclic carbene ligands.68 However, Luh et al. showed that the 
coupling product between primary alkyl bromide or iodide derivatives and lithiated 
TBSO
11
OTIPS
188, 189
X
Acetylene derivative
190,191,192
(see table 4)
1. n-BuLi, 
    THF/HMPA (10:1)
2.
TBSO OTIPS
R
TBSO OTIPS
195193 (R = Me)
194 (R = TMS)
190
190
TMS
191
TMS
191
Br
192
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alkynyl compounds (or the corresponding Grignard reagents) could be obtained in 
good yield using tris(dibenzylideneacetone)dipalladium [Pd2(dba)3]/ 
triphenylphosphine as catalyst system.69 This Kumada-Corriu type reaction was 
attempted with bromide derivative 189 and TMS-acetylene (Scheme 48). 
Unfortunately, no reaction occurred and only starting material was recovered. 
 
 
Scheme 48 – Attempted synthesis of 194 via Kumada-Corriu type coupling 
 
Finally the organozinc chemistry developed by Knochel was envisaged for this 
coupling. Knochel and co-workers showed that copper, zinc derivatives 
(RCuCNZnX) could react under mild conditions with 1-bromo- and 1-iodo-alkyne 
derivatives (Scheme 49).70  
 
 
Scheme 49 - Knochel organozinc chemistry 
 
However since the steric hindrance at C-11, caused by the adjacent methyl group and 
the TIPS-protecting group, was probably the reason why the coupling between halides 
188 or 189 and propyne derivatives was unsuccessful, it was decided to investigate a 
new route. 
TMS
196
TBSO OTIPSTBSO OTIPS
TMS
Br
1. Pd2(dba)3 (2 wt. %)
    PPh3 (10 wt. %), THF, 65°C
189 194
2.
Li
R1 ZnI
CuCN, 2 LiCl
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R1 Cu(CN)ZnI
R2X
199 (X = I)
200 (X = Br)
R2R1
197 198
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2.1.2.2 Synthesis of acid 201 (similar to key fragment 168) using a hydroboration 
reaction followed by carbon homologation 
 
Similarly to the strategy developed earlier, 201 could be obtained from 193 after 
selective silyl cleavage and oxidation. The acetylene moiety of 193 could be installed 
via a one-carbon homologation reaction from alcohol 202. Finally 202 could derive 
from the previously described alkene 186 using a hydroboration reaction (Scheme 
50). 
 
 
Scheme 50 - Key disconnections for acid 201 
 
Hydroboration71 of alkene 186 was first attempted with 9-borabicyclo[3.3.1]nonane 
(9-BBN), the reagent of choice for an enhanced regioselectivity. However, TLC 
analysis of the crude mixture revealed a low conversion rate after 48 hours. The steric 
hindrance was propably the cause, therefore borane in tetrahydrofuran was used and 
primary alcohol 202 was obtained in 82% yield with no trace of the other regioisomer 
(Scheme 51). In this case the use of a dialkyl borane, such as 9-BBN, to control the 
regiochemistry of the reaction was unnecessary. Primary alcohol 202 was then 
oxidized to the corresponding aldehyde 203 using o-iodoxybenzoïc acid (IBX) in 
dimethylsulfoxide. IBX was chosen over the Dess-Martin reagent because of its 
simple one-step preparation (IBX being a precursor of the Dess-Martin reagent). 72 
HO
O OTIPS
201
TBSO O
TBSO OTIPSTBSO OTIPS
TBSO OTIPS
202 186 172
193
OH
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Scheme 51 - Synthesis of aldehyde 203 via hydroboration reaction 
 
The next step was the homologation of 203 to the corresponding acetylenic compound 
207. The Corey-Fuchs73 and the Seyferth-Gilbert74 reaction are well established for 
the synthesis of alkynes from aldehydes. The Corey-Fuchs methodology is a two-step 
procedure including first, the formation of a dibromoalkene derivative, then treatment 
with n-butyllithium to obtain the desired terminal alkyne after aqueous work-up. The 
use of a strong base can limit its application. The Seyferth-Gilbert homologation 
involves the use of diazoalkylphosphonate reagents, which undergo 
Horner-Wadsworth-Emmons type reactions with aldehydes producing diazoalkene. 
After loss of nitrogen and 1,2-rearrangement of the resulting alkylidene carbene, the 
desired alkyne is obtained. The use of dimethyl-1-diazo-2-oxopropyl phosphonate 
206 (known as Bestmann-Ohira reagent)75 over dimethyldiazomethyl phosphonate 
204 is generally preferred as it can be prepared in one step from commercially 
available 205 and reacts with aldehyde under very mild conditions (Scheme 52). 
 
 
Scheme 52 - Seyferth-Gilbert (204) and Bestmann-Ohira (206) reagents 
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For the conversion of 203 to 207, the Seyferth-Gilbert homologation using 206 and 
potassium carbonate in methanol was chosen. 207 was obtained in 92% yield.76 
Finally, methylation of terminal alkyne 207 using n-butyllithium and methyl iodide 
afforded 193 in good yield (Scheme 53). 
 
 
Scheme 53 - Synthesis of 193 via Seyferth-Gilbert reaction 
 
Selective cleavage of the TBS-protecting group in the presence of the TIPS-protecting 
group was achieved following a procedure reported by Roush et al. for the total 
synthesis of angelmicin B.77 Using 0.5 equivalent of p-toluenesulfonic acid, 208 was 
obtained in 92% yield (Scheme 54). Finally in order to obtain desired acid 201, a 
two-step oxidation procedure was carried out. First primary alcohol was converted to 
the corresponding aldehyde 209 using IBX in dimethylsulfoxide. Then 209 was 
oxidised to the corresponding acid using a Pinnick reaction,78 a mild oxidation 
method suitable for functionalized aldehyde and involving the use of sodium chlorite 
and sodium dihydrogen phosphate. Side reactions can occur during this reaction due 
to the formation of hypochlorite ions, however the use of a scavenger such as 
2-methyl-2-butene is a simple way to circumvent this problem. Following this 
procedure, aldehyde 209 was oxidised to acid 201 in 90% yield.  
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O
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207
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MeOH, 0 ºC to rt
92% 90%
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Scheme 54 - Synthesis of acid 201 
 
A direct oxidation of alcohol 208 to acid 201, using stoichiometric sodium chlorite 
and catalytic 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) and sodium 
hypochlorite, was attempted too (Scheme 55).79 This one step process was preferred 
when a large amount of acid 201 was prepared. 
 
 
Scheme 55 - TEMPO oxidation of alcohol 208 to acid 201 
 
2.1.3 Synthesis of diketo-dioxinone 215 (similar to key fragment 131) from acid 
201 
 
With acid 201 in hand it was possible to envisage the synthesis of diketo-dioxinone 
derivative 215. As reported in Sub-section 2.1.1, several methods for the synthesis of 
this class of compounds have been developed by members of the Barrett Group and 
can be classified in two groups: C-acylation with dioxinone 114 or keto-dioxinone 
150 (Scheme 56). 
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 72 
   
Scheme 56 - C-acylation with dioxinone 114 ou keto-dioxinone 150 
 
In our case, the procedure involving the C-acylation of a suitable electrophile (derived 
from 201) with diketo-dioxinone 150 was chosen. The one-step procedure reported by 
Pöverlein and Barrett in 2008 was initially attempted.52 This mild alternative to the 
strategy developed by Navarro and Barrett proved to be highly suitable for the 
synthesis of natural products and functionalized diketo-dioxinone53 derivatives since 
it does not require prior conversion of acid derivatives to highly reactive acid 
chlorides. Therefore, acid 201 was transformed into the corresponding Weinreb amide 
213 in good yield using (benzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate (PyBOP) as coupling agent and N-methoxy-N-methylamine 
(Scheme 57). 
 
 
Scheme 57 - Synthesis of Weinreb amide 213 
 
Keto-dioxinone 150 was prepared from dioxinone 114 and acyl chloride in 55% yield 
following the procedure described by Calo and Barrett (Scheme 58).51 
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Scheme 58 - Synthesis of keto-dioxinone 150 
 
As reported Table 5, different conditions to obtain diketo-dioxinone 215 were 
investigated. The general procedure starts with deprotonation of keto-dioxinone 150 
with 2 equivalents of LDA to form the corresponding dianion. At this stage 
diethylzinc can be added if necessary. Finally Weinreb amide 213 is added (Scheme 
59). The first attempt was carried out with 1 equivalent of keto-dioxinone 150 and no 
addition of diethylzinc. Desired product 215 could not be isolated and TLC analysis 
of the crude mixture revealed the formation of several by-products. Furthermore, 55% 
of the starting material was recovered (Table 5, Entry a). Addition of diethylzinc 
proved to be beneficial to avoid side-reactions (e.g. O-acylation, double C-acylation) 
as no by-products were isolated when this reagent was used (Table 5, Entry b to d). 
Furthermore we observed that formation of 215 occurred only at temperature above 
-5 ºC. However degradation of the dianion of 150 was observed above 0 ºC. Therefore 
carefull temperature monitoring was essential. Finally excess of keto-dioxinone 150 
(3 equivalents) was necessary to obtain full conversion of Weinreb amide 213 (Table 
5, Entry e). The optimized conditions for the formation of 215 are summarized 
entry e, and afforded diketo-dioxinone 215 in 67% yield.† 
 
 
                                                
† All diketo-dioxinone derivatives exist as mixture of keto and enol tautomers but are 
drawn as single entities. 
O
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Scheme 59 - Synthesis of diketo-dioxinone 215 
 
Entry 
150 
(eq.) 
Et2Zn 
Temperature after 
addition of 213 
Results 
a 1 No -40 ºC to rt (slowly) 
-No 215 isolated 
-55% of 213 recovered 
b 1 Yes -40 to 0 ºC (slowly) 
-21% of 215 isolated 
-40% of 213 recovered 
c 1 Yes 
-40 to 0 ºC (quickly) 
then -5 to 0 ºC 
-45% of 215 isolated 
-27% of 213 recovered 
d 2 Yes 
-40 to 0 ºC (quickly) 
then -5 to 0 ºC 
-59% of 215 isolated 
-9% of 213 recovered 
e 3 Yes 
-40 to 0 ºC (quickly) 
then -5 to 0 ºC 
-67% of 215 isolated 
-No 213 recovered 
Table 5 - Different conditions for the synthesis of diketo-dioxinone 215 
 
2.1.4 Summary 
 
To summarize, the synthesis of diketo-dioxinone 215 has been reported following a 
highly straightforward route (Scheme 60). Starting from cheap and commercially 
available 1,3-propanediol (173), acid 201 was initially obtained in 10 steps and 28% 
O OTIPS
N
213
OMe
1. LDA
    THF, -78 to -40 ºC
2. Et2Zn, -78 to -40 ºC
3.
O O O O
O
150 215
O O O
O
OTIPS
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overall yield using a Brown crotylation to install the two stereocenters. Then acid 201 
was successfully converted into key diketo-dioxinone 215 in two steps following one 
of the procedures developed in the group for the synthesis of this class of compound. 
 
 
Scheme 60 - Synthesis of diketo-dioxinone 215 
 
Key fragment 215 was obtained in 12 steps and 13% overall yield. This 
straightforward strategy allowed the synthesis of 3.7 g of 215 (2 batches).  
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2.2 Towards the synthesis of key fragment 132 
 
The other key fragment to prepare was 132, which would later react with the 
previously described diketo-dioxinone 215. Allyl amide 132 was a challenging 
fragment with 6 chiral centers. The first disconnection, which would lead to two 
simplified molecules, corresponds at the amide bond. Hexanoic acid 134 could clearly 
be constructed by asymmetric aldol reaction. The syn-configuration of the methyl 
group at C-24 and the hydroxy group at C-25 indicates that an Evans aldol reaction 
should be the right choice with butyraldehyde (216) as the electrophile. On the other 
hand, synthesis of 133 might not be as straightforward. Four contiguous quaternary 
carbons bearing hydroxy and methyl groups show that 133 could be obtained by 
asymmetric reaction such as alkylation, aldolisation, crotylation. Furthermore, 
depending on the strategy, the (Z)-alkene functionality could either be constructed by 
an olefination reaction or the reduction of a triple bond (Scheme 61). 
 
 
Scheme 61 - Key disconnections for amide 132 
 
With these considerations in mind, a first strategy for the synthesis of 133 was 
established (Scheme 62). The homopropargyl moiety could be obtained via 
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asymmetric propargylation of 217. The method chosen for this reaction will be 
discussed later. 217 could be synthesized via aldol reaction, the syn-configuration at 
C-17 and C-16 indicating that again an Evans aldol reaction should be suitable. 
Finally in order to obtain 218 and set the last stereocenter at C-18, an asymmetric 
alkylation could be used. An Evans alkylation was chosen, as this reaction is 
generally user-friendly and leads to the desired compound with high enantiomeric 
excess (ee). Two electrophiles 219 and 220 were suitable for this reaction. However 
because alkene 219 could lead to undesired SN2’ reaction, the less reactive alkyne 220 
was chosen. 
 
 
Scheme 62 - Key disconnections for 133 
 
2.2.1 Towards the synthesis of key fragment 218 
 
Our first objective was to find the right strategy to synthesize 218. We needed a 
reliable method, which would allow large-scale preparation. It was decided to try the 
Evans alkylation because, as explained earlier, the protocol is easy and products are 
obtained with high enantioselectivity, even after the cleavage of the auxiliary, which 
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occurs in mild conditions. Furthermore compared to other asymmetric alkylation 
methods such as (S)-1-amino-2-methoxymethylpyrrolidine (SAMP)/RAMP or 
Oppolzer’s sultam, the necessary chiral auxiliary is relatively cheap. 
 
2.2.1.1 Preparation of electrophiles 224 and 226 (similar to key fragment 220) 
 
Compound 220 could either be an amino or alcohol derivative (R = OPG or NPG2). 
However since a hydroxy group was needed to introduce the halide, it was easier to 
start from a symmetric molecule, 1,4-butynediol (221), and convert the alcohol to an 
amine later on. The first attempt to synthesize 224 is outlined Scheme 63. The 
chlorination of diol 221 with thionyl chloride yielded the desired mono-chlorinated 
product 222 in 40%. The dichlorinated product was also observed as a side product of 
this reaction, which explains the moderate yield. TBS-protection of the alcohol 
followed by a Finkelstein reaction in order to convert the chloride atom by an iodide 
led to a mixture of the desired iodide 224 and starting material 223.80 Since it was 
neither possible to separate these two compounds nor to force the reaction to 
completion, an alternative route was desired. 
 
 
Scheme 63 - Synthesis of electrophile 224 
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In an alternative procedure, compound 224 could finally be obtained in two steps 
(Scheme 64). 221 was monoprotected using an excess of diol (5 equivalents) and 
directly converted to the iodide 224 using Appel reaction conditions.81,82 This method 
gave the desired product in 46% yield over two steps. The bromide derivative 226 
was prepared in an analogous fashion in 40% overall yield. However, attempts to 
prepare 224 and 226 on large scale failed. 
 
 
Scheme 64 - Synthesis of electrophile 224 and 226 
 
2.2.1.2 Synthesis of 227 via Evans alkylation 
 
The next step was the alkylation between 224 or 226 and Evans auxiliary ent-42 
(Scheme 65).28,29 Evans auxiliaries are successful in directing diastereoselective 
alkylation and, very importantly, can be cleaved easily without racemization. The 
chiral auxiliary 42 is deprotonated with either a lithium or sodium amide base at low 
temperature to give the rigidly chelated (Z)-enolate. Subsequent alkylation with 
halogenated electrophiles occurs preferentially from the less hindered face. 
Electrophile structure plays a role as well in stereoselectivity as small alkyl halides 
are less stereoselective. Different conditions were tried for the alkylation and are 
reported Table 6. It shows that no reaction occurred with bromide 226 (Table 6, Entry 
a). The different experiments show as well that it was necessary to warm the reaction 
temperature between -20 ºC and 0 ºC when using LiHMDS (Table 6, Entry b). 
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However formation of by-products was observed. The best conditions were those 
reported by Evans et al. in 1982 and combined the use of sodium 
bis(trimethylsilyl)amide (NaHMDS) at -78 ºC with iodide 224 as electrophile.83 After 
purification of the crude by flash chromatography, 1H and 13C NMR analysis proved 
227 to be a single diastereomer. 
 
  
Scheme 65 – Synthesis of 227 via Evans alkylation 
 
Entry Base Electrophile Temperature Yield 
a LiHMDS 226 -78 ºC to 0 ºC 0% 
b LiHMDS 224 -78 ºC to 0 ºC 33% 
c NaHMDS 224 -78 ºC 
72% 
dr ≥ 97:3 
Table 6 - Different conditions for the Evans alkylation 
 
2.2.1.3 Attempted synthesis of 233 (similar to key fragment 218) 
 
With compound 227 in hand, our next objective was to obtain amine 218 by 
conversion of the alcohol moiety to an amine and Lindlar reduction of the triple bond. 
The removal of the silyl protecting group TBS of 227 using TBAF was unsuccessful 
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and only led to decomposition of the starting material. The use of aqueous 
fluorosilicic acid as fluorinated deprotecting agent, in acetonitrile84 gave the desired 
free alcohol 228 in 83% yield. Subsequent reduction using Lindlar catalyst under an 
H2 atmosphere, led to (Z)-olefin 229. Furthermore, quinoline was added as a poison in 
order to enhance the selectivity of the reduction and to also prevent over reduction.85 
The 1H NMR spectrum of the crude material showed the presence of only one 
diastereomer with a (Z)-configuration confirmed by the coupling constant 
(J = 10.9 Hz) between the two vinylic protons (Scheme 66). A direct conversion of 
alcohol 229 to azide 230 using diphenyl phosphorazidate (DPPA) and 1,8-
diazabicyclo [5.4.0]undec-7-ene (DBU) was then attempted.86 This reaction takes 
place in two steps: initial phosphate formation followed by displacement by the azide 
generated in-situ. Compared to more conventional methods, this direct azidation is 
advantageous because a separate tosylate formation is unnecessary and only one 
water-soluble by-product is formed compared to several for the Mitsunobu. In this 
case, the azidation was successful, however, the conditions led to epimerisation at the 
?-carbon. According to 1H NMR spectrum, approximately 30% of product was 
epimerised and the two diastereomers were unable to be separated by flash 
chromatography (Scheme 66). 
 
 
Scheme 66 - Synthesis of allyl azide 230 
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We wanted to investigate the reason of this epimerisation. The azidation was tried 
with various bases (triethylamine, i-Pr2NEt) however the same ratio of epimerisation 
was observed. We speculated that the cause was maybe not the base but the alkoxide 
formed during the reaction. Because of the (Z)-geometry of compound 229, the 
alcoholate could easily deprotonate at the ?-carbon. Therefore, the azidation was 
attempted with alkyne 228 (Scheme 67). In the event, the 1H NMR spectrum only 
showed one diastereoisomer and the desired azide 231 was obtained in 61% yield. 
The next steps were the reduction of the azide to the corresponding amine and the 
Lindlar reduction. First, hydrogenation of the azide and the triple bond and 
tert-butyloxycarbonyl (Boc) protection were tried in one pot using Lindlar catalyst 
and di-tert-butyl dicarbonate in ethyl acetate under an H2 atmosphere. This reaction 
was reported in the literature by Bohno et al. for the total synthesis of 
(+)-haemanthamine with a yield of 99%.87 However, the desired product 232 could 
not be isolated. According to these results, it was decided to proceed in two steps with 
a Staundinger reduction of azide 231 to the corresponding amine and in-situ 
Boc-protection followed by Lindlar reduction. Following this route Boc-protected 
allylic amine 232 was obtained in 60% yield over two steps. The final step to obtain 
233 was the reductive cleavage of the chiral auxiliary, however standard method 
using sodium borohydride led only to decomposition.  
 
 
 83 
 
Scheme 67 - Attempted synthesis of 233 
 
Compound 232 was obtained in 7 steps and 8% overall yield. Unfortunately the 
cleavage of the auxiliary failed. However, simultaneously, a more straightforward 
route was investigated. 
 
2.2.2. Synthesis of allylamine 238 (similar to key fragment 218) 
 
In order to avoid the problems encountered with the azidation step and the cleavage of 
the chiral auxiliary, it was decided in this new strategy to remove the auxiliary 
immediately after the Evans alkylation. The cleavage of the oxazolidinone was 
attempted with lithium aluminium hydride at 0 °C following Evans procedure.83 
However this method led to the formation of numerous non identified by-products 
and the desired product was obtained with a low yield. Therefore, the cleavage was 
performed with sodium borohydride, a milder reducing agent, in a mixture of 
tetrahydrofuran/water and alcohol 234 was isolated in 83% yield (Scheme 68).88 The 
protection of the free alcohol was the next step. The required protecting group had to 
be stable under TBS cleavage conditions, in this case aqueous hexafluorosilicic acid 
in acetonitrile, and its cleavage conditions had to be compatible with the molecule. 
Therefore, para-methoxybenzyl (PMB) protecting group was chosen as it could be 
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cleaved under mild conditions. Desired protected alcohol 235 was obtained using 
potassium bis(trimethylsilyl)amide (KHMDS) as base, para-methoxybenzyl bromide 
and triethylamine in tetrahydrofuran.89 After TBS cleavage, alcohol 236 was 
converted to the corresponding azide 237 using the conditions previously described 
(Sub-section 2.2.1.3).86 Since we observed the formation of a precipitate a 0 ºC, the 
reaction mixture was heated to 40 ºC and azide 237 was obtained in 60 % yield. 
 
 
Scheme 68 - Synthesis of azide 237 
 
The next transformations was the reduction of the azide and the alkyne moieties as 
both could be achieved in one step by hydrogenation with Lindlar catalyst. The main 
challenge was to find the right conditions to avoid overreduction to the alkane. First, 
the usual conditions for Lindlar reduction, which were used to obtain 229 (Scheme 
66) were tried. The reaction was monitored by TLC and stopped as soon as the 
starting material had disappeared. Unfortunately, the 1H NMR spectrum of the crude 
material only indicated the presence of the aminoalkane derivative. Since the presence 
of an unprotected amine next to the alkyne moiety can accelerate the rate of 
overreduction, we believe that the reduction of the azide moiety occurred first, 
explaining this disappointing result. Several attempts were made with different 
loadings of catalyst and quinoline. Despite careful monitoring, all trials led to partial 
O
N
O
Bn
O
OTBS
227
NaBH4, THF/H2O
PMBBr, KHMDS
NEt3, THF
OTBS
235
OPMB
H2SiF6 
(25 wt. % in H2O)
N3
237
OPMB(PhO)2P
O
N3
DBU, PhMe
40 ºC, 60%
OTBS
234
OH
OH
236
OPMB
78 ºC to 0 ºC, 86%0 ºC to rt, 83%
MeCN
0 ºC to rt, 91%
 85 
over reduction and results were not reproducible. The use of ethylenediamine, as 
poison, was reported as successful to prevent overreduction of aminoalkyne 
derivative.90 This observation is due to the fact that ethylenediamine, being a 
bidentate ligand, is more efficient than quinoline to compete for catalyst surface 
association. The Lindlar reduction of 237 was therefore performed with 
ethylenediamine and afforded 238 in 66% yield (Scheme 69). 
 
 
Scheme 69 - Synthesis of allylamine 238 
 
Allylamine 238 was obtained in 8 steps and 9% overall yield from 1,4-butynediol.  
 
2.2.3 Synthesis of acid 247 and 248 (similar to key fragment 134) and amide 250 
 
In order to introduce the two stereocenters of acid 134, Evans aldol reaction was 
considered. This method is based on the reaction of a chiral (Z)-enolates, formed 
using boron-mediated-enolization, with an aldehyde and gives, as the major product, 
the Evans syn aldol with high diastereoselectivity. The diastereoselectivity can be 
explained by a Zimmerman-Traxler transition state model. The pericyclic transition 
state determines the syn/anti selectivity: the preferred transition state is the one which 
minimizes 1,3-diaxial interaction and corresponds to the one which places the 
aldehyde substituent in the equatorial position. This leads to the syn aldol products 
244 and 245. Then the chirality of the oxazolidinone differentiates the two syn 
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transition states. As shown in Scheme 70, the preferred transition state 240, which 
gives the major product 244, is the one where the dipoles of the enolate oxygen and 
carbonyl group are opposed and where there is the least number of unfavored steric 
interactions.91 It is noteworthy that the syn aldol product will only be obtained if one 
equivalent the chelating agent, dibutylboron triflate is used. 
 
 
Scheme 70 - Transition states for Evans aldol reaction 
 
The synthesis of acids 247 and 248 started with the Evans aldol reaction with 
butyraldehyde 216. 1H NMR analysis of the crude material showed the presence of 
another diastereomer (7%). After column chromatography, NMR analysis showed the 
presence of a single diastereomer which was proved to have the desired configuration 
by comparison with literature data.14b For the protection of the secondary alcohol, we 
decided to investigate two possible silyl groups. A TIPS-protecting group would be 
robust enough for the rest of the synthesis but problematic to cleave, whereas a TBS 
would be cleaved more easily. Both protections were carried out with the 
corresponding triflate reagent and 2,6-lutidine as proton sponge.92 The final step was 
the oxidative cleavage of the oxazolidinone following a standard protocol with 
lithium hydroxide and aqueous hydrogen peroxide in tetrahydrofuran at 0 °C.93 The 
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desired acids 247 and 248 were obtained in a good yield and analytically pure after 
acidic aqueous work-up (Scheme 71). 
 
 
Scheme 71 - Synthesis of acids 247 and 248 
 
We decided to attempt the synthesis of amide 250 using N-(3-dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (EDC) and HOBt as coupling agents. The 
reaction was monitored by TLC, which showed the formation of many different 
products. After work-up, mass spectroscopy analysis showed the presence of the 
desired product 250, but no product could be isolated after flash chromatography. The 
Yamaguchi coupling, known as an efficient method for translactonisation,22 was 
attempted for the coupling between 250 and 238 (Scheme 72).94 Initially acid 247 was 
added to the Yamaguchi reagent 249 to form the desired mixed anhydride. Without 
isolation of the mixte anhydride, 4-(dimethylamino)pyridine (DMAP) and amine 238 
were added. Two main products were formed: the desired amide 250 in 35% yield, 
and amide 251 resulting from the coupling between amine 238 and the Yamaguchi 
reagent. At this stage it was believed that an excess of Yamaguchi reagent was 
responsible for the by-product formation. A better control during the addition of the 
Yamaguchi reagent (no excess) or simply isolation of the mixed anhydride could have 
overcome this problem. However, only limited amount of amine 238 was available.  
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Scheme 72 - Synthesis of amide 250 using Yamaguchi reagent 
 
2.2.4 Summary 
 
To summarize, we reported the synthesis of amide 250 from amine 238 and acid 247 
in 9 steps and 3% yield for the longest linear sequence (Scheme 73). Amine 238 was 
obtained in 8 steps starting with 1,4-butynediol, with an Evans alkylation as a key 
step. Acid 247 was synthesized in 3 steps using an Evans aldol reaction to set the two 
stereocenters. 
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Scheme 73 - Attempted synthesis of amide 252 (similar to 132) 
 
The objective was to synthesize amide 252, however this strategy allowed only 
obtaining small quantity of intermediate 250 especially because of the difficulties to 
prepare 224 on a large scale. Therefore, it was impossible to complete this synthesis 
and it was decided to design a more efficient strategy.  
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2.3 Synthesis of alcohol 312 (similar to key fragment 133) 
 
First, regarding the sensitivity of alkyne metathesis catalysts towards free N-H, it was 
decided that the amide bond would be installed at a late stage of the synthesis. This 
would help limiting the number of protection/deprotection steps. However, it is worth 
noting that our first attempt of coupling resulting in the formation of amide 250 
(Sub-section 2.2.3, Scheme 72) would be helpful to optimize the conditions for the 
late stage coupling. Furthermore, the reason why it was decided to develop a new 
route for the synthesis of 133 was because we needed highly efficient steps from the 
beginning to gain access to a large amount of 253. Starting from chiral pool (S)-Roche 
ester would be an elegant answer, which would circumvent the problems encountered 
during the synthesis of electrophile 224 (Sub-section 2.2.1.1). Our new retrosynthetic 
plan is outlined Scheme 74, the key cuts remaining the same. The main changes are 
for the formation of alcohol 253, which should be constructed by substitution reaction 
of nucleophile 254 on 255, directly obtained from (S)-Roche ester (256). 
 
 
Scheme 74 - Key disconnections for key fragment 133 
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2.3.1 Synthesis of 275 (similar to key fragment 253) 
 
2.3.1.1 Synthesis of alkyne 271 
 
The primary objective was to obtain electrophile 255 from (S)-Roche ester (256). It 
was first decided to prepare the iodide derivative. Primary alcohol 256 was protected 
with a TBS-protecting group, then reduction of the ester was carried out with lithium 
aluminium hydride, as described by Koseki et al.,95 but failed to give alcohol 257. 
Instead, 2-methylpropane-1,3-diol was isolated. Lithium aluminiun hydride was 
therefore replaced by DIBAL-H, a milder reducing agent compatible with 
silyl-protecting groups, and 257 was obtained in 70% yield over two steps. 257 was 
converted into the corresponding iodide derivative 258 using Appel reaction 
conditions. The moderate yield for this step could be explained by the relative 
unstability of 258 (Scheme 75). 
 
 
Scheme 75 - Synthesis of 258 
 
For the next step, the idea was to perform a coupling between alkyl iodide 258 and a 
metal acetylide derivative in order to form 253. As reported earlier in Sub-section 
2.1.2.1.2, this type of reaction generally requires the use of HMPA as a co-solvent in 
tetrahydrofuran. This method was unsuccessful for the synthesis of 193 (Scheme 47, 
Table 4), however this result was unknown to us since both couplings (for the 
formation of 193 and 253) were studied at the same time. Following the usual 
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procedure, it was decided to first test propargylamine derivatives with various 
protecting groups and the appropriate base (Scheme 76, Table 7). The use of 
di(TMS)-protected propargylamine as a nucleophile has been extensively described 
by Moreau and Corriu in the late 1980s’.96  They showed that 259 deprotonated with 
n-butyllithium could perform nucleophilic attack on various nucleophiles including 
alkyl halide derivatives. However, our attempts with 259 were not successful. Instead, 
the 1H NMR spectrum of the crude reaction mixture showed that iodide 258 
underwent elimination of HI and produced alkene 262. Starting material 258 was 
recovered too (Table 7, Entry a). This result could be due to the rapid degradation of 
258. Boc-protected propargylamines 26097 and 26198 were then tested. In this case 
LDA was used. With the mono-protected amine, a mixture of two products was 
isolated: alkene 262 and amino derivative 263 (Table 7, Entry b). Finally alkene 262 
was the only product detected by 1H NMR of the crude reaction mixture from the 
coupling with di(Boc)-protected propargylamine 261 (Table 7, Entry c). These 
disappointing results led us to considerate the use of a more activated nucleophile. 
Since 258 was highly subject to elimination, we needed a nucleophile which would 
react fast enough to avoid the formation of alkene 262.  
 
 
Scheme 76 - Coupling between 258 and propargylamine derivatives 
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Entry R Base Product 
a 
-N(TMS)2 
259 
n-BuLi 
 
b 
-NHBoc 
260 
LDA 
 
c 
-N(Boc)2 
261 
LDA 
 
Table 7 - Different conditions for the coupling between 258 and propargyl amine 
derivatives 
 
para-Methoxybenzyl (PMB)-protected propargyl alcohol 26499 was used to perform 
the coupling with 258. With the strong donating effect of the PMB group, compared 
to the withdrawing groups previously used, 264 should be able to react fast enough to 
circumvent the elimination of HI. Following the same procedure previously used, 264 
was deprotonated with n-butyllithium in a mixture of HMPA and tetrahydrofuran. 
Electrophile 258 was then added. Desired product 265 was isolated as well as a 
mixture of alkene 262 and 266, product of an intermolecular silyl migration (Scheme 
77). This result was encouraging, but a better yield was definitely needed.  
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Scheme 77 - Coupling between 258 and propargyl alcohol 264 
 
At this stage we believed that changes should be made to electrophile 258 in order to 
improve the yield. The instability of 258 was most likely the cause of the formation of 
elimination product 262. By replacing the iodine by less reactive leaving groups, it 
could have been possible to reduce or even avoid completely the elimination of HI. 
Furthermore, isolation of product 266 showed that a silyl migration was possible 
between 258 and 264. Therefore TBS-protecting group was replaced by a 
trityl-protecting group. With this new plan, electrophiles 268, 269 and 270 were 
prepared in an analogous fashion to 258, in three steps from (S)-Roche ester (Scheme 
78).100 
 
 
Scheme 78 - Synthesis of electrophiles 268, 269, 270 
 
The coupling was first performed with iodide 268 following the conditions previously 
used. Desired product 271 was obtained with 55% yield and alkene 272 was isolated 
too (Scheme 79). 
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Scheme 79 - Coupling between 268 and propargyl alcohol 264 
 
In 1986, Chong et al. reported that acetylide derivative with an inductively stabilizing 
group could be easily alkylated in dimethylsulfoxide as solvent despite its competing 
metalation.101 This method was later used by Molander and co-workers for the 
alkylation of propiolaldehyde diethyl acetal with 1-chloro-3-isopropane.102 This 
procedure was tested with the three electrophiles. Less than 20% of desired product 
271 was isolated when both of the alkyl halides were employed whereas the reaction 
with tosylate 270 led to the exclusive formation of 271 in good yields (Scheme 80). 
Tosylate derivative 270 was isolated as white needles and seemed to be indefinitely 
stable on the bench, on the contrary to the iodide and bromide derivatives that could 
not be isolated pure but as a mixture with the elimination product. The stability of 270 
could explain the good results obtained for the coupling and the fact that no alkene 
272 was isolated. 
 
 
Scheme 80 - Coupling between 270 and propargyl alcohol 264 
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Finally a reliable method was found for the synthesis of 271. Compared to the first 
route developed for the synthesis of 238 (Sub-section 2.2.2), this new method 
contained only high yielding steps and had the advantage to start from chiral pool 
(S)-Roche ester. With this new method we were able to prepare 60 g of 271 in 2 
batches. 
 
2.3.1.2 Synthesis of amine 275 
 
The synthesis of amine 275 could be achieved in three steps from 271 (Scheme 81). 
First PMB-cleavage was performed under standard conditions with the oxidizing 
agent DDQ, which afforded primary alcohol 273 in good yield. Following this, 
conversion to the corresponding azide was performed with the conditions used to 
obtain 237 (Sub-section 2.2.2) and led to desired azide 274 in 84% yield. Finally, 
hydrogenation of the azide group and the triple bond was carried out under H2 
atmosphere with Lindlar catalyst and ethylenediamine as poison. Amine 275 was 
obtained in 75% yield. However, degradation of 275 was observed, especially when 
dissolved in deuterated chloroform. Therefore it was decided that the amine function 
would be installed at a late stage of the synthesis of cruentaren A.  
 
 
Scheme 81 - Synthesis of amine 275 
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2.3.2 Synthesis of 279 (similar to key fragment 217) 
 
2.3.2.1 Synthesis of alcohol 277 (similar to key fragment 253) 
 
Alcohol 277 was available from 271 in two steps (Scheme 82). Trityl protecting 
groups are generally cleaved with protic and Lewis acid or by hydrogenolysis. In this 
case, para-toluenesulfonic acid was used in methanol. 271 had first to be dissolved in 
a minimum amount of dichloromethane, as it was insoluble in methanol.103 Primary 
alcohol 276 was obtained in good yield. Then Lindlar reduction was performed with 
quinoline as poison to afford 277 in 90% yield. The 1H NMR and 13C NMR spectra 
only showed the presence of the (Z)-isomer.  
 
 
Scheme 82 - Synthesis of alcohol 277 
 
2.3.2.2 Synthesis of 279 via Evans aldol reaction 
 
The next key step was an Evans aldol reaction (Scheme 83). 277 was first oxidised to 
the corresponding aldehyde. In this case, a classic Dess-Martin oxidation was not 
suitable. The presence of acetic acid in this reagent could have been responsible for 
epimerization at the alpha-position. In this situation, pyridine or sodium bicarbonate 
are normally added in order to quench any acid traces.104 Therefore oxidation of 277 
was first tried with Dess-Martin reagent and pyridine in dichloromethane at 0 ºC. The 
corresponding aldehyde was obtained pure after flash chromatography and because no 
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racemization (enantiomers) could be detected by NMR spectroscopy, it was decided 
to carry on with the aldol reaction and check at this stage if diastereoisomers were 
obtained. The Evans aldol reaction was performed with dibutylboron triflate and 
Hünig’s base and the 1H NMR spectrum of the crude material showed a mixture of 
diastereoisomers (the ratio could not be exactly identified, dr ≥ 80:20). This poor 
result could have been the result of a mismatched reactant pair as both the enolate of 
42 and the aldehyde contained pre-existing stereochemistry. However since Fürstner 
obtained good results with similar partners,15 we speculated another reason for the 
low diastereoselectivity. After several trials leading to the same results, the oxidation 
method was changed for a Swern oxidation. Then, following the same procedure for 
the Evans aldol reaction, 278 was obtained in high yield and excellent 
diastereoselectivity (dr = 96:4).  This result might be surprising, as the Dess-Martin 
oxidation is usually well known to circumvent the racemization problem. However, in 
our case, purification by flash chromatography was necessary after the Dess-Martin 
oxidation to remove excess of reagent and by-products. This might be the cause of the 
racemization since no flash chromatography was necessary after the Swern oxidation. 
It is worth noting that partial cleavage of the PMB group was observed when the 
reaction was carried out with triethylamine instead of Hünig’s base. The next step was 
the protection of the secondary alcohol with a TBS-protecting group in 91% yield. 
The reductive cleavage of the Evans’ auxiliary was then performed with sodium 
borohydride. However the reaction time (48 hours) and low yield led us to use lithium 
borohydride, a stronger reducing agent, which afforded 279 in 63 % yield. 
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Scheme 83 - Synthesis of alcohol 279 
 
2.3.3 Synthesis of 312 (similar to key fragment 133) via asymmetric 
propargylation 
 
The next key step for the synthesis of key alcohol 133 was an asymmetric 
propargylation in order to introduce the propargyl moiety and set the last stereocenter. 
Asymmetric propargylation reactions have been widely studied over the past decades 
resulting in important progress therefore numerous methods were available to us for 
this step. 
 
2.3.3.1 Asymmetric propargylation 
 
Propargylation reactions can be classified into two types. The most common involves 
the formation of an organometallic reagent (allenyl or propargyl), which reacts with a 
carbonyl compound. The second involves the substitution of propargyl alcohols with 
a nucleophile. Only the first category will be discussed in this Sub-section. Numerous 
organometallic reagents have been successfully applied to propargylation reactions. 
The asymmetric version of the propargylation reaction has been essentially developed 
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through the use of stoichiometric chiral reagents and more recently through the use of 
catalytic chiral Lewis acids. 105 
 
An early report by Yamamoto showed that the addition of chiral allenyl boronic esters 
(e.g. 284) derived from tartrates onto aldehydes provided homopropargylic alcohols 
with excellent enantioselectivity.106 This method has been extensively used for the 
synthesis of natural products despite the non-friendly preparation of the allenyl 
boronic esters (Scheme 84).  
 
 
Scheme 84 - Yamamoto asymmetric propargylation 
 
The fact that only propargylic alcohol 286 was isolated indicated that the reaction 
proceeds through a cyclic transition state (Figure 8), which also shows the role of the 
bulky chiral tartrate in controlling the enantioselectivity of the reaction. It is 
noteworthy that this transition state is only accepted for propargylation of an aldehyde 
with an allenyl organometallic reagent if no other reagents (e.g. Lewis acid) are 
added. 
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Figure 8 - Transition state for the Yamamoto asymmetric propargylation 
 
Recently, Soderquist developed a new method for the synthesis of chiral 
homopropargylic alcohols via asymmetric allenyl boration.30 His work represents an 
impressive improvement of Yamamoto and Corey’s methodologies.107 It involves the 
treatment of chiral borabicyclodecanes 288 with propargylmagnesium bromide, which 
then reacts with the aldehyde to provide the desired homopropargylic alcohol 
(Scheme 85). 71 is in fact a stable crystalline product, now commercially available, 
which makes this procedure very user-friendly. 
 
 
Scheme 85 - Soderquist asymmetric propargylation 
 
The work of Marshall et al. on the synthesis of chiral allenic metal reagents 
contributed greatly to the development of enantioselective propargylation reactions. A 
wide range of axially chiral organometallic compounds (tin, silicon, zinc, indium) 
were prepared through an anti-SN2’ mechanism. Their addition onto aldehydes 
produced homopropargylic alcohols with excellent diastereoselectivity. Using 
different substrates or Lewis acids can modify the outcome of the reaction (Scheme 
86).108 
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Scheme 86 - Marshall asymmetric propargylation 
 
Barbier-type reactions with various metals have been widely used for the synthesis of 
homopropargylic alcohol as the addition of an external chiral reagent can make this 
reaction enantioselective. In particular, the use of indium has been extensively 
examined as it can be used in aqueous media. Furthermore, studies by Chan and 
co-workers showed that when indium is used with R = H, the homopropargylic 
alcohol is observed to be the sole product (no formation of allene derivatives 
observed).109  Singaram et al. reported the use of stoichiometric amount of chiral 
(1S,2R)-(+)-2-amino-1,2-diphenylethanol (297) with indium under Barbier-type 
reaction to produce homopropargylic alcohols in high enantiomeric excess. They 
showed that the use of pyridine greatly improved the enantioselectivity of the reaction 
during previous studies on allylation reactions (Scheme 87).110 The great advantage of 
this method is that all reagents are commercially available and cheap and the protocol 
is very easy. 
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Scheme 87 - Barbier type asymmetric propargylation by Singaram et al. 
 
The catalytic version of the asymmetric propargylation reaction appeared in 1994 
when Keck and co-workers reported the use of a chiral Lewis acid (prepared from 
titanium(IV) isopropoxide and (R)-(+)-1,1′-bi(2-naphthol) (BINOL) to catalyse the 
addition of allenylstannane to aldehydes. However this reaction needed a high catalyst 
loading (50-100 mol%).111 Yu et al. improved this method by adding iso-propyl 
diethylthioborinate (Et2BSiPr) and extended the substrate scope to a variety of 
aldehydes (Scheme 88). It is believed that Et2BSiPr is involved in the dissociation of 
the product from the reaction complex and in the regeneration of the catalyst, which 
explains the low catalyst loading needed (≤ 10 mol %) and the shorter reaction time 
when this reagent is added.112 
 
 
Scheme 88 - Asymmetric propargylation by Yu et al. 
 
Denmark et al. applied the Lewis base activation of a Lewis acid strategy to the 
asymmetric propargylation reaction (Scheme 89). Thus, the strong chiral Lewis acid 
binaphthyl-based phosphoramide 303•SiCl4 was used to catalyse the addition of 
allenyltributylstannane (300) onto aldehydes. Varieties of homopropargyl alcohol 
were obtained in good yield and high enantiomeric excess.113 
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Scheme 89 - Asymmetric propargylation by Denmark et al. 
 
Finally, the use of chromium salts for propargylation reactions was introduced by 
Nozaki and Hiyama with Chromium (II) generally used in large excess to produce the 
organochromium reagent.114 Cozzi and co-workers showed that, by adding the chiral 
complex [Cr(Salen)], asymmetric catalysis of the Nozaki-Hiyama propargylation 
reactions could be achieved. However results where limited by low yields and 
enantioselectivity.115 Later, Kishi et al developed a new kind of chiral ligand derived 
from chromium (III) bromide and 305 that permitted to achieve highly 
enantioselective propargylation reactions (Scheme 90).116 
 
 
Scheme 90 - Asymmetric propargylation by Kishi et al. 
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2.3.3.2 Application to the synthesis of 312 
 
The previous Sub-section 2.3.3.1 constitutes of a non-exhaustive list of some 
well-known methods for asymmetric propargylation reactions that are frequently used 
for the synthesis of natural product. The aim was to present the different strategies 
that were available to us to synthesize homopropargyl alcohol 312. As mentioned 
earlier, Fürstner and co-workers decided to use the Soderquist propargylation to 
obtain a similar fragment.15 Their choice was indeed successful as 72 was obtained in 
good yield and high diastereomeric ratio (Sub-section 1.2.3.2, Scheme 12). However, 
despite being recognised as a user-friendly reaction, the Soderquist propargylation 
still involves three distinct steps from commercially available borane 71. We believed 
that, if successful, a Barbier type reaction would be a much easier and quicker 
solution to the synthesis of 312. Initially the protocol described by Singaram et al. 
involving the use of indium(0) with amino-alcohol 297 as a chiral ligand was tested 
with benzaldehyde. In the event, the desired product 304 was obtained as outlined 
with similar yield and ee (Scheme 91)110 (checked by comparison of the optical 
rotation data reported in the literature30). 
 
 
Scheme 91 - Synthesis of 304 using the Barbier type procedure described by 
Singaram et al. 
 
With these pleasing results in hand, the same protocol was applied to aldehyde 306, 
obtained as a single diastereoisomer from 279 by Swern oxidation (Scheme 92). After 
280295
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Ph
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2 hours at -78 ºC, TLC analysis of the reaction mixture indicated 50% conversion. 
The reaction was then slowly allowed to warm up over 10 h to reach room 
temperature. However, TLC analysis indicated the same rate of conversion. After 
acidic aqueous work-up, the unreacted aldehyde had been converted to the 
??ß-unsaturated aldehyde 309 via elimination of the O-TBS group. Furthermore 
desired product 307 (one diastereoismer by 1H NMR analysis) was obtained as a 9:1 
mixture with the corresponding allene 308 (Table 8, Entry a). Since it was impossible 
to recover the starting material, we needed to improve the procedure to obtain a 
conversion rate close to 100%. Using more equivalents of reagents did not help 
(Table 8, Entry b). However, we were pleased to find that by stirring the reaction at 
-20 ºC for 18 hours, full conversion was obtained (Table 8, Entry c). Furthermore 307 
was isolated as a single diastereoisomer, as confirmed by the 1H NMR and 13C NMR 
spectra, but still as a 9:1 mixture (inseparable by silica flash chromatography) with 
308, in 80% yield.  
 
 
Scheme 92 - Synthesis of 307 using the Barbier type procedure described by 
Singaram et al. 
 
280
Br
Ph
HO NH2
Ph
297
In(0), pyridine
THF
OTBSO
OPMB
306
H
OTBSOH
OPMB
H
OTBSOH
OPMB
•
H
1 M HCl
O
OPMB
309
H
+ 9:1
308
307
OTBS
OPMB
279
OH Swern oxidation
95%
 107 
Table 8 - Different conditions for the synthesis of 307 
 
Since no transition state model was available for this method, it was important to 
ascertain the stereochemistry of 307. To do so, 307 was converted to the 
corresponding (S)- and (R)-Mosher esters. By comparison of the 1H-NMR spectrum, 
it was possible to confirm that the desired stereochemistry had been installed.  
 
The final step of the synthesis of alcohol 312 was the methylation of the terminal 
alkyne (Scheme 93). First, a three-step procedure was carried out with a temporary 
triethylsilyl (TES)-protecting group, as described be Fürstner et al.15 However, as the 
free alcohol of 307 was slightly hindered and that a lithium alkoxide would be less 
reactive than a lithium acetylide anion, we believed that direct methylation of the 
terminal alkyne might be possible. Using 2 equivalents of n-butyllithium, 307 was 
deprotonated at -78 ºC and stirred for 1h. After addition of methyl iodide, the reaction 
Entry Conditions Temperature Results 
a 
In(0) 2 eq 
Pyridine 2 eq 
297 2 eq 
-78 ºC to rt 
in 10 h 
50% conversion 
309 (after work-up) 
307 and 308 (9:1, 37% yield, dr ≥ 97:3 
b 
In(0) 4 eq 
Pyridine 4 eq 
297 4 eq 
-78 ºC to rt 
in 10 h 
50% conversion 
309 (after work-up) 
307 and 308 (9:1, 37% yield, dr ≥ 97:3 
c 
In(0) 2 eq 
Pyridine 2 eq 
297 2 eq 
-20 ºC  
for 10 h 
full conversion 
307 and 308 (9:1, 80% yield, dr ≥ 97:3 
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mixture was warmed up to room temperature. In 30 minutes, the methylation was 
completed and 312 was isolated as the sole product in 68% yield. The yield was much 
higher than for the three steps version (35%). 
 
 
Scheme 93 – Synthesis of alcohol 312 via selective methylation 
 
2.3.4 Summary 
 
Finally, we reported the synthesis of key alcohol 312 starting from chiral pool 
(S)-Roche ester (256) (Scheme 94). Key features included Evans aldol reaction and 
Barbier type asymmetric propargylation to install the 3 other stereocenters. 
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Scheme 94 - Synthesis of alcohol 312 
 
Finally, 2.5 g of alcohol 312 was synthesized in two batches. The overall yield is 7% 
for 13 steps.  
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2.4 Aromatization and RCAM studies on a model system 
 
With alcohol 312 and diketo-dioxinone 215 in hand we had to find the most suitable 
conditions for the aromatization, the key step of our synthesis of cruentaren A. An 
initial set of experiments was conducted on a model system with diketo-dioxinone 
215 and homopropargylic alcohol 313. If successful, this model system should lead to 
the formation of resorcylate 314, a perfect candidate to study the subsequent RCAM 
(Scheme 95).  
 
 
Scheme 95 – Model system 
 
2.4.1 Aromatization studies 
2.4.1.1 Total synthesis of RALs utilizing late stage aromatization 
 
In 2008, Basset and Barrett reported the first biomimetic synthesis of 
S-(-)-zearalenone (1) utilizing a late stage aromatization strategy.50 Inspired by Hyatt 
et al. (Sub-section 1.4.2, Scheme 23),45 they reported that thermolysis of 
diketo-dioxinone derivative 148 led to the formation of the corresponding ketene 
intermediate 316, via a retro-Diels-Alder reaction, which was trapped in situ with 
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O
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alcohol 317 to give triketo-ester 318 (Scheme 96). The 1H-NMR spectrum of the 
crude mixture showed that 318 was in fact a mixture of keto and enol tautomers.  
 
 
 
Scheme 96 - Synthesis of triketo-ester 318 via thermolysis and ketene trapping 
 
Harris first showed that the resorcylic acid ring could be obtained from triketo-esters 
via aldol condensation under basic conditions (potassium hydroxide).43 Later Barrett 
et al. reported the use of a pH 9.2 buffer solution for the same purpose (Scheme 97).44  
 
 
Scheme 97 - Aromatization of triketo-esters 
 
Aromatization studies for the synthesis of S-(–)-zearalenone (1) showed that 318 
could undergo aldol condensation using a solution of potassium methoxide in 
methanol. Subsequent addition of hydrochloric acid (to pH = 1) was required to 
promote the dehydration and the subsequent aromatization leading to resorcylate 319 
in 82% yield (Scheme 98).50 
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Scheme 98 - Synthesis of resorcylate 319 via late stage aromatization 
 
This biomimetic aromatization procedure was then applied to the synthesis of other 
RAL natural products. However, the conditions for the aromatization had to be 
adapted to the substrate, therefore several combinations of basic and acidic media 
have been used. Few examples are reported in Table 9. For the synthesis of 15G256, 
potassium carbonate in iso-propanol followed by aqueous hydrochloric acid was 
preferred.50 A combination of cesium acetate in iso-propanol followed by 
trifluoroacetic acid was used towards the synthesis of ent-W1278.52 Finally, the use of 
cesium carbonate followed by acetic acid was reported for the synthesis of 
LL-Z1640-2.117 
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Entry Conditions Product 
a 
1. PhMe, 110 ºC 
2. K2CO3, CH2Cl2/i-PrOH 
then HCl in MeOH to pH = 2 
 
b 
1. PhMe, 110 ºC 
2. CsOAc, CH2Cl2/i-PrOH 
then TFA  
c 
1. PhMe, 110 ºC 
2. Cs2CO3, MeOH 
then AcOH (glacial) 
 
Table 9 – Different conditions for the late stage aromatisation 
 
Interestingly, Basset and Barrett also discovered that the aromatization could occur 
under neutral conditions (Scheme 99). When dioxinone 161 was treated with 4 Å 
molecular sieves in a mixture of iso-propanol and dichloromethane in a sealed tube at 
100 ºC, orsellinate ester 110 was obtained in 82% yield.55 
 
 
Scheme 99 - Aromatization under neutral conditions 
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2.4.1.2 Synthesis of resorcylate 314 via late stage aromatization 
 
The synthesis of 314 was attempted using the two steps method previously described, 
which includes first trapping of the ketene derivative followed by the aromatization 
(Scheme 100). Diketo-dioxinone 215, in the presence of one equivalent of alcohol 
313 was heated to reflux until complete consumption of both reagents. The 1H NMR 
spectrum of the crude material showed a mixture of keto and enol tautomeres of 323. 
Without further purifications (triketo-ester derivatives are reported to be unstable), 
323 in methanol was treated with cesium carbonate followed by acetic acid. 314 was 
isolated as the sole product in 67% yield 
 
 
Scheme 100 - Aromatization studies with diketo-dioxinone 215 and alcohol 313 
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2.4.2 RCAM studies 
 
Having established the conditions for the biomimetic aromatization on our model 
system, we wanted to go further and optimize the conditions for the subsequent 
RCAM. 
 
2.4.2.1 Synthesis of (pre)catalyst 100  
 
The RCAM is a key step for the synthesis of cruentaren A. Maier et al. reported the 
use of the Schrock catalyst 52 while Fürstner and co-workers used one of their own 
catalysts, the trisamido molybdenum(III) complex 74 to complete the RCAM.14,15 
These two catalysts were successful, however, their sensitivity towards air and 
moisture meant they required careful handling. Therefore we decided to screen the 
different catalysts available to us (Sub-section 1.3). Fürstner had recently disclosed a 
new catalytic alkyne metathesis system offering better stability.33 These molybdenum 
nitride complexes with silanolate ligands were appealing, especially the pyridine 
adduct 100 which was reported to be robust enough to be weighed in air (Figure 8). 
 
 
Figure 8 - Catalysts for alkyne metathesis 
 
Since 100 was not commercially available, its synthesis was carried out following 
Fürstner’s protocol.33 It is worth noting that if pyridine adduct 100 can be considered 
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air stable, this is not the case for its intermediates. Therefore careful handling and 
manipulation under an inert atmosphere of argon were required throughout its 
synthesis. First sodium molybdate (324) was treated with trimethylsilyl chloride in 
dimethoxyethane at reflux to yield the dioxo-species 325. LiHMDS was added to the 
crude mixture and complex 98 was obtained pure after filtration and distillation under 
high vacuum. Treatment of 98 with triphenylsilanol in hot toluene afforded active 
catalyst 99. Subsequent addition of pyridine followed by recrystallisation gave access 
to the desired pyridine adduct 100 on gram scale (Scheme 101). It was unclear from 
the spectroscopic data if 100 had been successfully synthesized. However, 
crystallographic data showed that the desired complex had been obtained (Appendix 
1). 
 
 
Scheme 101 - Preparation of (pre)catalyst 100 
 
2.4.2.2 Synthesis of macrolactone 315 
 
Since (pre)catalyst 100 was incompatible with free hydroxy groups, resorcylate 314 
was first converted to 326 using methyl iodide and potassium carbonate in refluxing 
acetone. The formation of macrolactone 315 by RCAM was then investigated 
(Scheme 102) and the different attempts are reported in Table 10. First the conditions 
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reported by Fürstner et al. were followed33 (Table 10, Entry a), however no reaction 
occurred and starting material 326 was recovered. Since the catalytic activity of 100 is 
restored upon heat by decomplexation of pyridine, we believed that addition of 100 to 
a pre-heated solution of 326 in toluene at 80 ºC could be beneficial (Table 10, Entry 
b). The desired macrolactone 315 was identified by 1H NMR spectroscopy but only 
with moderate conversion. Furthermore, because 315 could only be isolated as a 
mixture with residual triphenylsilanol, it was impossible to obtain the exact yield of 
the reaction. In order to obtain a higher conversion, the same procedure was repeated 
at 110 ºC (Table 10, Entry c). After 18 hours, the 1H NMR spectrum of the crude 
material confirmed full conversion of 326 into 315 but once again the yield could not 
be determined. 
 
 
Scheme 102 - Synthesis of 315 via RCAM 
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Entry Reagents and Conditions Results 
a 
-326 added to a suspension of 100 
(20 mol %) in PhMe at rt 
-Mixture stirred 18 h at 80 ºC 
No reaction 
b 
-326 in PhMe at 80 ºC 
-100 (20 mol %) added, stirred 18 h at 
80 ºC 
40% conversion 
c 
-326 in PhMe at 110 ºC 
-100 (20 mol %) added, stirred 18 h at 
110 ºC 
Full Conversion 
Table 10 - Different conditions for the RCAM 
 
2.4.3 Summary 
 
In summary, the biomimetic aromatization developed by the Barrett group proved to 
be successful on our model system. Furthermore, alkyne metathesis (pre)catalyst 100 
was prepared and used for the construction of macrolactone 315 (Scheme 103). 
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Scheme 103 - Aromatization and RCAM studies towards the synthesis of 315 
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2.5 Total Synthesis of cruentaren A (6) 
 
In view of the successful results reported earlier (Sub-section 2.4) and with key 
building blocks 215 and 312 in hand, we could now attempt to complete the synthesis 
of cruentaren A. As reported in our initial retrosynthetic analysis (Sub-section 1.5, 
Scheme 29), we believed Lindlar reduction of the triple bound within the 
macrolactone should be the last step of our synthesis, thus avoiding translactonisation.  
The side chain could be extended at this stage too, therefore cruentaren A (6) could be 
obtained from 327, which in turn could be synthesized via RCAM of precursor 328. 
Finally aromatic intermediate 328 could be constructed following our biomimetic 
aromatization with 215 and 312 (Scheme 104). 
 
 
Scheme 104 – Key cuts for the synthesis of cruentaren A (6) 
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2.5.1 Synthesis of the core structure of cruentaren A 
 
We planned to undertake the synthesis of the core structure in an analogous manner to 
the synthesis of the model resorcylate 315. 
 
2.5.1.1 Biomimetic aromatization with diketo-dioxinone 215 and alcohol 312 
 
After the success of the biomimetic aromatization on our model system (Sub-section 
2.4.1.2), we decided to follow the same protocol for the synthesis of 330 (Scheme 
105, Table 11). Diketo-dioxinone 215 was subjected to thermolysis and trapping with 
alcohol 312 followed by aromatization using cesium carbonate and then acetic acid 
(Table 11, Entry a). Unfortunately, desired compound 330 was only isolated in 
10% yield, which led to identifying two problems. During the trapping, degradation of 
diketo-dioxinone 215 occurred before alcohol 312 was fully consumed. Moreover, the 
dehydration step under acidic conditions, despite using a large excess of acetic acid, 
was very slow. Based on this first attempt it was decided to carry out the trapping 
with an excess of 215 and to use a stronger acid for the dehydration. First, 1.5 
equivalents of diketo-dioxinone 215 reacted with alcohol 312 (Table 11, Entry b). 
Subsequent treatment with cesium carbonate, followed by an excess of hydrochloric 
acid in methanol resulted in two main products (1:1 ratio) as well as unreacted alcohol 
312. The most polar compound was identified as the expected resorcylate 330. The 
other product 331 was in fact bearing a methoxy ether group instead of a hydroxy 
group at C-5. We believe 331 was formed during the dehydration step by acid 
catalysis of the ketone function. 330 and 331 were isolated in 58% yield. Finally 
following the same procedure, diketo-dioxinone 215 was used in 1.7 equivalents 
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leading to full consumption of alcohol 312 (Table 11, Entry c) and the isolation of 
330 and 331 in 62% yield. 
 
 
Scheme 105 - Aromatization studies with diketo-dioxinone 215 and alcohol 312 
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Entry 
Reagents and 
Conditions 
(Trapping) 
Results 
Reagents and 
Conditions 
(Aromatization) 
Results 
a 
215 (1 eq.) 
312 (1 eq.) 
- After 30 min, 215 
and 312 detected 
- After 2 h, 
degradation of 
215, 312 detected 
Cs2CO3, MeOH 
then AcOH 
- 10 % of 330 
- 312 recovered 
b 
215 (1.5 eq.) 
312 (1 eq.) 
- After 1 h, 215 
and traces of 312 
detected 
Cs2CO3, MeOH 
then HCl in 
MeOH 
- 330 and 331 
(58%) 
- 312 recovered 
c 
215 (1.7 eq.) 
312 (1 eq.) 
- Reaction 
completed 
Cs2CO3, MeOH 
then, HCl in 
MeOH 
- 330 and 331 
(62%) 
Table 11 - Different conditions for the aromatization 
 
Using an excess of diketo-dioxinone 215 was problematic since its synthesis requires 
12 steps and therefore an improved strategy was needed. We decided to try the one 
step aromatization under neutral conditions reported by Basset and Barrett 
(Sub-section 2.4.1.1, Scheme 99).55 215 and 312 were treated with 4 Å molecular 
sieves in dichloromethane in a sealed tube at 110 ºC. After 12 hours, no aromatic 
compound was isolated however full conversion of both starting material to 
triketo-ester 329 was obtained. With these observations in mind, a new aromatization 
protocol was attempted. The trapping of 215 with 312 was carried out in 
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dichloromethane at 110 ºC in a sealed tube for 2 hours (molecular sieves were no 
longer needed since they were used to promote the dehydration), followed by 
subsequent addition of cesium carbonate and hydrochloric acid in methanol (Scheme 
106). 330 and 331 were obtained in gram scale with up to 74% yield.  
 
 
Scheme 106 - Synthesis of 330 and 331 via late stage aromatization 
 
It is worth noting that when triketo-ester 329 failed to react completely under basic 
conditions, formation of a by-product was observed after addition of hydrochloric 
acid. Harris reported that triketo-ester derivatives could form pyrones derivatives 
under harshly acidic conditions (Scheme 107).43  
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Scheme 107 - Pyrone formation under acidic conditions 
 
According to this observation and spectroscopic data, the by-product could be 
identified as compound 332 or 333 (Figure 9). Since the mechanism leading to this 
by-product is unclear, it is difficult to ascertain which one of these structures is the 
by-product. The formation of this by-product could be easily avoided by monitoring 
(TLC analysis) that the cyclization of 329 was complete before the acidification step. 
 
 
Figure 9 - By-product formed from triketo-ester 329 under acidic conditions 
 
2.5.1.2 RCAM on precursor 328 
 
Despite the successful use of catalyst 100 for the synthesis of model system 
resorcylate 315, its application in the formation of 327 was uncertain: precursor 328 
contained a dense array of functional groups that might interfere with the catalyst. 
First, 330 and 331 were converted to the dimethoxy-protected resorcylate 328. With 
the previous results in mind (Sub-section 2.4.2.2), 100 (20 mol %) was added to a 
pre-heated solution of 328 in toluene at 110 ºC. We were pleased to observe full 
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conversion of 328 after 20 hours, however 327 was isolated in only 55% yield. We 
believed that the cause of this rather disappointing yield might be the long exposure 
of 328 and 327 to high temperature. Since heating to 110 ºC was necessary for the 
reaction to proceed, the only solution was to reduce the reaction time. Therefore, the 
catalyst loading was increased (100, 40 mol %) and the desired macrolactone 327 was 
isolated in 75% yield after 8 hours (Scheme 108). It is worth noting that any attempts 
carried out with commercially available (Aldrich) (pre)catalyst 100 failed. 
 
 
Scheme 108 – Synthesis of macrolactone 327 via RCAM 
 
The core structure of cruentaren A 327 was synthesized over three steps in 46% yield 
from key fragments 215 and 312, providing 0.85 g (three batches). 
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2.5.2 Introduction of the side chain and completion of the synthesis of 
cruentaren A 
 
With the core structure of cruentaren A in hand, we could now envisage attaching the 
side chain corresponding to carboxylic acids 247 or 248 in order to obtain the 
allylamide derivatives 338 or 339. Then, three more steps would be necessary to 
complete the synthesis of cruentaren A.  
 
2.5.2.1 Synthesis of allylamide derivatives 33 (similar to key fragment 129) 
 
Amide bond formation is usually achieved through activation of the acid, by 
conversion to an acyl chloride or anhydride, or by using coupling reagents. 
Accordingly, amide 250 (Sub-section 2.2.3, Scheme 72) was formed using the 
Yamaguchi protocol.22,94 Since this method had been successful for the synthesis of 
250, we believed similar results could be achieved to obtain 338 or 339 after 
deprotection of terminal alcohol 327 and conversion into the corresponding 
allylamine 337. However, very recently Crich and co-workers reported the 
condensation of carboxylate salts with isocyanates to afford the corresponding amides 
in high yield.118 Giving the fact that isocyanate derivatives can be prepared from the 
corresponding alcohol using a variant of the Mitsunobu reaction, this protocol could 
be a shorther alternative for synthesis of amides 338 or 339 and was consequently 
preferred (Scheme 109). 
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Scheme 109 - Different pathways for the formation of allylamide derivatives 338 and 
339 
 
2.5.2.1.1 Towards the synthesis of 338 via formation of isocyanate 335 
 
The condensation of carboxylic acids with isocyanates is a well-known reaction and 
the methodology developed by Crich et al. is appealing because it does not require 
thermal decomposition of the adduct (Scheme 110).118 
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Scheme 110 - Amide bond formation via isocyanates 
 
First 327 was treated with DDQ in order to remove the PMB-protecting group 
(Scheme 111). Attempts to convert alcohol 334 into the corresponding isocyanate 
derivatives were carried out using a method reported by Akhlaghinia et al.119 This 
variant of the Mitsunobu reaction involves the use of triphenylphosphine, DDQ and 
tetrabutylammonium cyanate (in this case DDQ proved to be a better reagent than the 
usual diethyl azodicarboxylate (DEAD) or diisopropyl azodicarboxylate (DIAD)). 
Following the procedure described by Akhlaghinia et al., and despite several trials, 
we were unable to isolate or even detect (NMR and mass spectrometry analysis) 
desired product 335.  
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Scheme 111 - Attempted synthesis of isocyanate 335 
 
Isocyanates derivatives are typically produced from amines and phosgene. However, 
we decided not to consider this option since it was in contradiction with why we 
chose to investigate this route: shorter access to amide deivatives 338 or 339. 
 
2.5.2.1.2 Towards the synthesis of 338 and 339 using a Yamaguchi reaction 
 
We undertook the synthesis of 338 and 339 in an analogous manner to the synthesis 
of amide 250. First 334 was converted to azide 336, by treatment with 
diphenylphosphorazidate and DBU in toluene at 80 ºC, in 65% yield (Scheme 112). 
The by-product resulting from a SN2’ was neither detected nor isolated. A possible 
cause for this moderate yield could be the required high temperature. In the hope to 
obtain a higher yield, we decided to follow the Mitsunobu procedure reported by 
Fürstner et al. for the synthesis of cruentaren A.15 334 was treated with 
triphenylphosphine, DIAD and a zinc azide/bis-pyridine complex, prepared in one 
step from commercially available sodium azide and zinc nitrate.120 Desired azide 336 
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was obtained in 85% yield. Finally, Staudinger reduction of azide 336 afforded amine 
337 in excellent yield.  
 
 
Scheme 112 - Synthesis of amine 337 
 
Difficulties were encountered to purify azide 336 and amine 337 because of their 
sensitivity towards acidic conditions. Indeed, NMR analysis showed that 336 and 337 
were subject to isomerization (disappearance of 22-H on the 1H NMR spectrum) 
(Scheme 113). Therefore, silica gel columns were flushed with a basic solution prior 
to purification and NMR spectra were recorded in deuterated dichloromethane instead 
of chloroform. Furthermore, amine 337 was found to be rather unstable (isomerisation 
and decomposition) and was therefore used with immediately for the subsequent 
amide formation. 
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Scheme 113 – Possible isomerisation of allylamine 337 to enamine 346 
 
Previously reported was the synthesis of amide 250 using the Yamaguchi method. 
Amide 251 was isolated too as a by-product and we supposed its formation was due to 
an excess of Yamaguchi reagent (Sub-section 2.2.3, Scheme 72). Taking these results 
into account, we decided to proceed to the formation of 338 in two steps: first 
formation and isolation of the mixed anhydride 347, then addition of 337. 
Unfortunately this procedure led to the exclusive formation of by-product 349. The 
regioselectivity of the nucleophilic attack on the Yamaguchi mixed anhydride is 
thought to be controlled by the steric hindrance of the aromatic part. Therefore we 
supposed that the steric hindrance caused by the TIPS-protecting group on 347 was 
responsible for this outcome. The reaction was repeated with acid 248 bearing a 
TBS-protecting group. Unfortunately by-product 349 was again the only product 
formed during this reaction (Scheme 114). 
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Scheme 114 - Attempted synthesis of 338 and 339 using Yamaguchi reaction 
 
2.5.2.1.3 Synthesis of 338 using coupling reagents 
 
Maier and Fürstner both reported the formation of this amide bond using coupling 
reagents.14,15 We only considered this method as our last option because of the 
possible generation of inseparable by-products. However, studies were initiated to 
find the best conditions for the formation of allylamide 338 (Scheme 115, Table 12). 
Coupling attempts using EDC and HOBt in dichloromethane (Table 12, Entry a) and 
dimethylformamide (Table 12, Entry b) were unsuccessful. Then we decided to use a 
more reactive uronium reagent, HBTU, in combination with HOBt. No reaction 
occurred in dichloromethane (Table 12, Entry c), however desired amide 338 was 
finally isolated in 67% yield when the reaction was carried out in dimethylformamide 
(Table 12, Entry d), giving the full skeleton of cruentaren A. 
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Scheme 115 - Synthesis of 338 using coupling reagents 
 
Entry Reagents and Conditions Results 
a EDC, HOBt, i-Pr2NEt in CH2Cl2 No reaction 
b EDC, HOBt, i-Pr2NEt in DMF No reaction 
c HBTU, HOBt, i-Pr2NEt in CH2Cl2 No reaction 
d HBTU, HOBt, i-Pr2NEt in DMF 338 (67%) 
Table 12 - Different conditions for the synthesis of 338 
 
2.5.2.2 Total synthesis of cruentaren A (6) 
 
At this stage, we needed to proceed to the full deprotection of 338 followed by 
Lindlar reduction of the alkyne moiety within the macrolactone. As mentioned earlier, 
the translactonization possible with 9-OH explains this strategy. First the methyl ether 
adjacent to the ester was cleaved using boron trichloride, leaving the other methyl 
ether intact. The use of boron trichloride as selective demethylating agent was first 
reported in 1966 by Dean et al.25 It was important to carry out this step before 
removal of the silyl protecting groups, as free hydroxy groups can deactivate boron 
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trichloride. The cleavage of the silyl groups was carried out with fluorosilicic acid in 
acetonitrile. The TBS- and TIPS-protecting groups, respectively at C-9 and C-25 were 
readily cleaved. However, the TBS-protecting group at C-15 required higher 
temperature (40 ºC) and longer reaction time (24 hours). This was presumably due to 
the steric hindrance. These conditions led to fully deprotected 351 in 76% yield 
(Scheme 116). 
 
 
Scheme 116 - Final deprotections 
 
Finally, strained cycloalkyne 351 was subjected to Lindlar hydrogenation, using 
quinoline as a poison to give cruentaren A (6) in 83% yield. Two batches afforded 
14 mg in total (Scheme 117). The spectroscopic and analytical data were matching 
with those reported for the natural product (Appendix 2, Appendix 3).12 
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Scheme 117 - Lindlar reduction and synthesis of cruentaren A (6) 
 
2.5.4 Summary 
 
To summarize, cruentaren A was successfully obtained using our key strategy. First, 
the synthesis of the core of cruentaren A was achieved on gram scale in three high 
yielding and reproducible steps from diketo-dioxinone 215 and alcohol 312. The 
successful synthesis of 330 and 331 and the stability of delicate functionalities during 
the generation of the resorcylate unit by aromatization proved that this biomimetic 
strategy developed by the Barrett group is a powerful tool towards the synthesis of 
RAL natural products. Equally rewarding is the fact that both Maier and Fürstner 
encountered major difficulties for the esterification step while only few adjustments 
were needed to find the right conditions for this aromatization. Furthermore, the 
choice of the catalyst for the RCAM was important and the use (pre)catalyst 100 gave 
access to macrolactone 327 showing the remarkable stability of this class of catalyst, 
recently introduced by Fürstner et al.33 After deprotection of 327 and conversion into 
the corresponding amine 337, the amide coupling was conducted using coupling 
agents and afforded allylamide 338. Finally, full deprotection of 338 and Lindlar 
reduction afforded cruentaren A (6) (Scheme 118). 
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Scheme 118 - Synthesis of cruentaren A (6) 
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3 Conclusion 
 
The total synthesis of cruentaren A was reported in 23 steps and 0.7% yield for the 
longest linear sequence. This synthesis showcases the biomimetic aromatization 
strategy developed within the Barrett group. Thus, the aromatic ring of cruentaren A 
was constructed using a ketene generation-trapping-aromatization cascade sequence 
featuring diketo-dioxinone 215 and alcohol 312 (Scheme 119). 
 
 
Scheme 119 - Key disconnections for cruentaren A 
 
Diketo-dioxinone 215 was prepared in 12 steps and 13% overall yield. Key features 
included a Brown crotylation to install the two stereocenters and a Seyferth-Gilbert 
homologation. Acid 201 was converted into diketo-dioxinone 215 in two steps 
following a procedure developed within the group for this class of compounds 
(Scheme 120). 
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Scheme 120 - Key steps for the synthesis of diketo-dioxinone 215 
 
The synthesis of alcohol 312, the most challenging fragment because of its 4 chiral 
centers, started with chiral pool (S)-Roche ester. The other stereocenters were set 
using an Evans aldol reaction and a Barbier type propargylation. 312 was obtained in 
13 steps and 7% overall yield (Scheme 121). 
 
 
Scheme 121 - Key steps for the synthesis of alcohol 312 
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The core structure of cruentaren A was constructed using the biomimetic 
aromatization strategy followed by RCAM (Scheme 122). The amide side chain was 
then installed using coupling reagents to afford 338. Final deprotection and Lindlar 
reduction afforded cruentaren A. In total 16 mg of cruentaren A (6) were obtained, 
which allowed full characterisation. Spectroscopic data were in full accordance with 
those reported for the natural product. 
 
 
Scheme 122 - Key steps for the synthesis of the core structure of cruentaren A (6) and 
completion of its synthesis 
 
OH
MeO
O
HO
O
NH
O
HO
HO
Cruentaren A
(6)
OMe
MeO
O
TIPSO
O
338
TBSO
NH
O
OTIPS
OMe
MeO
O
TIPSO
O
337
TBSO
NH2 HO
O OTIPS
247
OMe
MeO
O
TIPSO
O
327
TBSO
OPMB
O O
O
O O OTIPS
215
OH OTBS
312
OPMB
+
 141 
To conclude, using the biomimetic aromatization strategy allowed us to circumvent 
the difficulties encountered by Maier and Fürstner during the esterification step. We 
showed how effective was this method even when sterically hindered alcohol with 
sensitive functional groups, such as 312, were involved. This total synthesis of 
cruentaren A proves that the Barrett group has developed a highly general method for 
the synthesis of resorcylic acid lactones. Furthermore, since the resorcylate unit is a 
privileged pharmacophore, this strategy could facilitate the discovery of new 
medicines. 
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4 Experimental 
 
All manipulations of air or moisture sensitive materials were carried out in oven-dried 
glassware under an inert atmosphere of nitrogen or argon unless otherwise stated. 
Reaction temperatures other than rt were recorded as the bath temperature unless 
otherwise stated. Syringes, which were used to transfer reagents and solvents, were 
purged with nitrogen or argon prior to use. Reaction solvents were distilled under 
nitrogen from CaH2 (dichloromethane, MeOH, pyridine, triethylamine), Na/Ph2CO 
(tetrahydrofuran, diethyl ether), Na (toluene) or obtained as anhydrous from Sigma-
Aldrich (N,N-dimethylformamide, acetonitrile). Hexanes refers to BDH AnalaR® 
petroleum spirit 40-60 ºC. Water/H2O refers to distilled H2O. Other solvents and all 
reagents were obtained from commercial suppliers (Fluka, Sigma-Aldrich, Lancaster 
Chemicals, ABCR) and were used as obtained if purity was >98%. Flash column 
chromatographies were carried out on VWR silica gel 60, particle size 0.040-0.063 
mm unless otherwise stated. Thin layer chromatography (TLC) was performed on 
pre-coated aluminium backed or glass backed plates (Merck Kieselgel 60 F254), and 
visualised with ultraviolet light (366 nm and 254 nm) or potassium permanganate 
(KMnO4), vanillin or ninhydrine stains as deemed appropriate. 
 
Melting points: obtained using a Reichert-Thermovar melting point apparatus and are  
uncorrected.   
Infrared spectra: obtained using a Mattson 5000 FTIR apparatus with automatic  
background subtraction. Indicative features of each spectrum are given with  
adsorptions reported in wavenumbers (cm-1) 
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Proton magnetic resonance spectra (1H NMR): recorded at 400 MHz on Bruker 
DRX-400 spectrometers or at 125 MHz on an AM 500 spectrometer. All spectra are 
referenced to the residual solvent peak. Chemical shifts (δ) are quoted in parts per 
million (ppm) and coupling constants (J) recorded in Hertz (Hz).  
Carbon magnetic resonance spectra (13C NMR): recorded at 100 MHz on Brüker 
DRX-400 spectrometers or at 125 MHz on an AM 500 spectrometer. Chemical shifts 
(δ) are quoted in ppm and referenced to the residual solvent peak. Spectra recorded at 
500 MHz (1H NMR) and 125 MHz (13C NMR) were carried out by the Imperial 
College Department of Chemistry NMR service. 
Mass spectrometry: Low and high resolution mass spectra were recorded by Imperial 
College Mass Spectrometry Service using a Micromass Platform II and Micromass 
AutoSpec-Q spectrometer.  
Microanalysis: determined by the University of North London Analytical Service.  
Optical Rotations: recorded at 25 °C on a Perkin-Elmer 241 Polarimeter with a path 
length of 1 dm, using the 589.3 mn D-line of sodium. Concentrations (c) are quoted in 
g/100 mL.  
X-ray Diffraction: X-ray diffraction data were recorded by the Imperial College 
Department of Chemistry X-ray diffraction service.  
 
Note: carbon numbering is for NMR characterisation and does not necessarily follow 
the IUPAC rules. 
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3-(tert-Butyldimethylsilyl)oxy)propan-1-ol 
 
 
173’ 
 
To a solution of propane-1,3-diol (173) (20 g, 263 mmol) dissolved in THF (500 mL) 
was added NaH (60% in mineral oil, 10.5 g, 263 mmol). After stirring for 1 h, TBSCl 
(39.5 g, 263 mmol) was added portionwise and the reaction mixture was stirred for 
18 h. The reaction mixture was then quenched with water and the aqueous layer was 
extracted with Et2O (X 2). Combined organic layers were washed with a saturated 
solution of NH4Cl, dried (MgSO4), filtered and concentrated under reduced pressure. 
The crude mixture was purified by silica flash chromatography (20% Et2O in 
hexanes) to afford mono-protected alcohol 173’ (43 g, 86%) as a colourless oil. 
 
IR (neat): 3417, 2953, 2929, 2857, 1475, 1253, 1085, 833, 773 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 3.88-3.82 (m, 4H, 1-H2, 3-H2), 1.81 (tt, J = 5.6, 5.6 Hz, 2H, 
2-H2), 0.93 (s, 9H, TBS-H), 0.10 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) 
δ 63.0 (C-1), 62.5 (C-3), 34.1 (C-2), 25.8 (CTBS), 18.1 (CTBS), -5.4 (CTBS); 
MS (CI) m/z 191 [M+H]+; HRMS (CI) m/z calculated for C9H23O2Si [M+H]+ 
191.1467, found 191.1466. Match the literature data.59 
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3-[(tert-Butyldimethylsilyl)oxy]propanal 
 
 
172 
 
To a solution of oxalyl chloride (20 mL, 87 mmol) in CH2Cl2 (700 mL) was added 
DMSO (24 mL, 332 mmol) at -78 °C. The mixture was stirred for 15 min then 173’ 
(30 g, 158 mmol) dissolved in CH2Cl2 (50 mL) was added dropwise. The resulting 
mixture was stirred for 15 min then NEt3 (130 mL, 790 mmol) was added. The 
mixture was slowly allowed to reach 0 ºC and was quenched by addition of a 
saturated solution of NaHCO3. The aqueous layer was extracted with CH2Cl2 (X 2). 
The combined organic layers were washed with a saturated solution of CuSO4, brine 
and water, dried (MgSO4), filtered and concentrated under reduced pressure. The 
crude material was dissolved in hexanes and filtered over celite to afford the crude 
aldehyde 172 (27.5 g, 93%), which was used without any further purification. 
 
1H NMR (400 MHz, CDCl3) δ 9.82 (t, J = 2.1, 4.0 Hz, 1H, 3-H), 3.96 (t, J = 6.0 Hz, 
2H, 1-H2), 2.61 (dt, J = 6.0, 2.1 Hz, 2H, 2-H2), 0.88 (s, 9H, TBS-H), 0.08 (s, 6H, 
TBS-H); 13C NMR (100 MHz, CDCl3) δ 202.1 (C-3), 57.4 (C-1), 46.5 (C-2), 25.8 
(CTBS), 18.2 (CTBS), -5.4 (CTBS). Match the literature data.121 
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(3R,4S)-1-[(tert-Butyldimethylsilyl)oxy]-4-methylhex-5-en-3-ol 
 
 
171 
 
To a stirred mixture of potassium tert-butoxide (1 M in THF, 146 mL) and 
trans-2-butene (30 mL), was added n-BuLi (2.5 M in hexanes, 53 mL) at -78 °C. After 
complete addition of n-BuLi, the mixture was stirred at -45 °C for 10 min. The 
resulting solution was recooled to -78 °C, and (–)-(Ipc)2BOMe in THF (1 M, 175 mL) 
was added dropwise. The reaction mixture was stirred at -78 °C for 30 min, then 
BF3•Et2O (24 mL, 196 mmol) was added dropwise. The aldehyde 173 (27.5 g, 
146 mmol) was then added dropwise at -78 °C. The mixture was stirred at -78 °C for 
4 h and then treated with aqueous NaOH (3 M, 150 mL) H2O2 (50 wt. % in water, 
40 mL). The resulting mixture was refluxed for 1 h. The organic layer was separated, 
washed with water and brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The crude mixture was purified by silica flash chromatography (5% Et2O in 
hexanes) to afford the desired compound 171 (19.0 g, 74%) as a colourless oil. NMR 
of the crude material showed the presence of one diastereoisomer (dr ≥ 97:3). 
 
IR (neat): 3417, 2939, 2931, 2863, 1465, 1386, 1254, 1086, 832, 775, 671 cm-1; 
1H NMR (400 MHz, CDCl3) δ 5.86 (ddd, J = 17.7, 9.8, 7.8 Hz, 1H, 5-H), 5.18-5.08 
(m, 2H, 6-H2), 3.95-3.89 (m, 1H, 3-H), 3.86-3.70 (m, 2H, 1-H2), 2.33-2.23 (m, 1H, 
4-H) 1.68-1.62 (m, 2H, 2-H2), 1.07 (d, J = 6.9 Hz, 3H, 4-CH3), 0.89 (s, 9H, TBS-H); 
1
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0.07 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 140.8 (C-5), 115.1 (C-6), 75.1 
(C-3), 62.9 (C-1), 43.9 (C-4), 35.5 (C-2), 25.9 (CTBS), 18.2 (CTBS), 15.8 (4-CH3), 
-5.5 (CTBS); MS (CI) m/z 245 [M+H]+; HRMS (CI) m/z calculated for C13H29O2Si 
[M+H]+ 245.1937, found 245.1934; [α]D: -9.2 (c 2, CHCl3). Match the literature 
data.121 
 
 
(4R)-4-[(2S)-But-3-en-2-yl]-2,2-dimethyl-1,3-dioxane 
 
 
185 
 
A-To a solution of 171 (400 mg, 1.64 mmol) in THF (10 mL) was added TBAF (1 M, 
2 mL) at 0 °C and the reaction mixture was stirred for 1 h. The reaction was then 
quenched with a saturated solution of NH4Cl and the aqueous layer was extracted 
with Et2O (X 2). The combined organic layers were washed with brine, dried 
(MgSO4) filtered and evaporated to afford the crude product (170 mg, 84%), which 
was used straight away for the next step.  
 
1H NMR (400 MHz, CDCl3) δ 5.78-5.69 (m 1H, 5-H), 5.16-5.11 (m, 2H, 6-H2), 
3.90-3.79 (m, 2H, 1-H2), 3.64 (ddd, J = 9.4, 6.5, 2.8 Hz, 1H, 3-H), 2.28-2.19 (m, 1H, 
4-H), 1.80-1.62 (m, 2H, 2-H2), 1.03 (d, J = 6.7 Hz, 3H, 4-CH3). 
 
1
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B-To a mixture of acetone/dimethoxypropane (2.8 mL, 2:1) with 4 Å MS were added 
the previous crude product (170 mg, 1.31 mmol) and camphorsulfonic acid (30 mg, 
0.17 mmol. The reaction mixture was stirred for 18 h and quenched with a saturated 
solution of NaHCO3. The aqueous layer was extracted with Et2O (X 2) and combined 
organic layers were dried (MgSO4), filtered and concentrated under reduced pressure 
to afford 185 (5 mg, 2%). No NMR attempted. 
 
 
(7R)-7-[(2S)-But-3-en-2-yl]-2,2,3,3,10-pentamethyl-9,9-bis(propan-2-yl)-4,8-
dioxa-3,9-disilaundecane 
 
 
186 
 
To a solution of 171 (19 g, 78 mmol) dissolved in CH2Cl2 (500 mL) was added 
2,6-lutidine (19 mL, 195 mmol) followed by TIPSOTf (31 mL, 94 mmol) at 0 °C. The 
reaction mixture was stirred for 4 h then quenched with a saturated solution of NH4Cl. 
The aqueous layer was extracted with CH2Cl2 (X 2). The combined organic layers 
were dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
material was purified by silica flash chromatography (10% Et2O in hexanes) to afford 
186 (30 g, 97%) as a colourless oil. 
 
IR (neat): 2937, 2865, 1464, 1391, 1253, 1097, 883, 834 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 5.84-5.76 (m, 1H, 5-H), 5.03-4.96 (m, 2H, 6-H2), 3.98 (td, J = 6.1, 3.1 Hz, 
1
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1H, 3-H), 3.66 (m, 2H, 1-H2), 2.41-2.37 (m, 1H, 4-H) 1.65-1.60 (m, 2H, 2-H2), 1.07 
(s, 21H, TIPS-H), 1.05 (d, J = 6.9 Hz, 3H, 4-CH3), 0.88 (s, 9H, TBS-H); 0.03 (s, 6H, 
TBS-H); 13C NMR (100 MHz, CDCl3) δ 140.8 (C-5), 114.4 (C-6), 72.7 (C-3), 60.3 
(C-1), 43.2 (C-4), 36.5 (C-2), 25.9 (CTBS), 18.2 (CTBS, CTIPS), 14.5 (4-CH3), 12.9 
(CTIPS) -5.5 (CTBS); MS (ESI) m/z 401 [M+H]+; HRMS (ESI) m/z calculated for 
C22H49O2Si2 [M+H]+ 401.3271, found 401.3260; [α]D: +4.9 (c 2.1, CH2Cl2); Elem. 
Anal. Calculated for C22H48O2Si2 C 65.93, H 7.98, found C 66.00, H 8.05. 
 
 
(2S,3R)-1-[(tert-Butyldimethylsilyl)oxy)-2-methyl-3-{[tris(propan-2-
yl)silyl]oxy}pentan-1-ol 
 
 
187 
 
186 (2.9 g, 6.74mmol) was dissolved in CH2Cl2/MeOH (100 mL, 1:1) and O3 was 
bubbled through this solution at -78 °C until a characteristic blue colour appeared 
(15 min). The mixture was flushed with N2, then NaBH4 (2.0 g, 20.2 mmol) was 
added at -78 °C and the reaction mixture was slowly allowed to reach rt and stirred 
for 1 h. The reaction was quenched with water and the aqueous layer was extracted 
with CH2Cl2 (X 2). The combined organic layers were dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude material was purified by silica flash 
chromatography (10% EtOAc in hexanes) to afford 187 (1.9 g, 65%) as a colourless 
oil. 
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IR (neat): 3390, 2937, 2864, 1465, 1253, 1091, 832, 774, 673 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 4.15-4.11 (m, 1H), 3.80 (dd, J = 11.1, 4.1, Hz, 1H, 5-Ha), 
3.70-3.67 (m, 2H, 1-H2), 3.55 (dd, J = 11.1, 5.5 Hz, 1H, 5-Hb), 2.66 (br s, 1H, O-H), 
1.87-1.83 (m, 3H, 2-H2, 4-H), 1.1 (br s, 24H, TIPS-H, 4-CH3), 0.88 (s, 9H, TBS-H), 
0.04 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 74.3 (C-3), 65.0 (C-5), 60.0 
(C-1), 38.4 (C-4), 37.4 (C-2), 25.9 (CTBS), 18.2 (CTBS, CTIPS), 14.5 (4-CH3), 12.9 
(CTIPS) -5.5 (CTBS); MS (ES) m/z 405 [M+H]+; HRMS (ES) m/z calculated for 
C21H48O23Si2 [M+H]+ 405. 3220, found 405.3231; [α]D: +3.5 (c 2.3, CH2Cl2). 
 
 
(7R)-7-[(2R)-1-Iodopropan-2-yl]-2,2,3,3,10-pentamethyl-9,9-bis(propan-2-yl)-4,8-
dioxa-3,9-disilaundecane 
 
 
188 
 
To a solution of I2 (355 mg, 1.4 mmol), imidazole (140 mg, 2.0 mmol) and PPh3 
(370 mg, 1.4 mmol) in CH2Cl2 (5 mL) was added 187 (400 mg, 1.0 mmol). The 
reaction mixture was stirred at rt for 24 h and was then concentrated under reduced 
pressure. The crude material was dissolved in a minimum amount of CH2Cl2 then 
pentane was added and this solution was filtered through celite. The filtrate was 
concentrated under reduced pressure and the resulting crude material was dissolved in 
Et2O, washed with a saturated solution of NaHCO3, a saturated solution of Na2S2O3 
and brine. The organic layer was dried (MgSO4), filtered and concentrated under 
1
TBSO
3
5
OTIPS
I
 151 
reduced pressure. The crude material was purified by silica flash chromatography to 
afford 188 (280 mg, 63%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3) δ 4.09-4.05 (m, 1H, 3-H), 3.75-3.24 (m, 2H, 1-H2), 3.24 
(dd, J = 9.8, 5.8, Hz, 1H, 5-Ha), 3.07 (dd, J = 9.8, 8.3 Hz, 1H, 5-Hb), 2.05-1.96 (m, 
1H, 4-H), 1.71-1.62 (m, 2H, 2-H2), 1.1 (br s, 24H, TIPS-H, 4-CH3), 0.88 (s, 9H, 
TBS-H); 0.04 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 71.5 (C-3), 59.8 (C-1), 
41.6, 30.9, 25.9 (CTBS), 18.3 (CTBS, CTIPS), 16.1 (4-CH3), 12.9 (CTBS), 10.9 
(C-5), -5.4 (CTBS); MS (ES) m/z 515 [M+H]+; HRMS (ES) m/z calculated for 
C21H48O2Si2I [M+H]+ 515.2238, found 515.2258. 
 
 
(7R)-7-[(2R)-1-Bromopropan-2-yl]-2,2,3,3,10-pentamethyl-9,9-bis(propan-2-yl)-
4,8-dioxa-3,9-disilaundecane 
 
 
189 
 
To a solution of 187 (0.8 g, 1.9 mmol) and CBr4 (0.8 g, 2.4 mmol) in CH2Cl2 (10 mL) 
was added PPh3 (1.0 g, 3.8 mmol). The reaction mixture was stirred for 18 h then 
Et2O was added. The mixture was filtered over celite and the resulting filtrate was 
concentrated under reduced pressure. The crude mixture was purified by silica flash 
chromatography (5% Et2O in hexanes) to afford 189 (0.45 mg, 51%) as a light yellow 
oil.  
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1H NMR (400 MHz, CDCl3) δ 4.20-4.12 (m, 1H, 3-H), 3.75-3.72 (m, 2H, 1-H2), 3.47 
(dd, J = 9.8, 5.8 Hz, 1H, 5-Ha), 3.30 (dd, J = 9.8, 8.3 Hz, 1H, 5-Hb), 2.15-2.03 (m, 
1H, 4-H), 1.70-1.62 (m, 2H, 2-H2), 1.04 (br s, 24H, TIPS-H, 4-CH3), 0.90 (s, 9H, 
TBS-H); 0.05 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 71.7 (C-3), 59.8 (C-5), 
41.3, 36.9, 36.0, 25.9 (CTBS), 18.3 (CTBS, CTIPS), 14.8 (4-CH3), 12.9 (CTBS), -5.4 
(CTBS); MS (ES) m/z 267 and 269 [M+H]+. 
 
 
 (7R)-7-[(2S)-Hex-4-yn-2-yl]-2,2,3,3,10-pentamethyl-9,9-bis(propan-2-yl)-4,8-
dioxa-3,9-disilaundecane 
 
 
193 
 
Procedure A 
To a solution of propyne (190) (36 µL, 0.63 mmol) dissolved in THF (3 mL) was 
added dropwise n-BuLi (1.6 M in hexanes, 0.5 mL) at 0 °C. The reaction mixture was 
stirred for 30 min, then HMPA (0.3 mL) was added, followed by 188 (65 mg, 
0.15 mmol). The reaction mixture was slowly allowed to reach rt, was stirred for 
another hour and quenched by addition of a saturated solution of NH4Cl. The aqueous 
layer was extracted with Et2O (X 2) and the combined organic layers were washed 
with a saturated solution of LiCl and brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. The crude material was purified by silica flash 
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chromatography (10% Et2O in hexanes) to afford by-product 195 (no reproducible 
yield) as a light yellow oil. The desired product 193 was not isolated.  
 
Procedure B 
To a solution of bromopropene (192) (36 µL, 0.63 mmol) dissolved in THF (3 mL) 
was added dropwise n-BuLi (1.6 M in hexanes, 0.5 mL) at 0 °C. The reaction mixture 
was stirred for 30 min, then 188 (65 mg, 0.15 mmol) was added. The reaction mixture 
was slowly allowed to reach rt, was stirred for another hour and then quenched by 
addition of a saturated solution of NH4Cl. The aqueous layer was extracted with Et2O 
(X 2) and the combined organic layers were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude material was purified by 
silica flash chromatography (10% Et2O in hexanes) to afford by-product 189 as a light 
yellow oil. Desired product 188 was not isolated. 
 
 
(7R)-2,2,3,3,10-pentamethyl-7-(prop-1-en-2-yl)-9,9-bis(propan-2-yl)-4,8-dioxa-
3,9-disilaundecane 
 
 
195 
 
1H NMR (400 MHz, CDCl3) δ 4.78 (s, 1H, 5-Ha), 4.72 (s, 1H, 5-Hb), 4.29 (dd, 
J = 7.5, 5.4 Hz, 1H, 3-H), 3.59-3.42 (m, 2H, 1-H2), 1.80-1.57 (m, 2H, 2-H2), 1.63 (s, 
3H, 4-CH3), 1.05-1.03 (m, 21H, 4-CH3), 0.90 (s, 9H, TBS-H), -0.03 (s, 3H, TBS-H), 
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-0.04 (s, 3H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 147.0 (C-4), 111.1 (C-5), 74.0 
(C-3), 59.6 (C-5), 39.0 (C-2), 25.9 (CTBS), 18.2 (CTBS, CTIPS), 16.7 (4-CH3), 12.4 
(CTBS), -5.4 (CTBS). 
 
 
(7R)-2,2,3,3,10-Pentamethyl-9,9-bis(propan-2-yl)-7-[(2S)-5-
(trimethylsilyl)pent-4-yn-2-yl]-4,8-dioxa-3,9-disilaundecane 
 
 
194 
 
Procedure A 
To a solution of TMS-acetylene (191) (0.1 mL, 0.8 mmol) dissolved in THF (1 mL) 
was added dropwise n-BuLi (1.6 M in hexanes, 0.33 mL) at 0 °C. The reaction 
mixture was stirred for 30 min, then HMPA (0.4 mL) was added, followed by 188 
(120 mg, 0.38 mmol). The reaction mixture was slowly allowed to reach rt, however 
TLC analysis showed no conversion and starting material 188 was recovered.  
 
Procedure B 
To a mixture of 189 (150 mg, 0.3 mmol), Pd2(dba)3 (10 mg, 15 mol %) and PPh3 
(50 mg, 60 mol %) in THF (1 mL) was added at 60 ºC a solution of TMS-acetylene 
(191) (32 µL, 0.32 mmol) and n-BuLi (1.6 M in hexanes, 128 µL) in THF (1 mL). The 
resulting mixture was stirred at 60 ºC for 24 h. After this time TLC analysis showed 
no conversion and starting material 189 was recovered. 
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(3S,4R)-6-[tert-Butyldimethylsilyl)oxy]-3-methyl-4-{[tris(propan-2-
yl)silyl]oxy}hexan-1-ol 
 
 
202 
 
To a solution of 186 (18.0 g, 45 mmol) in THF (150 mL) was slowly added BH3•THF 
(1 M, 135 mL) at 0 °C. The reaction mixture was allowed to reach rt and stirred for 
18 h. After cooling to 0 ºC, the reaction mixture was slowly cannulated to aqueous 
NaOH (2.5 M, 300 mL) at 0 °C, then aqueous H2O2 (30 wt. %, 150 mL) was added 
and the reaction mixture was stirred for another hour at rt. The mixture was diluted 
with Et2O, and the organic layer was washed with a saturated solution of NaHCO3 
and brine, dried (MgSO4), filtered and concentrated under reduced pressure. The 
crude material was purified by silica flash chromatography (20% Et2O in hexanes) to 
afford 202 as a colourless oil (15.4 g, 82%). 
 
IR (neat): 3330, 2934, 2864, 1464, 1384, 1253, 1092, 1052, 1005, 940, 832, 774, 674 
cm-1; 1H NMR (400 MHz, CDCl3) δ 3.97 (br s, 1H, 3-H), 3.75-3.58 (m, 4H, 1-H2, 
6-H2), 1.86-1.50 (m, 5H, 2-H2, 4-H, 5-H2), 1.08 (s, 21H, TIPS-H), 1.01 (d, J = 
6.9 Hz, 3H, 4-CH3), 0.88 (s, 9H, TBS-H), 0.04 (s, 6H, TBS-H); 13C NMR (100 MHz, 
CDCl3) δ 73.2 (C-3), 60.6 (CH2), 60.2 (CH2), 36.1 (C-2), 35.0 (C-4, C-5), 25.8 
(CTBS), 18.3 (CTIPS, CTBS), 15.0 (4-CH3), 12.9 (CTIPS), -5.4 (CTBS); MS (ESI) 
m/z 419 [M+H]+; HRMS (ESI) m/z calculated for C22H51O3Si2 [M+H]+ 419.3377, 
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found 419.3366; [α]D: +9.1 (c 2.2, CH2Cl2); Elem. Anal. Calculated for C22H50O3Si2 
C 63.09, H 12.03, found C 63.15, H 12.05 
 
(3S,4R)-6-[tert-Butyldimethylsilyl)oxy]-3-methyl-4-{[tris(propan-2-
yl)silyl]oxy}hexanal 
 
 
203 
 
To a solution of IBX (9.0 g, 30 mmol) dissolved in DMSO (50 mL) and stirred for 
approximately 10 min, was added 202 (6.5 g, 15.5 mmol) dissolved in DMSO (10 
mL). The reaction mixture was stirred for 4 h and was then filtered. The filtrate was 
diluted with Et2O and washed with water. The organic layer was dried (MgSO4), 
filtered and concentrated under reduced pressure. The resulting crude material was 
filtered on a short pad of silica (5% Et2O in hexanes) to afford 203 (4.8 g, 74%) as a 
colourless oil. 
 
IR (neat): 2940, 2864, 2712, 1727, 1464, 1252, 1093, 1049, 832, 774, 668 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 9.78 (s, 1H, 6-H), 3.94 (dt, J = 6.1, 2.8 Hz, 1H, 3-H), 3.67 
(d, J = 6.1 Hz, 2H, 1-H2), 2.32-2.23 (m, 2H, 5-H2), 1.77-1.48 (m, 3H, 2-H2, 4-H), 1.07 
(s, 21H, TIPS-H), 1.02 (d, J = 6.9 Hz, 3H, 4-CH3), 0.88 (s, 9H, TBS-H); 0.03 (s, 6H, 
TBS-H); 13C NMR (100 MHz, CDCl3) δ 202.0 (C-6), 73.2 (C-3), 59.8 (C-1), 46.3 
(C-5), 36.8 (C-2), 32.9 (C-4), 25.9 (CTBS), 18.3 (CTBS, CTIPS), 16.3 (4-CH3), 12.9 
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(CTIPS), -5.4 (CTBS); MS (ESI) m/z 417 [M-H]+; HRMS (ESI) m/z calculated for 
C22H49O3Si2 [M+H]+ 417.3220, found 417.3213. 
 
 
Dimethyl-1-diazi-2-oxopropylphosphonate 
 
 
206 
 
To a solution of dimethyl (2-oxopropyl)phosphonate (205) (25.0 g, 150 mmol) in a 
mixture of PhMe/THF (750 mL, 8:2) was slowly added NaH (60% in mineral oil) 
(6.6 g, 165 mmol) at 0  ºC. After 1 h, 4-acetamido-benzenesulfonyl azide (40.0 g, 
165 mmol) was added and the resulting mixture was stirred for 12 h. After filtration 
over celite, the filtrate was concentrated under reduced pressure. The crude mixture 
was purified by silica flash chromatography (50% EtOAc in hexanes) to afford 206 
(15 g, 51%) as a light yellow oil. Match the literature data.122 
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(7R)-2,2,3,3,10-Pentamethyl-7-[(2S)-pent-4-yn-2-yl]-9,9-bis(propan-2-yl)-4,8-
dioxa-3,9-disilaundecane 
 
 
207 
 
To a solution of 203 (4.7 g, 11.3 mmol) and anhydrous K2CO3 (5.7 g, 33.9 mmol) in 
MeOH (200 mL) was added freshly prepared Bestmann-Ohira diazophosphonate 206 
(5.7 g, 22.6 mmol). The solution was stirred at rt and rapidly turned milky green. 
After 3 h, the solution was diluted with Et2O. The organic layer was washed with 
water and brine, dried (MgSO4), filtered and concentrated under reduced pressure. 
The crude material was purified by silica flash chromatography (5% Et2O in hexanes) 
to afford 207 (4.3 g, 92%) as a colourless oil. 
 
IR (neat): 3318, 2950, 2930, 2898, 2869, 1467, 1390, 1256, 1092, 1011, 939, 882, 
834, 777, 680 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.02 (dt, J = 6.2, 3.8 Hz, 1H, 3-H), 
3.70-3.64 (m, 2H, 1-H2), 2.18 (ddd, J = 16.8, 6.3, 2.6 Hz, 1H, 5-Ha), 2.05 (ddd, 
J = 16.8, 8.2, 2.6 Hz, 1H, 5-Hb), 1.91 (t, J = 2.6 Hz, 1H, 7-H), 1.90-1.85 (m, 1H, 
4-H), 1.64-1.54 (m, 2H, 2-H2), 1.04 (s, 21H, TIPS-H), 1.00 (d, J = 6.8 Hz, 3H, 
4-CH3), 0.86 (s, 9H, TBS-H); 0.01 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) 
δ 83.8 (C-6), 72.2 (C-3), 69.0 (C-7), 60.0 (C-1), 38.0 (C-4), 36.0 (C-2), 25.9 (CTBS), 
21.4 (C-5), 18.3 (CTIPS, CTBS), 15.1 (4-CH3), 12.9 (CTIPS), -5.4 (CTBS); MS (ESI) 
m/z 413 [M+H]+; HRMS (ESI) m/z calculated for C23H49O2Si2 [M+H]+ 413.3271, 
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found 413.3271; [α]D: +5.4 (c 2.6, CH2Cl2); Elem. Anal. Calculated for C23H48O2Si2 
C 66.92, H 11.72, found C 66.94, H 12.00. 
 
 
 (7R)-7-[(2S)-Hex-4-yn-2-yl]-2,2,3,3,10-pentamethyl-9,9-bis(propan-2-yl)-4,8-
dioxa-3,9-disilaundecane 
 
 
193 
 
To a solution of 207 (4.3 g, 10.4 mmol) in THF (60 mL) cooled to -78 °C was slowly 
added n-BuLi (2.5 M in hexanes, 6.2 mL). After 45 min, MeI (1.3 mL, 20.8 mmol) 
was added and the reaction mixture was stirred at rt for 3 h. The reaction was then 
quenched by addition of a saturated solution of NH4Cl and the aqueous layer was 
extracted with Et2O (X 2). Combined organic layers were washed with brine, dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude material was 
purified by silica flash chromatography (5% Et2O in hexanes) to afford 193 (4.0 g, 
90%) as a colourless oil. 
 
IR (neat): 3317, 2937, 2865, 1465, 1391, 1363, 1253, 1097, 834, 376 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 4.09-4.05 (m, 1H, 1-H), 3.75-3.66 (m, 2H, 3-H2), 2.12-1.98 (m, 
2H, 5-H2), 1.91-1.81 (m, 1H, 4-H), 1.76 (t, J = 2.4 Hz, 3H, 7-CH3), 1.63-1.58 (m, 2H, 
2-H2), 1.07 (s, 21H, TIPS-H), 0.97 (d, J = 6.8 Hz, 3H, 4-CH3), 0.86 (s, 9H, TBS-H), 
0.01 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 78.2 (C-6), 76.2 (C-7), 71.9 
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(C-3), 60.2 (C-1), 38.7 (C-4), 35.6 (C-2), 25.9 (CTBS), 22.0 (C-5), 18.2 (CTBS, 
CTIPS), 14.8 (4-CH3), 12.9 (CTIPS), 3.5 (7-CH3), -5.4 (CTBS); MS (ESI) m/z 427 
[M+H]+; HRMS (ESI) m/z calculated for C24H51O2Si2 [M+H]+ 427.3428, found 
427.3415; [α]D: +8.1 (c 1.8, CH2Cl2). 
 
 
(3R,4S)-4-methyl-3-{[tris(propan-2-yl)silyl]oxy}oct-6-yn-1-ol 
 
 
208 
 
To a solution of 193 (4.0 g, 9.4 mmol) in MeOH (100 mL) was added p-TsOH (0.9 g, 
4.7 mmol) at 0 °C. The mixture was stirred for 2 h at rt and was then quenched by 
addition of NaHCO3 (1.5 g). The mixture was stirred for 10 min then filtered and the 
resulting filtrate was concentrated under reduced pressure. The crude material was 
diluted with Et2O and washed with brine. The organic layer was dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude material was purified by 
silica flash chromatography (10% Et2O in hexanes) to afford 208 (2.7 g, 92%) as a 
colourless oil.  
 
IR (neat): 3347, 2942, 2866, 1463, 1384, 1092, 1060, 1034, 882, 676 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 4.17-4.13 (m, 1H, 3-H), 3.80 (t, J = 6.3 Hz, 2H, 1-H2), 2.08-2.05 
(m, 2H, 5-H2), 1.95-1.89 (m, 1H, 4-H), 1.76 (t, J = 2.5 Hz, 3H, 7-CH3), 1.71-1.67 (m, 
2H, 2-H2), 1.09 (s, 21H, TIPS-H), 0.97 (d, J = 6.8 Hz, 3H, 4-CH3); 
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13C NMR (100 MHz, CDCl3) δ 77.7 (C-6), 77.2 (C-7), 73.5 (C-3), 60.7 (C-1), 38.6 
(C-4), 34.0 (C-2), 22.6 (C-5), 18.2 (CTIPS), 14.4 (4-CH3), 13.0 (CTIPS), 3.4 (7-CH3), 
-5.4 (CTBS); MS (ESI) m/z 313 [M+H]+; HRMS (ESI) m/z calculated for C18H37O2Si 
[M+H]+ 313.2563, found 313.2547; [α]D: +8.1 (c 1.8, CH2Cl2). 
 
 
 (3R,4S)-4-Methyl-3-{[tris(propan-2-yl)silyl]oxy}oct-6-ynoïc acid 
 
 
201 
 
Procedure A 
A-To a solution of IBX (800 mg, 1.46 mmol) dissolved in DMSO (2.5 mL) and 
stirred for approximately 10 min, was added 208 (227 mg, 0.73 mmol) dissolved in 
DMSO (0.5 mL). The reaction mixture was stirred for 4 h and was then filtrated. The 
filtrate was diluted with Et2O and washed with water. The organic layer was dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting crude 
material was filtered on a short pad of silica (5% Et2O in hexanes) to afford 209 
(201 mg, 89%) as a colourless oil. 
B-To a solution of 209 (201 mg, 0.65 mmol) dissolved in THF/tert-butanol (9 mL, 
2:1) was added 2-methyl-2-butene (616 µL, 5.8 mmol), followed by a mixture of 
NaClO2 (145 mg, 1.6 mmol) and NaH2PO4•H2O (193 mg, 1.4 mmol) dissolved in 
water (3 mL). The yellow reaction mixture was then stirred for 1 hour, carefully 
quenched by addition of aqueous HCl (1 M) and diluted with Et2O. The aqueous layer 
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was extracted with Et2O (X 2) and the combined organic layers were dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude material was purified by 
silica flash chromatography (20% EtOAc in hexanes) to afford 201 (180 mg, 90%) as 
a yellow oil. 
 
Procedure B 
To a solution of 208 (2.5 g, 8 mmol) dissolved in MeCN (60 mL) and cooled to 0 ºC 
were added phosphate buffer (pH = 7, 60 mL), NaClO2 (1.8 g, 20.0 mmol), TEMPO 
(0.1 g, 0.64 mmol), and aqueous NaClO (few drops) at 0 ºC. After 20 min, the 
reaction was quenched by addition of a saturated solution of Na2S2O3. The aqueous 
layer was extracted with EtOAc (X 2) and the combined organic layers were washed 
with water, dried (MgSO4), filtered and concentrated under reduced pressure. The 
crude material was purified by silica flash chromatography (20% in EtOAc) to afford 
201 (2.0 g, 79%) as a colourless oil. 
 
IR (thin layer): 2948, 2926, 2869, 1712, 1467, 1300, 1090, 1068, 1002, 948, 882, 750 
cm-1; 1H NMR (400 MHz, CDCl3) δ 4.46-4.42 (m, 1H, 3-H), 2.54 (ddq, J = 15.6, 5.2, 
2.4 Hz 1H, 5-Ha), 2.47 (ddq, J = 15.6, 6.4, 2.4 Hz, 1H, 5-Hb), 2.10-2.08 (m, 2H, 
2-H2), 2.00-1.94 (m, 1H, 4-H), 1.50 (t, J = 2.4 Hz, 3H, 7-CH3), 1.08 (s, 21H, 
TIPS-H), 1.00 (d, J = 6.8 Hz, 3H, 4-CH3); 13C NMR (100 MHz, CDCl3) δ 176.5 
(C-1), 77.2 (C-6), 77.1 (C-7), 71.8 (C-3), 39.0 (C-4), 37.6 (C-2), 22.4 (C-5), 18.1 
(CTIPS), 14.4 (4-CH3), 12.7 (CTIPS), 3.4 (7-CH3); MS (ESI) m/z 325 [M-H]+; 
HRMS (ESI) m/z calculated for C18H33O3Si [M-H]+ 325.2199, found 325.2200; 
[α]D: +3.5 (c 0.8, CHCl3); Elem. Anal. Calculated for C18H34O3Si C 66.21, H 10.49, 
found C 66.26, H 10.39. 
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(3R,4S)-N-methoxy-N,4-dimethyl-3-{[tris(propan-2-yl)silyl]oxy}oct-6-ynamide 
 
 
213 
 
To a solution of 201 (2.5 g, 7.7 mmol), N-methoxy-N-methylamine (1.0 g, 10 mmol) 
and PyBOP (4.0 g, 8 mmol) in CH2Cl2 (20 mL) was added i-Pr2NEt (4.0 mL, 23 
mmol) at 0 °C. The reaction was allowed to warm to rt and stirred for 30 min. The 
reaction mixture was poured into Et2O, and the organic layer was washed with 
aqueous HCl (1 M), a saturated solution of NaHCO3 and brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude oil was purified by silica 
flash chromatography (20% EtOAc in hexanes) to afford 213 as a colourless oil 
(2.1 g, 74%). 
 
IR (neat): 2935, 2926, 2866, 1664, 1383, 1181, 1093, 1064, 1013, 940, 882, 741, 674 
cm-1; 1H NMR (400 MHz, CDCl3) δ 4.53 (ddd, J = 7.5, 4.8, 3.3 Hz, 1H, 3-H), 3.69 (s, 
3H, N-CH3), 3.16 (s, 3H, O-CH3), 2.63 (dd, J = 15.2, 7.5 Hz, 1H, 2-Ha), 2.42 (dd, 
J = 15.2, 4.8 Hz, 1H, 2-Hb), 2.17-1.96 (m, 2H, 5-H2), 1.95-1.90 (m, 1H, 4-H), 1.77 (t, 
J = 2.44 Hz, 3H, 7-CH3), 1.09 (s, 21H, TIPS-H), 1.02 (d, J = 6.70 Hz, 3H, 4-CH3); 
13C NMR (100 MHz, CDCl3) δ 77.8 (C-6), 73.5 (C-7), 71.5 (C-3), 61.2 (O-CH3), 39.3 
(C-4), 35.1 (C-2), 32.1 (N-CH3), 22.0 (C-5), 18.1 (CTIPS), 14.6 (4-CH3), 12.7 
(CTIPS), 3.5 (7-CH3), (C-1 missing); MS (ESI) m/z 370 [M-H]+; HRMS (ESI) m/z 
calculated for C20H40NO3Si [M+H]+ 370.2777, found 370.2771 ; [α]D: +16.3 (c 0.3, 
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CHCl3); Elem. Anal. Calculated for C20H39O3Si C 64.99, H 10.64, N 3.79, found 
C 65.12, H 10.71, N 3.82. 
 
 
2,2-Dimethyl-6-(2-oxopropyl)-2,4-dihydro-1,3-dioxin-4-one 
 
 
150 
 
To a solution of dioxinone 114 (3.0 g, 21 mmol) in THF (60 mL) was added LiHMDS 
(1 M in THF, 21 mL) at -78 ºC. The reaction mixture was stirred for 1 h, then AcCl 
(0.9 mL, 12,6 mmol) was added. The reaction mixture was stirred for another 30 min 
at -78 ºC and then poured into aqueous HCl (1 M). The aqueous layer was extracted 
with Et2O (X 2) and the combined organic layers were washed with brine, dried 
(MgSO4) and concentrated under reduced pressure. The crude material was purified 
by silica flash chromatography (50% Et2O in hexanes to give 150 (2.1 g, 55%) as a 
pale yellow solid. 
 
mp: 46-50 ºC (hexanes/CH2Cl2); IR (neat): 1733, 1714, 1639, 1379, 1317, 1270, 
1253, 1197, 1160, 904, 862, 821, 794 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.31 (s, 
1H, 2-H), 3.31 (s, 2H, 4-H), 2.21 (s, 3H, 6-H), 1.68 (s, 6H, 7-CH3); 13C NMR 
(100 MHz, CDCl3) δ 201.0, 164.5, 160.8, 107.4, 96.9, 48.2, 30.3, 25.2; HRMS (CI) 
m/z calculated for C9H13O4 [M+H]+ 185.0814, found 185.0812. 
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 (6R,7S)-1-(2,2-Dimethyl-6-oxo-2,6-dihydro-1,3-dioxin-4-yl)-7-methyl-6-
{[tris(propan-2-yl)silyl]oxy}undec-9-yne-2,4-dione 
 
 
215 
 
To a freshly prepared solution of LDA (27.8 mmol) in THF (25 mL) was added 
keto-dioxinone 150 (2.4 g, 12.8 mmol) at -78 °C. After 30 min at -40 °C the reaction 
mixture was cooled to -78 °C and Et2Zn (1 M in THF, 25.7 mL) was added. After 
another 30 min at -40 °C, 213 (1.6 g, 4.28 mmol) was added. The mixture was stirred 
for 4 h at a temperature comprises between -5 °C. After this time the mixture was 
quenched with aqueous HCl (1 M) and diluted with EtOAc (X 2). The combined 
organic layers were washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. The crude material was purified by silica flash 
chromatography (10 to 20% Et2O in hexanes) to afford 215 (1.4 g, 67%) as a light 
yellow oil.  
 
IR (neat): 2938, 2920, 2866, 1731, 1604, 1378, 1271, 1014, 882 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 15.1 (br s, 1H, O-H), 5.63 (s, 1H), 5.40 (s, 1H), 4.47-4.43 (m, 
1H, 9-H), 3.19 (s, 2H), 2.42 (dd, J = 14.2, 4.7 Hz, 1H, 8-Ha), 2.34 (dd, J = 14.2, 
7.8 Hz, 1H, 8-Hb), 2.07-2.05 (m, 2H, 11-H2), 1.96-1.89 (m, 1H, 10-H), 1.77 (t, 
J = 2.46 Hz, 3H, 13-CH3), 1.7 (s, 6H, 14-(CH3)2), 1.04 (s, 21H, TIPS-H), 0.97 (d, 
J = 6.83 Hz, 3H, 10-CH3); 13C NMR (100 MHz, CDCl3) δ 190.9, 188.3, 165.0, 160.7, 
107.1, 101.5, 96.4, 77.2 (C-12), 76.8 (C-13), 72.1 (C-9), 43.5, 41.2, 39.1, 25.0 
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(14-(CH3)2), 22.2, 18.1 (CTIPS), 14.4 (CH3), 12.7 (CTIPS), 3.5 (CH3); MS (ESI) m/z 
493 [M+H]+; HRMS (ESI) m/z calculated for C27H45O6Si [M+H]+ 493.2985, found 
493.3003; Elem. Anal. Calculated for C27H44O6Si C 65.82, H 9.00, found C 65.75, H 
8.99; [α]D: +9.5 (c 0.6, CHCl3). 
 
 
4-Chloro-2-yn-1-ol 
 
 
222 
 
To a solution of 2-butyne-1,4-diol (221) (10 g, 116.2 mmol) dissolved in pyridine 
(10 mL, 127.8 mmol) and PhMe (20 mL) was added dropwise thionyl chloride (9 mL, 
127.8 mmol) at 10 °C. The reaction mixture was then slowly allowed to reach rt and 
was stirred for 18 h. The reaction was quenched with iced-water and the aqueous 
layer was extracted with Et2O (X 3). The combined organic layers were washed with 
a saturated solution of NaHCO3 and brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. The crude material was purified by distillation (0.5 mmHg, 
84 °C oil bath) to afford 222 (2.2 g, 40%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3) δ 4.29 (t, J = 2.0 Hz, 2H, 4-H2), 4.16 (t, J = 2.0 Hz, 2H, 
1-H2), 1.75 (br s, 1H, O-H); 13C NMR (100 MHz, CDCl3) δ 84.7 (C), 80.4 (C), 
50.9(C-4), 30.0 (C-1). 
Match the literature data.80 
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tert-Butyl[(4-chlorobut-2-yn-1-yl)oxy]dimethylsilane 
 
 
223 
 
To a solution of 222 (1.5 g, 14.3 mmol) dissolved in CH2Cl2 (20 mL) were added 
NEt3 (4 mL, 28.6 mmol) and DMAP (0.2 g, 1.4 mmol). The solution was cooled to 
0 °C and TBSCl (3.0 g, 20 mmol) dissolved in CH2Cl2 (20 mL) was added dropwise. 
The reaction mixture was slowly allowed to reach rt and stirred for 5 h. The reaction 
was quenched by addition of a saturated solution of NH4Cl. The aqueous layer was 
extracted with CH2Cl2 (X 2) and the combined organic layers were washed with brine, 
dried (MgSO4) and concentrated under reduced pressure. The crude material was 
purified by silica flash chromatography (10% EtOAc in hexanes) to afford 223 (1.9 g, 
60%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3) δ 4.38 (t, J = 2.0 Hz, 2H, 4-H2), 4.19 (t, J = 2.0 Hz, 2H, 
1-H2), 0.93 (s, 9H, TBS-H), 0.14 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) 
δ 84.7 (C), 80.4 (C), 51.4 (C-4), 30.4 (C-1), 25.8 (CTBS), 18.4 (CTBS), -5.4 (CTBS). 
Match the literature data.123 
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4-[(tert-Butyldimethylsilyl)oxy]but-2-yn-1-ol 
 
 
225 
 
To a solution of 2-butyne-1,4 diol (221) (80 g, 930 mmol) dissolved in CH2Cl2 
(700 mL) was added imidazole (32 g, 465 mmol). The solution was cooled to 0 °C 
and TBSCl (35 g, 233 mmol) dissolved in CH2Cl2 (300 mL) was added dropwise. The 
reaction mixture was slowly allowed to reach rt and stirred for 18 h. The reaction 
mixture was filtered and half of the filtrate was concentrated under reduced pressure. 
The resulting solution was washed with water. The aqueous layer was extracted with 
CH2Cl2 (X 2) and the combined organic layers were washed with a saturated solution 
of NH4Cl, dried (MgSO4), filtered and concentrated under reduced pressure to afford 
a mixture of the desired mono-protected alcohol and of the di-protected alcohol. The 
crude material was purified by silica flash chromatography (5% Et2O in hexanes) to 
afford mono-protected alcohol 225 (28 g, 63%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3) δ 4.38 (t, J = 2.0 Hz, 2H), 4.33 (t, J = 2.0 Hz, 2H), 0.94 
(s, 9H, TBS-H); 0.15 (s, 6H, TBS-H); 13C NMR (400 MHz, CDCl3) δ 84.2 (C), 82.8 
(C), 51.6 (CH2), 51.0 (CH2), 25.6 (CTBS), 18.1 (CTBS), -5.3 (CTBS). Match the 
literature data.124 
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tert-Butyl[(4-iodobut-2-yn-1-yl)oxy]dimethylsilane 
 
 
224 
 
Procedure A 
To a solution of NaI (2.4 g, 15.8 mmol) dissolved in acetone was added 223 (2.3 g, 
10.5 mmol) and the reaction mixture was stirred for 12 h. The mixture was then 
filtered and concentrated under reduced pressure. The resulting crude oil was 
dissolved in a minimum amount of CHCl3 and hexanes was added. The precipitate 
was filtered and the resulting solution was concentrated under reduced pressure to 
afford 224 (1.2 g, 50%) as a mixture with starting material 223 (7:3). 
 
Procedure B 
To a solution of 225 (33 g, 147 mmol) dissolved in THF (300 mL) were added 
imidazole (25 g, 3.7 mmol), PPh3 (46 g, 176.4 mmol) and iodine (48.5 g, 
191.1 mmol). The reaction mixture was stirred for 30 min then concentrated under 
reduced pressure. The resulting crude product was purified by silica flash 
chromatography (5% EtOAc in hexanes) to afford 224 (28 g, 72%) as a pale yellow 
oil. 
 
1H NMR (400 MHz, CDCl3) δ 4.34 (t, J = 2.0 Hz, 2H, 4-H2), 3.74 (t, J = 2.0 Hz, 2H, 
1-H2), 0.93 (s, 9H, TBS-H); 0.14 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) 
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δ 83.9 (C), 81.5 (C), 51.9 (C-4), 25.8 (CTBS), 18.3 (CTBS), -5.4 (CTBS), -18.6 
(C-1). Match the literature data.125 
 
 
 [(4-Bromobut-2-yn-1-yl)oxy](tert-butyl)dimethylsilane 
 
 
226 
 
To a solution of 225 (5.0 g, 25 mmol) in Et2O (95 mL) were added PPh3 (13.1 g, 
50 mmol) and CBr4 (16.6 g, 50 mmol). The reaction mixture was stirred for 4 h then 
filtered through celite and concentrated under reduced pressure. The resulting crude 
product was purified by silica flash chromatography (5% EtOAc in hexanes) to afford 
226 as a light brown oil (3.9 g, 60%). 
 
1H-NMR (400 MHz, CDCl3) δ 4.34 (t, J = 2.0 Hz, 2H, 4-H2), 3.91 (t, J = 2.0 Hz, 2H, 
1-H2), 0.88 (s, 9H, TBS-H), 0.10 (s, 6H, TBS-H); 13C-NMR (100 MHz, CDCl3) 
δ 83.3 (C), 79.8 (C), 51.7 (C-4), 25.8 (CTBS), 18.2 (CTBS), 14.4 (C-1), -5.2 (CTBS). 
Match the literature data.125 
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(4S)-4-Benzyl-3-[(2R)-6-[(tert-butyldimethylsilyl)oxy]-2-methylhex-4-ynoyl]-1,3-
oxazolidin-2-one 
 
 
227 
 
To a solution of propionyloxazolidinone ent-42 (7.5 g, 32.3 mmol) was added 
dropwise a solution of NaHMDS (1 M in THF, 35.5 mL) at -78 °C. After the mixture 
was stirred for 1 h at -78 °C, iodide 224 (30.0 g, 96.7 mmol) was added and the 
reaction was stirred for 3 h at -78 °C. The reaction was quenched with brine and the 
aqueous layer was extracted with Et2O (X 2). The combined organic layers were 
washed with a saturated solution of NaHCO3 and a saturated solution of NH4Cl, dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude material was 
purified by silica flash chromatography (10% Et2O in hexanes) to afford 227 (7.5 g, 
72%, dr ≥ 97:3) as a colourless oil. 
 
IR (thin layer): 3420, 2900, 1800, 1720, 1400, 1320, 1050, 1000 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.38-7.24 (m, 5H, Ar-H), 4.74-4.68, (m, 1H, 3-H), 4.31 (t, 
J = 2.0 Hz, 2H, 10-H2), 4.25-4.18 (m, 2H, 2-H2), 3.98-3.91 (dt, J = 6.8, 6.8 Hz, 1H, 
6-H), 3.32 (dd, J = 13.4, 3.2 Hz, 1H, 4-Ha), 2.79 (dd, J = 13.4, 9.6 Hz, 1H, 4-Hb), 
2.66 (ddt, J = 16.7, 6.8, 2.1 Hz, 1H, 7-Ha), 2.52 (ddt, J = 16.7, 6.8, 2.1 Hz, 1H, 7-Hb), 
1.29 (d, J = 6.8 Hz, 3H, 6-CH3), 0.91 (s, 9H, TBS-H), 0.12 (s, 6H, TBS-H); 13C NMR 
(100 MHz, CDCl3) δ 175.4 (C-5), 153.0 (C-1), 135.3 (CAr), 129.4 (2 X CAr), 129.0 
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(2 X CAr), 127.4 (CAr), 82.0 (C), 80.5 (C), 66.1 (C-2), 55.3 (C-10), 51.9 (C-3), 37.9 
(C-4), 37.4 (C-6), 25.8 (CTBS), 22.9 (C-7), 17.8 (CTBS), 16.7 (6-CH3), -5.1 (CTBS); 
MS (ESI) m/z 416 [M+H]+; HRMS (ESI) calculated for C23H34NO4Si [M+H]+ 
416.2279, found 416.2276; [α]D: + 22.2 (c 1.2, CHCl3); Elem. Anal. calculated for 
C23H33NO4Si C 66.47 H 8.00 N 3.37, found C 66.57, H 7.93, N 3.32. 
 
 
(4S)-4-Benzyl-3-[(2R)-6-hydroxy-2-methylhex-4-ynoyl]-1,3-oxazolidin-2-one 
 
 
227 
 
To a solution of 227 (627 mg, 2.08 mmol) dissolved in MeCN (30 mL) was added a 
solution of H2SiF6 (25 wt. % in water, 1.25 mL). The reaction mixture was stirred for 
2 h and was then poured into water. The aqueous layer was extracted with CH2Cl2 
(X 2) and the combined organic layers were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The resulting crude material was 
purified by silica flash chromatography (30% EtOAc in hexanes) to afford 228 
(563 mg, 83%) as a colourless oil. 
 
IR (thin layer): 3470, 2930, 1780, 1700, 1390, 1300, 1050, 1000 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.39-7.25 (m, 5H, Ar-H), 4.76-4.70, (m, 1H, 3-H), 4.24 (t, 
J = 2.0 Hz, 2H, 10-H2), 4.22-4.17 (m, 2H, 2-H2), 3.95 (dt, J = 6.8, 6.8 Hz, 1H, 6-H), 
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3.32 (dd, J = 13.4, 3.2 Hz, 1H, 4-Ha), 2.80 (dd, J = 13.4, 9.5 Hz, 1H, 4-Hb), 2.64 (ddt, 
J = 16.7, 6.8, 2.1 Hz, 1H, 7-Ha), 2.58 (ddt, J = 16.7, 6.8, 2.1 Hz, 1H, 7-Hb), 1.30 (d, 
J = 6.8 Hz, 3H, 6-CH3); 13C NMR (100 MHz, CDCl3) δ 175.4 (C-5), 153.0 (C-1), 
135.0 (CAr), 129.3 (2 X CAr), 128.2 (2 X CAr), 127.2 (CAr), 83.1 (C), 80.5 (C), 66.0 
(C-2), 55.2 (C-10), 51.1 (C-3), 37.7 (C-4), 37.2 (C-6), 22.8 (C-7), 16.5 (6-CH3); 
[α]D: + 55.5 (c 0.9, CHCl3); MS (ESI) m/z 302 [M+H]+; HRMS (ESI) calculated for 
C17H19NO4 [M+H]+ 302.1392, found 302.1393. 
 
 
(4S)-Benzyl-3-[(2R,4Z)-6-hydroxy-2-methylhex-4-enoyl]-1,3-oxazolidin-2-one 
 
 
229 
 
To a solution of 228 (345 mg, 1.1 mmol) in CH2Cl2 (75 mL) was added quinoline 
(70 µL, mmol) followed by Lindlar catalyst (5 wt. % Pd on CaCO3, poisoned with 
lead, 350 mg, 100 wt. %). The reaction was placed under H2 atmosphere and stirred 
for 1 h. The reaction mixture was filtered through celite, washed with aqueous HCl 
(0.5 M) and brine, dried (MgSO4), filtered and concentrated under reduced pressure to 
afford 229 (310 mg, 89%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3) δ 7.39-7.23 (m, 5H, Ar-H), 5.78 (dt, J = 10.9, 7.0 Hz, 
1H), 5.60 (dt, J = 10.9, 7.0 Hz, 1H), 4.73-4.68, (m, 1H, 3-H), 4.35-4.14 (m, 4H, 
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10-H2, 2-H2), 3.95 (dt, J = 7.0, 7.0 Hz, 1H, 6-H), 3.32 (dd, J = 13.4, 3.2 Hz, 1H, 
4-Ha), 2.77 (dd, J = 13.4, 9.6 Hz, 1H, 4-Hb), 2.73-2.65 (m, 1H, 7-Ha), 2.24-2.18 (m, 
1H, 7-Hb), 1.23 (d, J = 7.0 Hz, 3H, 6-CH3); 13C NMR (100 MHz, CDCl3) δ 176.7 
(C-5), 153.1 (C-1), 135.2 (CAr), 130.8 (CH), 129.5 (2 X CAr), 129.4 (CH), 129.0 
(2 X CAr), 127.4 (CAr), 66.1 (C-2), 58.3 (C-10), 55.4 (C-3), 38.1 (C-4), 37.8 (C-6), 
31.5 (C-7), 17.0 (6-CH3); MS (CI) m/z 304 [M+H]+. 
 
 
(4S)-3-[(2R,4Z)-6-Azido-2-methylhex-4-enoyl]-4-benzyl-1,3-oxazolidin-2-one 
 
 
230 
 
To a solution of 229 (50 mg, 0.15 mmol) dissolved in PhMe (500 µL) and cooled to 
0 °C was added dropwise DBU (25 µL) followed by DPPA (53 µL). The reaction 
mixture was slowly allowed to reach rt and stirred for 3 h. The reaction was quenched 
with water and the aqueous layer was extracted with EtOAc (X 2). The combined 
organic layers were washed with aqueous HCl (0.5 M), dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude material was purified by silica flash 
chromatography (30% Et2O in hexanes) to afford 230 (34 mg, 62%, dr = 70:30) as a 
colourless oil. 
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IR (thin layer): 2975, 2933, 2360, 2341, 2100, 1778, 1697, 1386, 1240, 1212, 970 
cm-1; 1H NMR (400 MHz, CDCl3) (Epimer 70%) δ 7.40-7.23 (m, 5H, Ar-H), 5.84-
5.63 (m, 2H), 4.74-4.68 (m, 1H, 3-H), 4.26-4.19 (m, 2H, 2-H2), 3.93-3.75 (m, 3H, 10-
H2, 6-H), 3.29 (dd, J = 13.3, 3.2 Hz, 1H, 4-Ha), 2.77 (dd, J = 13.3, 10.0 Hz, 1H, 4-
Hb), 2.66-2.24 (m, 2H, 7-H2), 1.25 (d, J = 7.4 Hz, 3H, 6-CH3); 1H NMR (400 MHz, 
CDCl3) (Epimer 30%) δ 7.40-7.23 (m, 5H, Ar-H), 5.38-5.30 (m, 2H), 4.74-4.68 (m, 
1H, 3-H), 4.26-4.19 (m, 2H, 2-H2), 3.93-3.75 (m, 3H, 10-H2, 6-H), 3.32 (dd, J = 13.3, 
3.2 Hz, 1H, 4-Ha), 2.74 (dd, J = 13.3, 10.0 Hz, 1H, 4-Hb), 2.66-2.24 (m, 2H, 7-H2), 
1.23 (d, J = 7.4 Hz, 3 H, 6-CH3); MS (ESI) m/z 327 [M-H]-. 
 
 
(4S)-3-[(2R)-6-Azido-2-methylhex-4-ynoyl]-4-benzyl-1,3-oxazolidin-2-one 
 
 
231 
 
To a solution of 228 (310 mg) dissolved in CH2Cl2 (2.5 mL) and cooled to 0 °C was 
added dropwise DBU (154 µL, 1.03 mmol) followed by DPPA (333 µL, 1.55 mmol). 
The reaction mixture was slowly allowed to reach rt and stirred for 3 h. The reaction 
was quenched with water and the aqueous layer was extracted with CH2Cl2 (X 2). The 
combined organic layers were washed with aqueous HCl (0.5 M), dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude material was purified by 
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silica flash chromatography (2% MeOH in CH2Cl2) to afford 231 as a colourless oil. 
(200 mg, 61%) 
 
1H NMR (400 MHz, CDCl3) δ 7.39-7.25 (m, 5H, Ar-H), 4.73-4.67, (m, 1H, 3-H), 
4.24-4.17 (m, 2H, 2-H2), 3.97 (dt, J = 6.8, 6.8 Hz, 1H, 6-H), 3.90 (t, J = 1.9 Hz, 2H, 
10-H2), 3.31 (dd, J = 13.4, 3.2 Hz, 1H, 4-Ha), 2.78 (dd, J = 13.4, 9.6 Hz, 1H, 4-Hb), 
2.64 (ddt, J = 16.8, 6.8, 2.2 Hz, 1H, 7-Ha), 2.58 (ddt, J = 16.8, 6.8, 2.2 Hz, 1H, 7-Hb), 
1.30 (d, J = 6.8 Hz, 3H, 6-CH3); 13C NMR (100 MHz, CDCl3) δ 175.0 (C-5), 153.0 
(C-1), 135.2 (CAr), 129.4 (2 X CAr), 128.9 (2 X CAr), 127.4 (CAr), 85.0 (C), 73.9 
(C), 66.2 (C-2), 55.4 (C-3), 40.2 (C-10), 37.9 (C-4), 37.4 (C-6), 22.8 (C-7), 16.6 
(6-CH3); MS (ES) m/z 327 [M+H]+; HRMS (ES) m/z calculated for C17H18N4O3 
[M+H]+ 327.1379, found 327.0779. 
 
 
tert-Butyl N-[(5R)-6-[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]-5-methyl-6-oxohex-
2-ynyl]carbamate 
 
 
231’ 
 
To a solution of 231 (361 mg, 1.11 mmol) in THF/water (13 mL, 8:2) was added PPh3 
(320 mg, 1.22 mmol). The mixture was stirred for 18 h at rt. The solvents were 
removed by co-evaporation with PhMe. Di-tert-butyldicarbonate (315 mg, 
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1.44 mmol) dissolved in THF (11 mL) was added. The resulting mixture was stirred 
at rt for 3 h and was then concentrated under reduced pressure. The crude material 
was purified by silica flash chromatography (20% EtOAc in hexanes) to afford 231’ 
(400 mg, 92%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3) δ 7.38-7.24 (m, 5H, Ar-H), 4.75-4.69, (m, 1H, 3-H), 
4.26-4.19 (m, 2H, 2-H2), 3.99-3.85 (m, 3H, 6-H, 10-H2), 3.31 (dd, J = 13.5, 3.2 Hz, 
1H, 4-Ha), 2.81 (dd, J = 13.5, 9.6 Hz, 1H, 4-Hb), 2.61 (ddt, J = 16.9, 6.8, 2.2 Hz, 1H, 
7-Ha), 2.49 (ddt, J = 16.9, 6.8, 2.2 Hz, 1H, 7-Hb), 1.43 (s, 9 H, Boc-H), 1.29 (d, 
J = 7.0 Hz, 3H, 6-CH3); 13C NMR (100 MHz, CDCl3) δ 175.3 (C-5), 153.0 (C-1), 
135.2 (CAr), 129.4 (2 X CAr), 128.9 (2 X CAr), 127.4 (CAr), 80.4 (C), 78.3 (C), 66.1 
(C-2), 55.3 (C-3), 37.9 (C-4), 37.4(C-6), 30.8 (C-10), 28.3 (CBoc), 22.9 (C-7), 16.6 
(6-CH3); MS (CI) m/z 423 [M+Na]+, 301 [M+H-Boc]+; HRMS (ESI) m/z calculated 
for C22H29N2O5 [M+H]+ 401.2076, found 401.2081. 
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tert-Butyl N-[(2Z,5R)-6-[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]-5-methyl-6-
oxohex-2-1-yl]carbamate 
 
 
232 
 
To a solution of 231’ (400 mg, mmol) in CH2Cl2 (90 mL) was added quinoline 
(80-µL, mmol) followed by Lindlar catalyst (5 wt. % Pd on CaCO3, poisoned with 
lead, 400 mg, 100 wt. %). The reaction was placed under H2 atmosphere and stirred 
for 4 h. The reaction mixture was filtered through celite and concentrated under 
reduced pressure. The crude oil was purified by silica flash chromatography (50% 
EtOAc in hexanes) to afford 232 (260 mg, 65%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3) δ 7.37-7.23 (m, 5H, Ar-H), 5.61-5.53 (m, 2H, 8-H, 9-H), 
4.73-4.68 (m, 1H, 3-H), 4.25-4.18 (m, 2H, 2-H2), 3.88-3.74 (m, 3H, 6-H, 10-H2), 3.28 
(dd, J = 13.4, 3.2 Hz, 1H, 4-Ha), 2.76 (dd, J = 13.4, 9.6 Hz, 1H, 4-Hb), 2.65-2.58 (m, 
1H, 7-Ha), 2.27-2.20 (m, 1H, 7-Hb), 1.44 (s, 9H, Boc-H), 1.28 (d, J = 7.4 Hz, 3H, 
6-CH3); MS (CI) m/z 403 [M+H]+; HRMS (EI) m/z calculated for C22H31N2O5 
[M+H]+ 403.2233, found 403.2237. 
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tert-Butyl N-[(2Z,5R)-6-hydroxy-5-methylhex-2-en-1-yl]carbamate 
 
 
233 
 
To a solution of 232 (75 mg, 19 mmol) in THF (2 mL) was added a solution of 
NaBH4 (40 mg, 0.93 mmol) in water (0.6 mL) at 0 °C. The reaction mixture was 
stirred at 0 °C for 5 min, allowed to warm to rt and stirred for 4 h. The reaction was 
quenched by addition of a saturated solution of NH4Cl and then stirred for 1 h. The 
aqueous layer was extracted with EtOAc (X 2) and the combined organic layers were 
washed with a saturated solution of NaHCO3 and brine, dried (MgSO4), filtered, and 
concentrated under reduced pressure. Alcohol 233 could no be isolated after silica 
flash chromatography. 
 
 
(2R)-6-[(tert-Butyldimethylsilyl)oxy)-2-methylhex-4-yn-1-ol 
 
 
234 
 
To a solution of 227 (9.8 g, 23 mmol) in THF (230 mL) was added a solution of 
NaBH4 (4.4 g, 117 mmol) in water (80 mL) at 0 °C. The reaction mixture was stirred 
at 0 °C for 5 min, allowed to warm to rt and stirred for 4 h. The reaction was 
OH
1
3
6 NHBoc
1
3
6
OTBS
OH
 180 
quenched by addition of a saturated solution of NH4Cl and then stirred for 1 h. The 
aqueous layer was extracted with EtOAc (X 2) and the combined organic layers were 
washed with a saturated solution of NaHCO3 and brine, dried (MgSO4), filtered, and 
concentrated under reduced pressure. The crude oil was purified by silica flash 
chromatography to afford 234 (4.6 g, 83%) as a colourless oil. 
 
IR (thin layer): 3372, 2956, 2929, 2858, 1463, 1371, 1255, 1079 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 4.32 (t, J =2.2 Hz, 2H, 6-H2), 3.58 (d, J = 6.3 Hz, 2H, 1-H2), 
2.31 (ddt, J = 16.9, 6.3, 2.2 Hz, 1H, 3-Ha), 2.24 (ddt, J = 16.9, 6.3, 2.2 Hz, 1H, 3-Hb), 
1.93-1.85 (m, 1H, 2-H), 1.01 (d, J = 6.8 Hz, 3H, 2-CH3), 0.93 (s, 9H, TBS-H), 0.13 
(s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 83.2 (C), 80.1 (C), 67.1 (CH2), 51.9 
(CH2), 35.1 (C-2), 25.8 (CTBS), 22.7 (C-3), 18.3 (CTBS), 16.2 (2-CH3), -5.1 (CTBS); 
MS (CI) m/z 243 [M+H]+, 260 [M+NH3]+; HRMS (EI) m/z calculated for C13H27O2Si 
[M+H]+ 243.1780, found 243.1787; [α]D: + 10.61 (c 1.4, CHCl3); Elem. Anal. 
calculated for C13H26O2Si C 64.41 H 10.81, found C 64.50, H 10.75. 
 
 
 
 
 
 
 
 
 
 
 181 
(tert-Butyl)({[(5R)-(6-[(4-methoxyphenyl)methoxy]-5-methylhex-2-yn-1-
yl]oxy})dimethylsilane 
 
 
235 
 
To a solution of 234 (2.0 g, 8.3 mmol) in THF (80 mL) was added NEt3 (3.5 ml, 
24.9 mmol) followed by PMBBr (2.2 ml, 14.9 mmol). The mixture was cooled to -
78 °C and a freshly prepared solution of KHMDS (0.5 M in THF, 20 mL) was added 
dropwise. This mixture was stirred for 15 min at -78 ºC then was warmed to 0 °C and 
stirred for an additional 30 min before a saturated solution of NaHCO3 was added. 
This mixture was stirred for 1 h at rt. The mixture was diluted with Et2O and the 
organic layer was washed with a saturated solution of NaHCO3 and brine, dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude material was 
purified by silica flash chromatography (10% Et2O in hexanes) to afford 235 (2.5 g, 
86%) as a colourless oil. 
IR (thin layer): 3350 (br), 2955, 2930, 2857, 2234, 1728 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.27-7.24 (m, 2H, Ar-H), 6.89-6.86 (m, 2H, Ar-H), 4.43 (s, 2H, 1-H2), 4.29 
(t, J =2.2 Hz, 2H, 7-H2), 3.81 (s, 3H, O-CH3), 3.37-3.30 (m, 2H, 2-H2), 2.33 (ddt, 
J = 16.6, 5.5, 2.2 Hz, 1H, 4-Ha), 2.18 (ddt, J = 16.6, 6.9, 2.2 Hz, 1H, 4-Hb), 2.01-1.93 
(m, 1H, 3-H), 0.99 (d, J = 6.8 Hz, 3H, 3-CH3), 0.91 (s, 9H, TBS-H), 0.11 (s, 6H, 
TBS-H); 13C NMR (100 MHz, CDCl3) δ 159.1 (CAr), 130.7 (CAr), 129.1 (2 X CAr), 
113.7 (2 X CAr), 83.5 (C), 79.8 (C), 74.0 (CH2), 72.7 (CH2), 55.3 (O-CH3), 52.0 
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(CH2), 33.0 (C-3), 25.9 (CTBS), 23.0 (C-4), 18.34 (CTBS), 16.6 (3-CH3), -5.08 
(CTBS); MS (CI) m/z 380 [M+NH4]+; HRMS (EI) m/z calculated for C21H38NO3Si 
[M+NH4]+ 380.2621, found 380.2620; [α]D: + 12.8 (c 1, CHCl3); Elem. Anal. 
calculated for C21H34O3Si C 69.56 H 9.45, found C 69.64, H 9.35. 
 
 
 (5R)-6-[(4-Methoxyphenyl)methoxy]-5-methylhex-2-yn-1-ol 
 
 
236 
 
To a solution of 235 (2.3 g, 6.35 mmol) dissolved in MeCN (100 mL) was added a 
solution of H2SiF6 (25 wt. % in water, 4.6 mL). The reaction mixture was stirred for 2 
h and was then poured into water. The aqueous layer was extracted with CH2Cl2 (X 2) 
and the combined organic layers were washed with brine, dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude material was purified by 
silica flash chromatography (30% EtOAc in hexanes) to afford 236 (1.4 g, 91%) as a 
colourless oil. 
 
IR (thin layer): 3410, 2958, 2930, 2910, 2866, 1612 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.30-7.28 (m, 2H, Ar-H), 6.92-6.90 (m, 2H, Ar-H), 4.47 (s, 2H, 1-H), 4.26 
(t, J =2.2 Hz, 2H, 7-H2), 3.83 (s, 3H, O-CH3), 3.37-3.30 (m, 2H, 2-H2), 2.37 (ddt, 
J = 16.6, 5.7, 2.2 Hz, 1H, 4-Ha), 2.23 (ddt, J = 16.6, 6.9, 2.2 Hz, 1H, 4-Hb), 2.06-1.94 
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(m, 1H, 3-H), 1.02 (d, J = 6.8 Hz, 3H, 3-CH3); 13C NMR (100 MHz, CDCl3) δ 159.1 
(CAr), 130.7 (CAr), 129.1 (2 X CAr), 113.7 (2 X CAr), 83.5 (C), 79.8 (C), 74.0 
(CH2), 72.7 (CH2), 55.3 (O-CH3), 52.0 (CH2), 33.0 (C-3), 22.9 (C-4), 16.5 (3-CH3); 
MS (CI) m/z 266 [M+NH4]+; HRMS (EI) m/z calculated for C15H24NO3 [M+NH4]+ 
256.1756, found 256.1764; [α]D: + 11.6 (c 1.5, CHCl3); Elem. Anal. calculated for 
C15H20O3 C 72.55 H 8.12, found C 72.43, H 8.01. 
 
 
1-({[(2R)-6-Azido-2-methylhex-4-yn-1-yl]oxy}methyl)-4-methoxybenzene 
 
 
237 
 
To a solution of 236 (100 mg, 0.36 mmol) dissolved in PhMe (800 µL) and cooled to 
0 °C was added dropwise DBU (80 µL) followed by DPPA (112 µL). The reaction 
mixture was slowly allowed to reach rt and was then stirred for 4 h at 50 ºC. The 
reaction was then quenched with water. Organic layer was washed with 0.5 M HCl, 
dried (MgSO4), filtered and concentrated under reduced pressure. The crude material 
was purified by silica flash chromatography (10% EtOAc in hexanes) to afford 237 
(59 mg, 60%) as a colourless oil. 
 
IR (thin layer): 2957, 2931, 2857, 2838, 2125 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.41-7.37 (m, 2H, Ar-H), 6.89-6.87 (m, 2H, Ar-H), 4.44 (s, 2H, 1-H2), 3.88 (t, 
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J = 2.2 Hz, 2H, 7-H2), 3.81 (s, 3H, O-CH3), 3.37-3.34 (m, 2H, 2-H2), 2.38 (ddt, 
J = 16.6, 5.4, 2.2 Hz, 1H, 4-Ha), 2.23 (ddt, J = 16.6, 6.8, 2.2 Hz, 1H, 4-Hb), 2.04-1.95 
(m, 1H, 3-H), 1.01 (d, J  = 6.8 Hz, 3H, 3-CH3); 13C NMR (100 MHz, CDCl3) δ 159.1 
(CAr), 130.7 (CAr), 129.2 (2 X CAr), 113.7 (2 X CAr), 84.6 (C), 79.4 (C), 73.8 
(CH2), 73.0 (CH2), 72.7 (CH2), 55.3 (CH3), 32.9 (C-3), 22.9 (C-4), 16.5 (3-CH3); MS 
(CI) m/z 291 [M+NH4]+; HRMS (CI) m/z calculated for C15H23N4O2 [M+NH4]+ 
291.1821, found 291.1823; [α]D: + 10.21 (c 1, CHCl3); Elem. Anal. calculated for 
C12H28O3Si C 65.91 H 7.01 N 15.37, found C 65.86, H 6.93 N 15.43. 
 
 
(2Z,5R)-6-[(4-Methoxyphenyl)methoxy]-5-methylhex-2-en-1-amine 
 
 
238 
 
To a solution of 237 (50 mg, 0.18 mmol) dissolved in DMF (400 µL), was added 
ethylenediamine (30 µL, 0.45 mmol) followed by Lindlar catalyst (5 wt. % Pd on 
CaCO3, poisoned with lead, 10 mg, 10 wt. %). The reaction was placed under a H2 
atmosphere and stirred for 1 h. The reaction mixture was filtered through Celite and 
washed with MeOH. The resulting solution was concentrated under reduced pressure, 
dissolved in EtOAc and washed with water and aqueous NH4Cl (2 wt. %). The 
organic layer was dried (MgSO4), filtered and concentrated under reduced pressure to 
afford 238 (30 mg, 66%) as a yellow oil with good purity without further purification. 
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1H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 8.5 Hz, 2H, Ar-H), 6.90 (d, J = 8.5 Hz, 
2H, Ar-H), 5.60-5.44 (m, 2H, 5-H, 6-H), 4.45 (s, 2H, 1-H2), 3.83 (s, 3H, O-CH3), 
3.37 (d, J = 6.6 Hz, 2H, 2-H2), 3.32-3.27 (m, 2H, 7-H2), 2.27-2.17 (m, 1H, 4-Ha), 
2.00-1.93 (m, 1H, 4-Hb), 1.87-1.82 (m, 1H, 3-H), 0.93 (d, J = 6.8 Hz, 3H, 3-CH3); 
13C NMR (100 MHz, CDCl3) δ 159.1 (CAr), 130.7 (CAr), 130.1 (CH), 130.0 (CH), 
129.2 (2 X CAr), 113.8 (2 X CAr), 74.8 (CH2), 72.7 (CH2), 55.3 (CH3), 38.4 (C-7), 
33.8 (C-3), 31.2 (C-4), 16.9 (3-CH3); MS (ES) m/z 250 [M+H]+; HRMS (ES) m/z 
calculated for C15H24NO2 [M+H]+ 250.1807, found 250.1812; [α]D: +12.6 (c 0.7, 
CHCl3). 
 
 
 (4R)-4-Benzyl-3-[(2R,3S)-3-hydroxy-2-methylhexanoyl]-1,3-oxazolidin-2-one 
 
 
246 
 
To a solution of 42 (3.0 g, 12.9 mmol) dissolved in CH2Cl2 and cooled to -78 °C was 
added dropwise Bu2BOTf (1 M in CH2Cl2, 12.9 mL) followed by NEt3 (2.3 mL, 
16.7 mmol). The reaction mixture was stirred for 1 h at -78 °C and 15 min at 0 °C. 
The solution was then cooled to -78 °C and butyraldehyde (216) (1.5 mL, 16.7 mmol) 
was added dropwise. The resulting mixture was stirred for 30 min at -78 °C, then 30 
min at 0 °C. The reaction was poured into aqueous HCl (1 M, 60 mL) and the aqueous 
layer was extracted with CH2Cl2 (X 2). The combined organic layers were dried 
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(MgSO4), filtered and concentrated under reduced pressure. The crude material 
(dr = 93:7) was purified by silica flash chromatography (0 to 5% Et2O in CH2Cl2) to 
afford 246 as a colourless oil and single diastereomer (2.9 g, 72%). 
 
IR (neat): 3526, 2958, 2933, 2871, 2360, 1719, 1693, 1385, 1209 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.42-7.03 (m, 5H, Ar-H), 4.71-4.67, (m, 1H, 3-H), 4.28-4.18 (m, 
2H, 2-H2), 4.01-3.98 (m, 1H, 7-H), 3.79 (dq, J = 7.1, 2.6 Hz, 1H, 6-H), 3.29 (dd, 
J = 13.3, 3.2 Hz, 1H, 4-Ha), 2.81 (dd, J = 13.3, 9.6 Hz, 1H, 4-Hb), 1.60-1.35 (m, 4H, 
8-H2, 9-H2), 1.29 (d, J = 7.1 Hz, 3H, 6-CH3), 0.97 (t, J = 7.1 Hz, 3H, 10-H3); 
13C NMR (100 MHz, CDCl3) δ 177.6 (C-5), 153.0 (C-1), 135.0 (CAr), 129.4 
(2 X CAr), 129.0 (2 X CAr), 127.4 (CAr), 71.2 (C-7), 66.1 (C-2), 55.1 (C-3), 42.0 
(C-6), 37.8 (C-4), 35.5 (C-8), 19.2 (C-9), 14.0 (CH3), 10.3 (CH3); MS (ES) m/z 306 
[M+H]+; HRMS (ES) m/z calculated for C17H24NO4 [M+H]+ 306.1704, found 
306.1712; Elem. Anal. calculated for C17H23NO4 C 66.86 H 7.59 N 4.59, found C 
66.95, H 7.49 N 4.68; [α]D: -53.8 (c 2.6, CHCl3). Match the literature data.14 
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(4R)-4-Benzyl-3-[(2R,3S)-2-methyl-3-{[tris(propan-2-yl)silyl]oxy}hexanoyl]-1,3-
oxazolidin-2-one 
 
 
246’ 
 
To a solution of 246 (1.1 g, 3.6 mmol) and 2,6-lutidine (1 mL, 9 mmol) in CH2Cl2 
(75 mL) at 0 °C was added TIPSOTf (1.2 mL, 4.7 mmol). The mixture was stirred for 
4 h at 0 °C and quenched with water. The aqueous layer was extracted with CH2Cl2 
(X 2) and the combined organic layer were washed with brine, dried (MgSO4), and 
concentrated under reduced pressure. The crude product was purified by silica flash 
chromatography (10% EtOAc in hexanes) to afford 246’ (1.3 g, 78%) as a white solid. 
 
mp = 115 ºC; IR (thin layer): 3526, 2958, 2933, 2871, 2360, 2341, 1719, 1693, 1385, 
1209 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.35-7.21 (m, 5H, Ar-H), 4.62-4.55, (tdd, 
J = 9.8, 7.3, 2.6 Hz, 1H, 3-H), 4.28-4.24 (m, 1H, 7-H), 4.20-4.11 (m, 2H, 2-H2), 3.85 
(dq, J = 6.9, 4.0 Hz, 1H, 6-H), 3.33 (dd, J = 13.5, 2.6 Hz, 1H, 4-Ha), 2.79 (dd, 
J = 13.5, 9.8 Hz, 1H, 4-Hb), 1.69-1.55 (m, 2 H), 1.42-1.32 (m, 2 H), 1.24 (d, 
J = 6.9 Hz, 3H, 6-CH3), 1.07 (br s, 21 H, H-TIPS), 0.97 (t, J = 7.3 Hz, 3H, 10-H3); 
13C NMR (100 MHz, CDCl3) δ 175.9 (C-5), 153.1 (C-1), 135.4 (CAr), 129.4 
(2 X CAr), 128.9 (2 X CAr), 127.3 (CAr), 73.0 (C-7), 66.0 (C-2), 55.9 (C-3), 42.5 
(C-6), 38.0 (C-4), 37.0 (C-8), 18.2 (C-9), 17.7 (CTIPS), 14.4 (CH3), 13.1(CTIPS), 
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10.3 (CH3); MS (ESI) m/z 462 [M+H]+; HRMS (ESI) m/z calculated for C26H44NO4Si 
[M+H]+ 462.3040, found 462.3035; [α]D: -60.1 (c 1.5, CHCl3). 
 
 
 (2R,3S)-2-Methyl-3-{[tris(propan-2-yl)silyl]oxy}hexanoïc acid 
 
 
247 
 
To a solution of LiOH (0.4 g, 10 mmol) dissolved in water (10 mL) was added H2O2 
(2 mL, 30 wt. % in water). This mixture was added to a solution of 246’ (1.9 g, 
4.1 mmol) dissolved in THF (40 mL) and the resulting mixture was stirred for 4 h at 
rt. The reaction was quenched by addition of aqueous Na2SO3 (1.3 M) and stirred for 
30 min. The aqueous layer was first extracted with CH2Cl2 then acidified to pH = 3 
with aqueous HCl (1 M) and finally (re)extracted with CH2Cl2 (X 3). The combined 
organic layers (of the 2nd extraction) were dried (MgSO4), filtered and concentrated 
under reduced pressure to afford 247 as a colourless oil (0.9 g, 70%). 
 
IR (neat): 2942, 2867, 1706, 1462, 1385, 1234, 1137, 881 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 4.15 (dt, J = 10.0, 5.5 Hz, 1H, 3-H), 2.72-2.66 (dq, J = 7.1, 5.5 Hz, 1H, 
2-H), 1.65-1.51 (m, 2H), 1.47-1.31 (m, 2H), 1.60 (d, J = 7.1 Hz, 3H, 2-CH3), 1.10 (s, 
21H, TIPS-H), 0.94 (t, J = 7.2 Hz, 3H, 6-H3); 13C NMR (100 MHz, CDCl3) δ 177.8 
(C-1), 74.1 (C-3), 43.9 (C-2), 36.0 (C-4), 18.5 (C-5), 18.1 (CTIPS), 14.2 (CH3), 12.3 
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(CTIPS), 10.9 (CH3); MS (ESI) m/z 301 [M-H]-; HRMS (ESI) m/z calculated for 
C16H33O3Si [M-H]- 301.2199, found 301.2192; [α]D: -9.8 (c 2.1, CHCl3). 
 
 
(4R)-4-Benzyl-3-[(2R,3S)-3-[(tert-(butyldimethylsilyl)oxy]-2-methylhexanoyl]-1,3-
oxazolidin-2-one 
 
 
246’’ 
 
To a solution of 246 (800 mg, 2.6 mmol) and 2,6-lutidine (0.8 mL, 6.5 mmol) in 
CH2Cl2 (40 mL) at 0 °C was added TBSOTf (0.8 mL, 3.4 mmol). The mixture was 
stirred for 4 h at 0 °C and quenched with water. The aqueous layer was extracted with 
CH2Cl2 (X 2) and the combined organic layer were washed with brine, dried 
(MgSO4), and concentrated under reduced pressure. The crude product was purified 
by silica flash chromatography (10% EtOAc in hexanes) to afford 246’’ (850 mg, 
73%) as a white solid. 
 
mp = 110 ºC; 1H NMR (400 MHz, CDCl3) δ 7.37-7.15 (m, 5H, Ar-H), 4.64-4.54 (m, 
1H, 3-H), 4.19-4.12 (m, 2H, 2-H2), 4.05-3.99 (m, 1H, 7-H), 3.90-3.80 (m, 1H, 6-H), 
3.30 (dd, J = 13.4, 2.8 Hz, 1H, 4-Ha), 2.77 (dd, J = 13.4, 9.5 Hz, 1H, 4-Hb), 1.55-1.45 
(m, 2H), 1.42-1.27 (m, 2H), 1.19 (d, J = 6.8 Hz, 3H, 6-CH3) 0.84-0.94 (m, 12H, 
10-H3, TBS-H), 0.02 (s, 3H, TBS-H), 0.00 (s, 3H, TBS-H); 13C NMR (100 MHz, 
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CDCl3) δ 175.3 (C-5) 153.1 (C-1), 135.4 (CAr), 129.5 (2 X CAr)), 128.9 (2 X CAr), 
127.3 (CAr), 72.7 (C-7), 66.0 (C-2), 55.8 (C-3), 42.8 (C-6), 37.8 (C-4), 37.6 (C-8), 
25.8 (CTBS), 18.4 (C-9), 18.0 (CTBS), 14.4 (C-10), 11.4 (6-CH3), -4.1 (CTBS), -4.8 
(CTBS); MS (ESI) m/z 420 [M+H]+; HRMS (ESI) m/z calculated for C26H44NO4 
[M+H]+ 420.2570, found 420.2560; [α]D = -58.0 (c 2, CH2Cl2). Match the literature 
data.14 
 
 
(2R,3S)-3-[(tert-(butyldimethylsilyl)oxy]-2-methylhexanoïc acid 
 
 
248 
 
To a solution of LiOH (200 mg, 4.8 mmol) dissolved in water (5 mL) was added 
H2O2 (1 mL, 30 wt. % in water). This mixture was added to a solution of 246’’ (800 
mg, 1.9 mmol) dissolved in THF (20 mL) and the resulting mixture was stirred for 4 h 
at rt. The reaction was quenched by addition of aqueous Na2SO3 (1.3 M) and stirred 
for 30 min. The aqueous layer was first extracted with CH2Cl2, then acidified to 
pH = 3 with aqueous HCl (1 M) and finally extracted with CH2Cl2 (X 3). The 
combined organic layers (of the 2nd extraction) were dried (MgSO4), filtered and 
concentrated under reduced pressure to afford 248 as a colourless oil (370 mg, 75%). 
 
1H NMR (400 MHz, CDCl3) δ 4.05-3.95 (dt, J = 10.0, 6.4 Hz, 1H, 3-H), 2.65-2.55 
(dq, J = 7.1, 4.3 Hz, 1H, 2-H), 1.58-1.40 (m, 3H), 1.32-1.22 (m, 1H), 1.14 (d, J = 7.1 
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Hz, 3H, 2-CH3), 0.98-0.88 (m, 12H, 6-H3, TBS-H), 0.08 (s, 6H, TBS-H); 13C NMR 
(100 MHz, CDCl3) δ 73.8 (C-3), 44.4 (C-2), 35.8 (C-4), 25.7 (CTBS), 18.8 (C-5), 
18.0 (CTBS), 14.2 (CH3), 11.4 (CH3), -4.4 (CTBS), -4.8 (CTBS); [α]D = -19.7 (c 2, 
CH2Cl2). Match the literature data.14 
 
 
 (2R,3S)-N-[(2Z,5R)-6-[(4-Methoxyphenyl)methoxy]-5-methylhex-2-en-1-yl]-2-
methyl-3-{(tris(propan-2-yl)silyloxy)hexanamide 
 
 
250 
 
To a solution of 247 (80 mg, 0.26 mmol) dissolved in THF (520 µL) were added NEt3 
(36 µL, 0.26 mmol) and 2,4,6-trichlorobenzoyl chloride (249) (39 µL, 0.26 mmol) at 
0 ºC. The mixture was allowed to reach rt and stirred for 2 h. When the starting 
material was consumed, amine 238 (70 mg, 0.20 mmol), NEt3 (40 µL, 0.28 mmol) 
and DMAP (31 mg, 0.26 mmol) were added. After 3 h the reaction mixture was 
diluted with Et2O, washed with aqueous HCl (1 M), a saturated solution of NaHCO3 
and brine, dried (MgSO4) and concentrated under reduced pressure. The crude 
mixture was purified by silica flash chromatography (10% EtOAc in hexanes) to 
afford by product 251 (46 mg) and 250 (52 mg, 35%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 9.1 Hz, 2H, Ar-H), 6.90 (d, J = 9.1 Hz, 
2H, Ar-H), 5.58-5.44 (m, 2H, 5-H, 6-H), 4.44 (s, 2H, 1-H2), 3.99-3.84 (m, 3H, 2-H2, 
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10-H), 3.82 (s, 3H, O-CH3), 3.32-3.24 (m, 2H, 7-H2), 2.56 (dq, J = 7.2, 3.5 Hz, 1H, 
9-H), 2.25-2.19 (m, 1H, 4-Ha), 2.03-1.95 (m, 1H, 4-Hb), 1.88-1.80 (m, 1H, 3-H), 
1.60-1.14 (m, 7H, 11-H2, 12-H2, 9-CH3), 1.12-1.09 (m, 24H, 3-CH3, TIPS-H), 0.91 (t, 
J = 7.2 Hz, 3H, 13-H3); 13C NMR (100 MHz, CDCl3) δ 173.9 (C-8), 159.1 (CAr), 
131.2 (CH), 130.7 (CAr), 129.1 (2 X CAr), 126.5 (CH), 113.5 (2 X CAr), 75.2 (CH2), 
74.9 (CH2), 72.6 (CH), 55.2 (O-CH3), 45.5 (C-9), 36.4 (CH2), 35.8 (CH2), 33.7 (CH), 
31.2 (CH2), 19.3 (CH3), 18.2 (CTIPS), 16.8 (CH2), 14.4 (CH3), 12.7 (CTIPS), 12.6 
(CH3); MS (ESI) m/z 534 [M+H]+, 556 [M+Na]+; HRMS (CI) m/z calculated for 
C31H56NO4Si [M+H]+ 534.3979, found 534.3972; [α]D: +4.7 (c 3, CHCl3). 
 
 
2,4,6-Trichloro-N-[(2Z, 5R)-6-[4-methoxyphenyl)methoxy]-5-methylhex-2-en-
1-yl)benzamide 
 
 
251 
 
1H NMR (400 MHz, CDCl3) δ 7.29 (s, 2H, Ar-H), 7.16 (d, J = 8.6 Hz, 2H, Ar-H), 
6.83 (d, J = 8.6 Hz, 2H, Ar-H), 6.08 (br s, 1H, N-H), 5.66-5.57 (m, 2H, 5-H, 6-H), 
4.35 (d, J = 1.6 Hz, 2H), 4.07 (t, J = 4.6 Hz, 2H), 3.80 (s, 3H, O-CH3), 3.32-3.24 (m, 
2H), 2.28-2.21 (m, 1H), 2.11-2.04 (m, 1H), 1.92-1.84 (m, 1H), 0.92 (t, J = 7.2 Hz, 3H, 
3-CH3); 13C NMR (100 MHz, CDCl3) δ 163.4 (C-8), 159.1, 135.6, 134.6 (2 X CAr), 
132.9, 132.4 (CH), 130.4, 129.2 (2 X CAr), 128.0 (2 X CAr), 125.3 (CH), 113.7 (2 X 
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CAr), 74.4, 72.6, 55.3 (O-CH3), 36.8, 33.4, 31.1, 16.8; MS (ESI) m/z 456 [M+H]+, 
478 [M+Na]+. 
 
 
(2R)-3-[(tert-Butyldimethylsilyl)oxy)-2-methylpropan-1-ol 
 
 
257 
 
A-To a solution of imidazole (1.7 g, 25.5 mmol) and TBSCl (3.8 g, 25.5 mmol) 
dissolved in DMF (15 mL) was added dropwise (2S)-3-hydroxy-2-methyl-propionic 
acid methyl ester (256) (2.0 g, 17 mmol). The reaction mixture was stirred for 16 h at 
rt and then quenched by addition of water. The aqueous layer was extracted with Et2O 
(X 2) and the combined organic layers were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude product was used without 
further purification.  
B-To a solution of the previous crude product (1.3 g, 5.6 mmol) dissolved in CH2Cl2 
(16 mL) was added dropwise DIBAL-H (1.0 M in CH2Cl2, 15 mL) at -40 ºC. The 
reaction mixture was stirred for 3 h at this temperature and was then allowed to reach 
rt. The reaction was quenched by addition of water followed by aqueous NaOH 
(10 wt. %, 50 mL). The aqueous layer was extracted with CH2Cl2 and the combined 
organic layers were washed with brine, dried (MgSO4) and concentrated under 
reduced pressure. The crude material was purified by silica flash chromatography 
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(30% Et2O in hexanes) to give alcohol 257 as a colourless oil (0.8 mg, 70% over two 
steps). 
 
1H NMR (400 MHz, CDCl3) δ 3.76-3.52 (m, 4H, 1-H2, 3-H2), 2.9 (br s, 1H, O-H), 
1.96-1.90 (m, 1H, 2-H), 0.90 (s, 9H, TBS-H), 0.83 (d, J = 7.0 Hz, 3H, 2-CH3), 0.07 
(s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 68.9 (CH2), 68.5 (CH2), 37.0 (C-2), 
25.8 (CTBS), 18.1 (CTBS), 13.1 (2-CH3), -5.4 (CTBS). Match the literature data.126 
 
 
tert-Butyl[(2S)-3-iodo-2-methylpropoxy)dimethylsilane 
 
 
258 
 
To a solution of I2 (535 mg, 12.1 mmol), imidazole (204 mg, 3 mmol) and PPh3 
(533 mg, 1.4 mmol) dissolved in THF (5 mL) was added 257 (300 mg, 1.5 mmol) 
dissolved in THF (5 mL). The reaction mixture was stirred for 24 h at rt. The reaction 
mixture was concentrated under reduced pressure and the crude material was 
dissolved in a minimum amount of CH2Cl2. Pentane was added and the resulting 
solution was filtered off. The filtrate was concentrated under reduced pressure. The 
resulting mixture was dissolved in Et2O, washed with a saturated solution of 
NaHCO3, a saturated solution of Na2S2O3 and brine. The organic layer were dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude mixture was 
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purified by silica flash chromatography to afford 258 (322 mg, 68%) as a colourless 
oil. 
 
1H NMR (400 MHz, CDCl3) δ 3.52 (dd, J = 9.9, 5.0 Hz, 1H, 1-Ha), 3.39 (dd, J = 9.9, 
6.9 Hz, 1H, 1-Hb), 3.32 (dd, J = 9.5, 5.1 Hz, 1H, 3-Ha), 3.25 (dd, J = 9.5, 5.6 Hz, 1H, 
3-Hb), 1.68-1.60 (m, 1H, 2-H), 0.95 (d, J = 6.8 Hz, 3H, 2-CH3), 0.90 (s, 9H, TBS-H), 
0.07 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 66.7 (C-1), 37.4 (C-2), 25.8 
(CTBS), 18.3 (CTBS), 17.2 (C-3), 13.8 (2-CH3), -5.4 (CTBS). 
 
 
 (Prop-2-yn-1-yl)bis(trimethylsilyl)amine 
 
 
259 
 
To a solution of propargyl amine (1.0 g, 18 mmol) dissolved in CH2Cl2 (30 mL) were 
added TMSCl (4.8 mL, 37.8 mmol) and NEt3 (7.7 mL, 55.2 mmol). The reaction 
mixture was stirred at rt for 12 h and quenched by addition of brine. The aqueous 
layer was extracted with CHCl3 (X 2) and the combined organic layers were washed 
with brine, dried (MgSO4), filtered and concentrated under reduced pressure to afford 
259 as a pale yellow oil (1.5 g, 42%). The compound was highly unstable and was 
used straight away. 
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1H NMR (400 MHz, CDCl3) δ 3.53 (m, J = 2.4 Hz, 2H), 2.13 (t, J = 2.4 Hz, 1H), 0.15 
(s, 18H). Match the literature data.96 
 
 
tert-Butyl N-(prop-2-yn-1-yl)carbamate 
 
 
260 
 
To a solution of propargyl amine (1.0 g, 18.2 mmol) dissolved in water (25 mL) was 
added NaHCO3 (1.5 g, 18.2 mmol) followed by Boc2O (4 g, 18.2 mmol) dissolved in 
CHCl3 (35 mL). The reaction mixture was stirred for 3 h at rt and the organic layer 
was subsequently separated. The aqueous layer was extracted with CHCl3 (X 2) and 
the combined organic layers were washed with water, dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude solid was purified by silica flash 
chromatography to afford 260  as a colourless oil (2.2 g, 79%). 
 
1H NMR (400 MHz, CDCl3) δ 3.8 (s, 2H, 3-H2), 2.15 (m, 1H, 1-H), 1.45-1.35 (3s, 
9H, Boc-H); 13C NMR (100 MHz, CDCl3) δ 155.2, 80.1, 79.9, 71.1, 28.2. Match the 
literature data.97 
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tert-Butyl N-[(tert-butoxy)carbonyl]-N-(prop-2-yn-1-yl)carbamate 
 
 
261 
 
To a solution of 260 (250 mg, 1.6 mmol) dissolved in MeCN (5 mL) were added 
DMAP (195 mg, 1.6 mmol) and Boc2O (1.05 g, 4.8 mmol). The reaction mixture was 
stirred for 1 h at rt and was then concentrated under reduced pressure. The crude solid 
was purified by silica flash chromatography (5% Et2O in hexanes) to afford 261 
(359 mg, 88%) as a white solid. 
 
1H NMR (400 MHz, CDCl3) δ 4.35 (d, J = 2.5 Hz, 2H, 3-H2), 2.18 (t, J = 2.5 Hz, 1H, 
1-H), 1.53 (s, 18H, Boc-H); 13C NMR (100 MHz, CDCl3) δ 151.0, 82.2, 79.1, 70.2, 
35.2, 27.4. Match the literature data.98 
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(8R)-2,2,8,11,11,12,12-Heptamethyl-3-(trimethylsilyl)-10-oxa-3-aza-2,11-
disilatridec-5-yne 
 
 
259’ 
 
To a solution of 259 (110 mg, 0.55 mmol) dissolved in THF (1 mL) was added 
freshly prepared LDA (1 M in THF, 0.55 mL) at -78 ºC. After 2 h, HMPA (0.1 mL) 
was added followed by 258 (160 mg, 0.5 mmol). The reaction mixture was slowly 
allowed to reach rt and was stirred for 1 h. The reaction was quenched by addition of 
water. The aqueous layer was extracted with EtOAc (X 2). The combined organic 
layers were washed with brine, dried (MgSO4), filtered and concentrated under 
reduced pressure. The crude material indicated no trace of desired product 259’ but 
the presence of by-product 262 and starting material 258. 
 
 
tert-Butyldimethyl[(2-methylprop-2-en-1-yl)oxy]silane 
 
 
262 
 
1H NMR (400 MHz, CDCl3) δ 5.00 (s, 1H, 3-Ha), 4.82 (s, 1H, 3-Hb), 4.05 (s, 2H, 
1-H), 1.72 (s, 3H, 2-CH3) 0.93 (s, 9H, TBS-H), 0.06 (s, 6H, TBS-H); 13C 
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NMR (100 MHz, CDCl3) δ 144.6 (C-2), 109.1 (C-3), 66.8 (C-1), 25.7 (CTBS), 18.9 
(2-CH3), 18.4 (CTBS), -5.6 (CTBS). 
 
 
tert-Butyl N-[(5R)-6-[(tert-butyldimethylsilyl)oxy]-5-methylhex-2-yn-1-
yl]carbamate 
 
 
260’ 
 
To a solution of 260 (85 mg, 0.55 mmol) dissolved in THF (1 mL) was added freshly 
prepared LDA (1 M in THF, 1.1 mL) at -78 ºC. After 2 h, HMPA (0.1 mL) was added 
followed by 258 (160 mg, 0.5 mmol). The reaction mixture was slowly allowed to 
reach rt and was stirred for 1 h. The reaction was quenched by addition of water. The 
aqueous layer was extracted with EtOAc (X 2). The combined organic layers were 
washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. 
The crude material was purified by silica flash chromatography (10% EtOAC in 
hexanes) but no desired product was isolated. Instead 263 was isolated as a mixture 
with by-product 262. 
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tert-Butyl N-[(2R)-3-[(tert-butyldimethylsilyl)oxy]-2-methylpropyl]-N-(prop-2-yn-
1-yl)carbamate 
 
 
263 
 
1H NMR (400 MHz, CDCl3) δ 4.18-3.90 (m, 2H), 3.47 (d, J = 5.5 Hz, 2H), 3.27-3.24 
(m, 2H), 2.17 (s, 1H), 2.01-1.93 (m, 1H), 1.46 (s, 9H, Boc-H), 0.89-0.86 (s, 9H, 
TBS-H, 2-CH3), 0.04 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 80.1, 76.8 
(CBoc), 65.9, 49.5, 37.2, 28.4 (CBoc), 25.9 (CTBS), 18.3 (CTBS), 14.8 (CH3), 5.6 
(CTBS), (two missing quaternary C). 
 
 
tert-Butyl N-[(tert-butoxy)carbonyl]-N-[(5R)-6-[(tert-butyldimethoxysilyl)oxy]-5-
methylhex-2-yn-1-yl]carbamate 
 
 
261’ 
 
To a solution of 261 (140 mg, 0.55 mmol) dissolved in THF (1 mL) was added 
freshly prepared LDA (1 M in THF, 0.55 mL) at -78 ºC. After 2 h, HMPA (0.1 mL) 
was added followed by 258 (160 mg, 0.5 mmol). The reaction mixture was slowly 
allowed to reach rt and was stirred for 1 h. The reaction was quenched by addition of 
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water. The aqueous layer was extracted with EtOAc (X 2). The combined organic 
layers were washed with brine, dried (MgSO4), filtered and concentrated under 
reduced pressure. The crude material indicated the presence of by-product 262 and no 
trace of starting material.  
 
 
1-Methoxy-4-[(prop-2-yn-1-yloxy)methyl)benzene 
 
 
264 
 
To a solution of propargyl alcohol (15 g, 267 mmol) dissolved in THF/DMF (400 mL, 
8:2) was added NaH (60% in mineral oil, 21.5 mg, 534 mmol) at 0 °C. The reaction 
mixture was stirred for 1 h, then PMBCl (36.2 mL, 267 mmol) was added and the 
reaction mixture was stirred for 48 h. The reaction was then quenched with water. The 
aqueous layer was extracted with CH2Cl2 (X 3) and the combined organic layers were 
dried (MgSO4), filtered and concentrated under reduced pressure. The crude material 
was purified by silica flash chromatography (10% EtOAc in hexanes) to 264 (55%, 
13 g) as a colourless oil. 
 
IR (neat): 3286, 2941, 2840, 1612, 1512, 1301, 1245, 1175, 1074, 1031, 817 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 8.7 Hz, 2H, Ar-H), 6.88 (d, J = 8.7 Hz, 
2H, Ar-H), 4.55 (s, 2H, 4-H2), 4.14 (d, J = 2.4 Hz, 2H, 3-H2), 3.81 (s, 3H, O-CH3); 
13C NMR (100 MHz, CDCl3) δ 159.4 (CAr), 129.8 (CAr), 129.3 (CAr), 113.8 (CAr), 
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79.8 (C), 74.5 (C), 71.1 (C-4), 56.7 (C-3), 53.4 (O-CH3); MS (ESI) m/z 176 [M-H]-; 
HRMS (ESI) m/z calculated for C11H12O2 [M+H]+ 176.0837, found 176.0839. Match 
the literature data.127 
 
 
tert-Butyl({[(2R)-6-[(4-methoxyphenyl)methoxy]-2-methylhex-4-yn-1-
yl]oxy})dimethylsilane 
 
 
265 
 
To a solution of 264 (205 mg, 1.15 mmol) dissolved in THF (2.5 mL) was added 
dropwise n-BuLi (2.5 M in hexanes, 0.46 mL) at 0 °C. The reaction mixture was 
stirred for 30 min, then HMPA (0.4 mL) was added, followed by 258 (120 mg, 
0.38 mmol). The reaction mixture was slowly allowed to reach rt, was stirred for 
another hour and quenched by a saturated solution of NH4Cl. The aqueous layer was 
extracted with Et2O (X 2) and the combined organic layers were washed with a 
saturated solution of LiCl and brine, dried (MgSO4), filtered and concentrated under 
reduced pressure. The crude material was purified by silica flash chromatography 
(10% Et2O in hexanes) to afford a mixture of 265 and by-products 262 and 266 as a 
pale yellow oil (65 mg, 45%) (mass and yield calculated for 265).  
 
1H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 8.6 Hz, 2H, Ar-H), 6.88 (d, J = 8.6 Hz, 
2H, Ar-H), 4.52 (s, 2H, 7-H), 4.14-4.13 (m, 2H), 3.81 (s, 3H, O-CH3), 3.53-3.46 (m, 
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2H), 2.35 (ddt, J = 16.4, 5.4, 3.0 Hz, 1H, 3-Ha), 2.17 (ddt, J = 16.4, 7.0, 2.0 Hz, 1H, 
3-Hb), 1.90-1.79 (m, 1H, 2-H), 0.98 (d, J = 6.8 Hz, 3H, 2-CH3), 0.93 (s, 9H, TBS-H), 
0.06 (s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 159.2 (CAr), 129.8 (CAr), 129.7 
(2 X CAr), 113.8 (2 X CAr), 85.6 (C), 70.8, 66.8, 57.2, 55.1, 35.2, 25.7 (CTBS), 22.3, 
16.8 15.9 (CTBS), -5.6 (CTBS), (one quaternary C missing); MS (CI) m/z 363 
[M+H]+, 380 [M+NH4]+. 
 
 
tert-Butyl({3-[(4-methoxyphenyl)methoxy)prop-1-yn-1-yl})dimethylsilane 
 
 
266 
 
1H NMR δ 7.29 (d, J = 8.6 Hz, 2H, Ar-H), 6.88 (d, J = 8.6 Hz, 2H, Ar-H), 4.55 (s, 
2H), 4.15 (s, 2H), 3.81 (s, 3H, O-CH3), 0.96 (s, 9H, TBS-H), 0.13 (s, 6H, TBS-H); 
13C NMR (100 MHz, CDCl3) δ 159.2 (CAr), 129.7 (2 X CAr), 129.3 (CAr), 113.6 
(2 X CAr), 77.0 (2C), 70.9, 57.2, 55.1, 25.7 (CTBS), 16.2 (CTBS), -5.6 (CTBS). 
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 (2R)-2-Methyl-3-(triphenylmethoxy)propan-1-ol 
 
 
267 
 
A-To a solution of trityl chloride (95 g, 339 mmol) dissolved in CH2Cl2 (600 mL) 
were added NEt3 (52 mL, 372 mmol), DMAP (4.1 g, 33.9 mmol) and (2S)-3-hydroxy-
2-methyl-propionic acid methyl ester (256) (20 g, 169 mmol). The reaction mixture 
was stirred for 12 h at rt and then quenched by addition of water. The aqueous layer 
was extracted with CH2Cl2 (X 2) and the combined organic layers were washed with 
brine, dried (MgSO4) filtered and concentrated under reduced pressure. The crude 
ester was used without further purification.  
B-To a solution of the crude ester dissolved in CH2Cl2 (500 mL) was added dropwise 
DIBAL-H (1.0 M in CH2Cl2, 400 mL) at -40 ºC. The reaction mixture was stirred for 
3 h at this temperature and was then allowed to reach rt. The reaction was quenched 
by addition of water followed by aqueous NaOH (10 wt. %) and stirred for 1 h. The 
aqueous layer was extracted with CH2Cl2 (X 2) and the combined organic layers were 
washed with brine, dried (MgSO4) and concentrated under reduced pressure. The 
crude product was purified by silica flash chromatography (30% Et2O in hexanes) to 
give alcohol 267 (34 g, 60%) as white needles. 
 
1H NMR (400 MHz, CDCl3) δ 7.48-7.40 (m, 6H, Ar-H), 7.37-7.18 (m, 9H, Ar-H), 
3.70-3.51 (m, 2H), 3.24 (dd, J = 9.1, 4.5 Hz, 1H), 3.03 (dd, J = 9.1, 5.1 Hz, 1H), 
2.35-2.31 (m, 2-H), 0.87 (d, J = 7.0 Hz, 3H, 2-CH3); 13C NMR (100 MHz, CDCl3) 
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δ 143.8 (CAr), 128.5 (CAr), 127.8 (2Ar), 127.0 (2 X CAr), 87.0, 67.8, 67.5, 35.9, 
13.7; [α]D: +25 (c 2.7, CH2Cl2). Match the literature data.128 
 
 
{[(2S)-3-Iodo-2-methylpropoxy]diphenylmethyl}benzene 
 
 
268 
 
To a solution of I2 (1.3 g, 5 mmol), imidazole (350 mg, 5 mmol) and PPh3 (1.3 mg, 
5 mmol) dissolved in CH2Cl2 (5 mL) was added 267 (300 mg, 1.5 mmol) dissolved in 
CH2Cl2 (5 mL). The reaction mixture was stirred for 24 h at rt. The reaction mixture 
was concentrated under reduced pressure and the crude material was dissolved in a 
minimum amount of CH2Cl2. Pentane was added and the resulting solution was 
filtered and concentrated under reduced pressure. The resulting mixture was dissolved 
in Et2O, washed with a saturated solution of NaHCO3, a saturated solution of Na2S2O3 
and brine. The combined organic layers were dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude mixture was purified by silica flash 
chromatography to afford 268 (550 mg, 83%) as a yellow oil. 268 was isolated pure 
(TLC analysis) however due to its instability 1H and 13C show a mixture of 268 and 
elimination product 272. 
 
1H NMR (400 MHz, CDCl3) δ 7.48-7.40 (m, 6H, Ar-H), 7.37-7.18 (m, 9H, Ar-H), 
3.44 (dd, J = 9.6, 4.8 Hz, 1H), 3.34 (dd, J = 9.6, 6.3 Hz, 1H), 3.11 (dd, J = 9.2, 
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5.1 Hz, 1H), 2.98 (dd, J = 9.2, 7.2 Hz, 1H), 1.90-1.78 (m, 1H, 2-H), 1.00 (d, 
J = 6.7 Hz, 3H, 2-CH3); 13C NMR (100 MHz, CDCl3) δ 142.6 (CAr), 128.6 (CAr), 
127.8 (2 X CAr), 127.0 (2 X CAr), 66.9, 36.0, 18.0, 13.2, (one quaternary C missing). 
Match the literature data.129 
 
 
{[(2-Methylprop-2-en-1-yl)oxy]diphenylmethyl}benzene 
 
 
272 
 
1H NMR (400 MHz, CDCl3) δ 7.48-7.40 (m, 6H, Ar-H), 7.37-7.18 (m, 9H, Ar-H), 
5.28 (s, 1H, 3-Ha), 4.96 (s, 1H, 3-Hb), 3.54 (s, 2H, 1-H), 1.74 (s, 3H, 2-CH3); 
13C NMR (100 MHz, CDCl3) δ 144.3 (C-2), 142.6 (CAr), 128.7 (CAr), 127.8 
(2 X CAr), 126.9 (2 X CAr), 110.2 (C-3), 67.4 (C-1), 19.9 (2-CH3), (one quaternary C 
missing). 
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{[(2S)-3-Bromo-2-methylpropoxy]diphenylmethyl}benzene 
 
 
269 
 
To a solution of NBS (0.8 mg, 4.5 mmol), and PPh3 (1.20 g, 4.5 mmol) dissolved in 
CH2Cl2 (50 mL) was added 267 (0.5 mg, 1.5 mmol) dissolved in CH2Cl2 (5 mL). The 
reaction mixture was stirred for 24 h at rt. The reaction mixture was concentrated 
under reduced pressure and the crude material was dissolved in a minimum amount of 
CH2Cl2. Pentane was added and the resulting solution was filtered and concentrated 
under reduced pressure. The resulting mixture was dissolved in Et2O, washed with a 
saturated solution of NaHCO3, a saturated solution of Na2S2O3 and brine. The organic 
layer was dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
mixture was purified by silica flash chromatography to afford 269 as a yellow oil 
(0.5 mg, 85%).  
 
1H NMR (400 MHz, CDCl3) δ 7.48-7.40 (m, 6H, Ar-H), 7.37-7.18 (m, 9H, Ar-H), 
3.62 (dd, J = 9.8, 5.0 Hz, 2H), 3.52 (dd, J = 9.8, 6.2 Hz, 1H), 3.13 (dd, J = 9.2, 
5.1 Hz, 1H), 3.05 (dd, J = 9.2, 7.0 Hz, 1H), 1.37-1.29 (m, 1H, 2-H), 1.00 (d, J = 
6.7 Hz, 3H, 2-CH3); 13C NMR (100 MHz, CDCl3) δ 144.1 (CAr), 128.7 (CAr), 127.8 
(2 X CAr), 127.0 (2 X CAr), 65.7, 38.4, 18.0, 16.0, (C(Ph3) missing). 
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(2S)-2-Methyl-3-(triphenylmethoxy)propyl 4-methylbenzene-1-sulfonate 
 
 
270 
 
To a solution of TsCl (17 g, 90 mmol) dissolved in pyridine (50 mL) was added 267 
(20 g, 60 mmol) in pyridine (50 mL) at 0 °C. The reaction mixture was stirred at 0 °C 
for 5 h. The reaction was quenched with water and stirred for 10 min in order to 
hydrolyse the excess of TsCl. The aqueous layer was then extracted with CH2Cl2 
(X 2) and the combined organic layers were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude solid was purified by 
trituration in hexanes to afford 270 as a white solid (28 g, 98%). 
 
mp: 90-92 ºC (CH2Cl2/hexane); IR (neat): 2967, 2880, 1492, 1448, 1360, 1174, 976, 
809, 778 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.81-7.79 (m, 2H, Ar-H), 7.36-7.26 (m, 
17H, Ar-H), 4.04 (dd, J = 9.0, 4.6 Hz, 1H, 3-Ha), 4.00 (dd, J = 9.0, 5.2 Hz, 1H, 
3-Hb), 3.60 (dd, J = 10.9, 5.0 Hz, 1H, 1-Ha), 3.03 (dd, J = 10.9, 6.5 Hz, 1H, 1-Hb), 
2.45 (s, 3H, CH3), 2.04-1.970 (m, 1H, 2-H), 0.86 (d, J = 7.06 Hz, 3H, 2-CH3); 
13C NMR (100 MHz, CDCl3) δ 144 6 (CAr), 143.9 (CAr), 133.0 (CAr), 129.8 (CAr), 
128.6 (CAr), 127.9 (CAr), 127.7 (CAr), 127.0 (CAr), 113.8 (CAr), 86.4 (C), 72.5 
(CH), 64.2 (CH), 34.0 (CH), 21.7 (CH3), 13.9 (CH3); MS (ESI) m/z 509 [M+Na]+, 
525 [M+K]+, 243 [CPh3]+; HRMS (ESI) m/z calculated for C30H30O4SNa [M+Na]+ 
509.1763, found 509.1743; [α]D: +10.0 (c 1.8, CH2Cl2). 
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1-Methoxy-4-({[(5R)-5-methyl-6-(triphenylmethoxy)hexyl]oxy}methyl)benzene 
 
 
271 
 
Procedure A 
To a solution of proparylic alcohol 264 (120 mg , 0.7 mmol) dissolved in THF (1 mL) 
was added dropwise n-BuLi (1.6 M in hexanes, 0.44 mL) at -78 °C. The reaction 
mixture was stirred for 30 min at 0 °C, then 268 (350 mg, 7.2 mmol) dissolved in 
DMSO (2 mL) was added. The reaction mixture was stirred for 2 h and quenched by 
addition of a saturated solution of NH4Cl. The aqueous layer was extracted with Et2O 
(X 2) and the combined organic layers were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude material was purified by 
silica flash chromatography (5% Et2O in hexanes) to afford 271 (60 mg, 20%) as a 
colourless oil and as the minor product. A mixture of starting material 268 and 
elimination product 272 was isolated too. 
 
Procedure B 
To a solution of proparylic alcohol 264 (120 mg, 0.7 mmol) dissolved in THF (1 mL) 
was added dropwise n-BuLi (1.6 M in hexanes, 0.44 mL,) at -78 °C. The reaction 
mixture was stirred for 30 min at 0 °C, then 269 (250 mg, 0.63 mmol) dissolved in 
DMSO (2 mL) was added. The reaction mixture was stirred for 2 h and quenched by 
addition of a saturated solution of NH4Cl. The aqueous layer was extracted with Et2O 
(X 2) and the combined organic layers were washed with brine, dried (MgSO4), 
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filtered and concentrated under reduced pressure. The crude material was purified by 
silica flash chromatography (5% Et2O in hexanes) to afford 271 (35 mg, 12%) as a 
colourless oil and the minor product. A mixture of starting material 269 and 
elimination product 272 was isolated too. 
 
Procedure C 
To a solution of proparylic alcohol 264 (17.9 g, 101 mmol) dissolved in THF (20 mL) 
was added dropwise n-BuLi (2.5 M in hexanes, 40.6 mL,) at -78 °C. The reaction 
mixture was stirred for 30 min at 0 °C, then 270 (26.0 g, 53 mmol) dissolved in 
DMSO (180 mL) was added. The reaction mixture was stirred for 2 h and quenched 
by addition of a saturated solution of NH4Cl. The aqueous layer was extracted with 
Et2O (X 2) and the combined organic layers were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude material was purified by 
silica flash chromatography (5% Et2O in hexanes) to afford 271 (22.0 g, 89%) as a 
colourless oil. 
 
IR (neat): 3059, 2959, 2913, 2865, 1611, 1586, 1512, 1490, 1461, 1356, 1247, 1173, 
1067, 1033, 986, 819, 763, 697 cm-1; 1H NMR δ 7.44-7.42 (m, 6H, Ar-H), 7.30-7.21 
(m, 11H, Ar-H), 6.91-6.82 (m, 2H, Ar-H), 4.50 (s, 2H, 7-H2), 4.14 (t, J = 2.1 Hz, 2H, 
6-H2), 3.80 (s, 3H, O-CH3), 3.03 (dd, J = 8.9, 5.5 Hz, 1H, 1-Ha), 3.03 (dd, J = 8.9, 
6.9 Hz, 1H, 1-Hb), 2.50-2.42 (m, 1H, 3-Ha), 2.30-2.23 (m, 1H, 3-Hb), 2.03-1.94 (m, 
1H, 2-H), 1.01 (d, J = 6.8 Hz, 3H, 2-CH3); 13C NMR (100 MHz, CDCl3) δ 159.3 
(CAr), 144.3 (CAr), 129.8 (2 X CAr), 128.8(2 X CAr), 127.7 (2 X CAr), 126.9 
(2 X CAr), 113.8 (2 X CAr), 86.2 (C), 85.5 (C), 70.9 (C-7), 67.0 (C-1), 57.3 (C-6), 
55.3 (O-CH3), 33.6, 23.3, 16.8, (C(Ph3) missing); MS (ESI) m/z 513 [M+Na]+, 529 
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[M+K]+, 243 [CPh3]+; HRMS (ESI) m/z calculated for C34H34O3Na [M+Na]+ 
513.2406, found 513.2414; [α]D: +4.3 (c 1, CHCl3); Elem. Anal. Calculated for 
C34H34O3 C 83.23, H 6.98, found C 83.17, H 6.86. 
 
 
(5R)-5-Methyl-6-(triphenylmethoxy)hex-2-yn-1-ol 
 
 
273 
 
To a solution of 271 (400 mg, 0.82 mmol) dissolved in CH2Cl2/water (30 mL, 2:1) 
was added DDQ (374 mg, 1.63 mmol). The mixture was vigorously stirred for 3 h. 
Then the reaction was quenched with water and the aqueous layer was extracted with 
CH2Cl2 (X 2). The combined organic layers were dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude material was purified by flash 
chromatography to afford 273 (225 mg, 75%) as a white gum. 
 
1H NMR δ 7.48-7.44 (m, 6H, Ar-H), 7.35-7.24 (m, 9H, Ar-H), 4.20 (t, J = 2.1 Hz, 
1H, 6-Ha), 4.19 (t, J = 2.1 Hz, 1H, 6-Hb), 3.09-3.00 (m, 2H, 1-H2), 2.44 (ddt, 
J = 16.6, 5.8, 2.1 Hz, 1H, 3-Ha), 2.30-2.23 (ddt, J = 16.6, 6.9, 2.1 Hz, 1H, 3-Hb), 
2.05-2.00 (m, 1H, 2-H), 1.02 (d, J = 6.8 Hz, 3H, 2-CH3); 13C NMR (100 MHz, 
CDCl3) δ 144.3 (CAr), 128.8 (CAr), 127.9 (CAr), 127.7 (CAr), 126.9 (2 X CAr), 86.0 
(C), 79.8 (C), 66.7, 51.4, 33.5, 23.1, 16.8, (C(Ph3) missing); [α]D: +4.3 (c 1, CHCl3). 
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({[(2R)-6-Azido-2-methylhex-4-yn-1-yl]oxy}diphenylmethyl)benzene 
 
 
274 
 
To a solution of 273 (400 mg, 1.08 mmol) dissolved in PhMe (4 mL) and cooled to 
0 °C was added dropwise DBU (210 µL) followed by DPPA (303 µL). The reaction 
mixture was slowly allowed to reach rt then heated to 50 °C and stirred for 4 h. The 
reaction was quenched with water and the aqueous layer was extracted with EtOAC 
(X 2). The combined organic layers were washed with aqueous HCl (0.5 M), dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude material was 
purified by silica flash chromatography (10% EtOAc in hexanes) to afford 274 
(360 mg, 84%) as a colourless oil. This intermediate was unstable. 
 
IR (thin layer): 3058, 2962, 2931, 2865, 2131, 1491, 1448, 1069, 901, 735 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.48-7.44 (m, 6H, Ar-H), 7.35-7.24 (m, 9H, Ar-H), 
3.86 (t, J = 2.2 Hz, 2H, 6-H2), 3.08 (dd, J = 8.9, 5.3 Hz, 1H, 1-Ha), 3.02 (dd, J = 8.9, 
7.0 Hz, 1H, 1-Hb), 2.52-2.47 (m, 1H, 3-Ha), 2.35-2.28 (m, 1H, 3-Hb), 2.08-1.98 (m, 
1H, 2-H), 1.04 (d, J = 6.8 Hz, 3H, 2-CH3); 13C NMR (100 MHz, CDCl3) δ 144.3 
(CAr), 128.7 (CAr), 127.7 (2 X CAr), 126.9 (2 X CAr), 86.7 (C), 86.2 (C), 66.7, 40.3, 
33.5, 23.0, 16.7, (C(Ph3) missing). 
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(2Z,5R)-5-Methyl-6-(triphenylmethoxy)hex-2-en-1-amine 
 
 
275 
 
To a solution of 274 (80 mg, 0.2 mmol) dissolved in DMF (1 mL) were added EDA 
(35 µL, 0.53 mmol) and Lindlar catalyst (5 wt. % Pd on CaCO3, poisoned with lead, 
8 mg, 10 wt. %). The reaction was placed under H2 atmosphere and stirred for 1 h. 
The reaction mixture was filtered through celite, washed with MeOH and 
concentrated under reduced pressure. The resulting mixture was dissolved in EtOAc 
and washed with water and aqueous NH4Cl (2 wt. %). The organic layer was 
concentrated under reduced pressure and the crude material was purified by silica 
flash chromatography (10% MeOH in CHCl3) to afford amine 275 (56 mg, 75%) as a 
colourless oil with good purity without further purification. 
 
1H NMR (400 MHz, CDCl3) δ 7.48-7.44 (m, 6H, Ar-H), 7.35-7.24 (m, 9H, Ar-H), 
5.50 (dt, J = 10.8, 6.8 Hz, 1H), 5.39 (dt, J = 10.8, 7.4 Hz, 1H), 3.29 (d, J = 6.7 Hz, 
2H, 6-H2), 3.02 (d, J = 6.0 Hz, 1H, 1-Ha), 2.97 (d, J = 6.0 Hz, 1H, 1-Hb), 2.27-2.21 
(m, 1H, 3-Ha), 2.00-1.93 (m, 1H, 3-Hb), 1.88-1.82 (m, 3H, 2-H, N-H2), 0.96 (d, 
J = 6.8 Hz, 3H, 2-CH3); 13C NMR (100 MHz, CDCl3) δ 144.3 (CAr), 131.3 (CH), 
129.0 (CH), 128.8 (CAr), 127.7 (2 X .CAr), 126.8 (2 X CAr), 86.2 (C), 67.9 (C-1), 
38.7 (C-6), 34.3 (C-3), 31.3 (C-2) 17.1 (2-CH3). 
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(2R)-6-[(4-Methoxyphenyl)methoxy]-2-methylhex-4-yn-1-ol 
 
 
276 
 
To a solution of 271 (23.5 g, 480 mmol) in MeOH (250 mL) was added p-TsOH 
(13.7 g, 720 mmol) at 0 °C. The mixture was allowed to reach rt and stirred for 2 h. 
The reaction was quenched by addition of NaHCO3, stirred for 15 min, then filtered 
and concentrated under reduced pressure. The resulting oil was dissolved in Et2O and 
the solution was washed with brine. The organic layer was dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude material was purified by silica 
flash chromatography (15 to 20% Et2O in hexanes) to afford 276 (8.5 g, 72%) as a 
colourless oil. 
 
IR (neat): 3423, 2960, 2919, 2871, 1614, 1588, 1516, 1461, 1356, 1356, 1246, 1175, 
1034, 989, 817 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 8.7 Hz, 2H, Ar-H), 
6.90 (d, J   8.7 Hz, 2H, Ar-H), 4.54 (s, 2H, 7-H2), 4.15 (t, J = 2.2 Hz, 2H, 6-H2), 3.83 
(s, 3H, O-CH3), 3.60 (d, J = 6.1 Hz, 2H, 1-H2), 2.36 (ddt, J = 16.8, 6.2, 2.2 Hz, 1H, 
3-Ha), 2.29 (ddt, J = 16.8, 6.4, 2.2 Hz, 1H, 3-Hb), 1.98-1.86 (m, 1H, 2-H), 1.04 (d, 
J = 6.8 Hz, 3H, 2-CH3); 13C NMR (100 MHz, CDCl3) δ 159.3 (CAr), 129.7 (CAr), 
128.6 (2 X CAr), 113.8 (2 X CAr), 85.0 (C), 71.0 (C-7), 67.0 (C-1), 57.3 (C-6), 55.3 
(O-CH3), 33.1 (C-2), 22.7 (C-3), 16.3 (2-CH3); MS (CI) m/z 266 [M+NH4]+, HRMS 
(ESI) m/z calculated for C15H24NO3 [M+NH4]+ 266.1756, found 266.1686; [α]D: +6.0 
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(c 1, CH2Cl2); Elem. Anal. Calculated for C15H20O3 C 72.55, H 8.12, found C 72.61, 
H 7.96. 
 
 
(2R,4Z)-6-[(4-Methoxyphenyl)methoxy]-2-methylhex-4-en-1-ol 
 
 
277 
 
To a solution of 276 (13.5 g, 54 mmol) dissolved in EtOAc (150 mL) were added 
quinoline (11 mL, 6.6 mmol) and Lindlar catalyst (5 wt. % Pd on CaCO3, poisoned 
with lead, 130 mg, 10 wt. %). The reaction was placed under a H2 atmosphere and 
stirred for 2 h. The reaction mixture was filtered through celite and the resulting 
solution was washed with aqueous HCl (1 M). The organic layer was concentrated 
under reduced pressure and the crude material was purified by silica flash 
chromatography (short pad, 20% EtOAc in hexanes) to afford 277 (12.2 g, 90%, less 
than 5% of E isomere by 1H NMR) as a colourless oil. 
 
IR (neat): 3423, 3019, 2960, 2959, 2933, 2913, 2875, 2833, 1614, 1590, 1515, 1464, 
1356, 1303, 1248, 1178, 1080, 1034, 986, 820 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.27 (d, J = 8.9 Hz, 2H, Ar-H), 6.88 (d, J = 8.9 Hz, 2H, Ar-H), 5.73-5.61 (m, 2H), 
4.45 (s, 2H, 7-H2), 4.07-3.97 (m, 2H, 6-H2), 3.80 (s, 3H, O-CH3), 3.51-3.41 (m, 2H, 
1-H2), 2.21-2.14 (m, 1H, 3-Ha), 2.04-1.97 (m, 1H, 3-Hb), 1.77-1.69 (m, 1H, 2-H), 
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0.93 (d, J = 6.8 Hz, 3H, 2-CH3); 13C NMR (100 MHz, CDCl3) δ 159.2 (CAr), 132.5 
(CH), 129.5 (CAr), 126.96 (CH), 113.8 (CAr), 72.1 (C-7), 67.0 (C-1), 65.1 (C-6), 
55.3 (O-CH3), 35.8 (C-2), 31.0 (C-3), 16.5 (2-CH3); MS (ESI) m/z 251 [M+H]+, 
HRMS (ESI) m/z calculated for C15H23O3 [M+H]+ 251.1647, found 251.1643; [α]D: 
-2.0 (c 1.1, CH2Cl2); Elem. Anal. Calculated for C15H22O3 C 71.97, H 8.86, found C 
72.89 H 8.73. 
 
 
(4S)-4-Benzyl-3-[(2S,3R,4R,6Z)-3-hydroxy-8-[(4-methoxyphenyl)methoxy]-2,4-
dimethyloct-6-enoyl]-1,3-oxazolidin-2-one 
 
 
278 
 
A-To a solution of oxalyl chloride (7.6 mL, 89.6 mmol) in CH2Cl2 (200 mL) was 
added DMSO (11.2 mL, 157 mmol) at -78 °C. The mixture was stirred 20 min, then 
277 (11.2 g, 44.8 mmol) dissolved in CH2Cl2 (40 mL) was slowly added. The mixture 
was stirred 45 min then NEt3 (30.0 mL, 179 mmol) was added. The mixture was 
slowly allowed to reach 0 °C and quenched by addition of a saturated solution of 
NaHCO3. The aqueous layer was extracted with CH2Cl2 (X 3) and the combined 
organic layers were washed with a saturated solution of CuSO4, brine and water, dried 
(MgSO4), filtered and concentrated under reduced pressure to afford the crude 
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aldehyde (11.0 g, 100%) which was used immediately without any further 
purification. 
B-To a solution of ent-42 (11.5 g, 49.2 mmol) in CH2Cl2 (100 mL) was added 
Bu2BOTf (40 mL, 1 M) followed by i-Pr2NEt (7 mL, 40.3 mmol) at -78 °C. The 
mixture was stirred at rt for 1 h. At -78 °C was slowly added previous aldehyde 
(11.0 g, 44.8 mmol) dissolved in CH2Cl2 (10 mL). The mixture was stirred for 3 h at 
-78 °C then slowly warmed up to -20 °C. The mixture was poured into a saturated 
solution of NaHCO3. Aqueous layer was extracted with CH2Cl2 (X 2). The combined 
organic layers were dried (MgSO4), filtered and concentrated under reduced pressure. 
The crude material was purified by silica flash chromatography (20 to 40% EtOAc in 
hexane) to afford 279 (15.7 g, 73% yield over two steps, dr = 96:4 by 1H NMR of the 
crude material) as a colourless oil. 
 
IR (neat): 3529, 2969, 2935, 2865, 1776, 1693, 1612, 1585, 1512, 1454, 1384, 1351, 
1241, 1208, 1075, 1032, 983, 819, 750, 701 cm-1; 1H NMR δ 7.39-7.22 (m, 7H, 
Ar-H), 6.90 (d, J = 8.6 Hz, 2H, Ar-H), 5.75-5.64 (m, 2H), 4.72-4.66 (m, 1H, 3-H), 
4.47 (s, 2H, 13-H2), 4.22-4.20 (m, 2H, 2-H2), 4.15-4.05 (m, 2H, 12-H2), 4.00-3.93 (m, 
1H, 6-H), 3.82 (s, 3H, O-CH3), 3.68-3.65 (m, 1H,7-H), 3.28 (dd, J = 13.4, 3.3 Hz, 1H, 
4-Ha), 2.82 (dd, J = 13.4, 9.5 Hz, 1H, 4-Hb), 2.45-2.39 (m, 1H, 9-Ha), 2.20-2.13 (m, 
1H, 9-Hb), 1.78-1.69 (m, 1H, 8-H), 1.26 (d, J = 7.1 Hz, 3H), 0.91 (d, J = 6.9 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 177.7 (C-5), 159.1 (CAr), 152.8 (C-1), 135.0 (CAr), 
131.5 (CH), 130.4 (CAr), 129.4 (3CAr), 128.9 (2 X CAr), 127.7 (CH), 127.4 
(2 X CAr), 113.7 (2 X CAr), 74.3 (C-7), 71.9 (C-13), 66.1 (C-2), 65.5 (C-12), 55.2 
(C-3), 55.1 (O-CH3), 39.4 (C-6), 37.7 (C-4), 35.8 (C-8), 30.7 (C-9), 15.3 (CH3), 9.5 
(CH3); MS (ESI) m/z 482 [M+H]+, 504 [M+Na]+, 520 [M+K]+; HRMS (ESI) m/z 
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calculated for C28H36NO6 [M+H]+ 482.2543, found 482.2535; [α]D: +27.5 (c 2.3, 
CH2Cl2); Elem. Anal. Calculated for C28H35NO6 C 69.83, H 7.33, found C 69.98, H 
7.50. 
 
 
(4S)-4-Benzyl-3-[(2S,3R,4R,6Z)-3-[(tert-butyldimethylsilyl)oxy]-8-[(4-
methoxyphenyl)methoxy]-2,4-dimethyloct-6-enoyl]-1,3-oxazolidin-2-one 
 
 
278’ 
 
To a solution of 278 (11.3 g, 23.5 mmol) in CH2Cl2 (150 mL) at 0 °C was slowly 
added i-Pr2NEt (16.4 mL, 94 mmol) followed by TBSOTf (11 mL, 47 mmol). The 
reaction mixture was stirred for 3 h at 0 °C and poured into a saturated solution of 
NaHCO3. The aqueous layer was extracted with CH2Cl2 (X 2). The combined organic 
layer were dried (MgSO4), filtered and concentrated under reduced pressure. The 
crude material was purified by silica flash chromatography (10% EtOAC in hexanes) 
to afford the 278’ (12.7 g, 91%) as a colourless oil. 
 
IR (neat): 2961, 2927, 2855, 1781, 1696, 1612, 1513, 1463, 1381, 1351, 1249, 1210, 
1085, 1036, 971, 836, 774, 702 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.36-7.20 (m, 
7H, Ar-H), 6.87 (d, J = 8.6 Hz, 2H, Ar-H), 5.66-5.53 (m, 2H), 4.62-4.56 (m, 1H, 
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3-H), 4.42 (s, 2H, 13-H2), 4.16-3.97 (m, 6H, 2-H2, 6-H, 7-H, 12-H2,), 3.82 (s, 3H, 
O-CH3), 3.25 (dd, J = 13.3, 3.2 Hz, 1H, 4-Ha), 2.75 (dd, J = 13.3, 9.6 Hz, 1H, 4-Hb), 
2.24-2.18 (m, 1H, 9-Ha), 1.85-1.77 (m, 1H, 9-Hb), 1.67-1.59 (m, 1H, 8-H), 1.24 (d, 
J = 6.5 Hz, 3H), 0.95-0.93 (m, 12H), 0.07 (s, 3H, TBS-H), 0.05 (s, 3H, TBS-H); 
13C NMR (100 MHz, CDCl3) δ 175.9 (C-5), 159.1 (CAr), 152.9 (C-1), 135.2 (CAr), 
132.3 (CH), 130.4 (CAr), 129.4 (CAr), 129.3 (CAr), 128.9 (CH), 127.3 (CAr), 113.7 
(CAr), 76.3 (C-7), 71.8 (C-13), 66.0 (C-2), 65.6 (C-12), 55.6 (C-3), 55.2 (O-CH3), 
41.3 (C-6), 39.2 (C-8), 37.6 (C-4), 30.0 (C-9), 26.1 (CTBS), 18.3 (CTBS), 16.3 
(CH3), 13.9 (CH3), -3.6 (CTBS), -4.0 (CTBS); MS (ESI) m/z 596 [M+H]+, 618 
[M+Na]+, 634 [M+K]+; HRMS (ESI) m/z calculated for C34H50NO6Si [M+H]+ 
596.3407, found 596.3417; [α]D: +52.1 (0.6, CH2Cl2); Elem. Anal. Calculated for 
C34H49NO6Si C 68.54, H 8.29, N 2.35, found C 68.58, H 8.18, N 2.29. 
 
 
(2R,3R,4R,6Z)-3-[(tert-Butyldimethylsilyl)oxy]-8-[(4-methoxyphenyl)methoxy]-
2,4-dimethyloct-6-en-1-ol 
 
 
279 
 
To a solution of 278’ (9.0 g, 15.1 mmol) in CH2Cl2/MeOH (100mL, 10:1) was added 
LiBH4 (0.7 g, 30 mmol) at 0 °C. The reaction was stirred 15 min at 0 °C and 2 h at rt. 
The mixture was quenched by addition of a saturated solution of NH4Cl and the 
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aqueous layer was extracted with CH2Cl2 (X 2). The combined organic layers were 
dried (MgSO4), filtered and concentrated under reduced pressure. The crude material 
was purified by silica flash chromatography (20% EtOAc in hexanes) to afford the 
alcohol 279 (3.8 g, 63%) as a colourless oil. 
 
IR (neat): 3939, 2955, 2927, 2855, 1613, 1513, 1463, 1381, 1302, 1249, 1172, 1092, 
1037, 836, 773 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 7.9 Hz, 2H, Ar-H), 
6.87 (d, J = 8.6 Hz, 2H, Ar-H), 5.69-5.55 (m, 2H), 4.44 (s, 2H, 9-H2), 4.09-3.94 (m, 
2H, 8-H2), 3.80 (s, 3H, O-CH3), 3.68 (dd, J = 5.2, 2.2 Hz, 1H, 3-H), 3.51-3.36 (m, 
2H, 1-H2), 2.28-2.21 (m, 1H, 5-Ha), 1.91-1.69 (m, 3H, 5-Hb, 1-H2), 0.90-0.83 (m, 
15H, 2-CH3, 4-CH3, TBS-H), 0.07 (s, 3H, TBS-H), 0.05 (s, 3H, TBS-H); 13C NMR 
(100 MHz, CDCl3) δ 159.1 (CAr), 132.3 (CH), 130.4 (CAr), 129.4 (2 X CAr), 126.7 
(CH), 113.7 (2 X CAr), 75.4 (C-3), 72.1 (C-9), 66.3 (C-1), 65.5 (C-8), 55.3 (O-CH3), 
38.2 (C-4), 38.1 (C-2), 31.3 (C-5), 26.1 (CTBS), 18.3 (CTBS), 16.5 (CH3), 11.8 
(CH3), -4.0 (CTBS), -4.3 (CTBS); MS (ESI) m/z 423 [M+H]+, 445 [M+Na]+, 461 
[M+K]+; HRMS (ESI) m/z calculated for C24H43O6Si [M+H]+ 423.2931, found 
423.2936; [α]D: -5.2 (c 0.6, CH2Cl2); Elem. Anal. Calculated for C24H42O4Si C 68.20, 
H 10.02, found C 68.20, H 9.88. 
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(1S)-1-phenylbut-3-yn-1-ol 
 
 
286 
 
To a suspension of In(0) (0.58 g, 5 mmol), chiral auxiliary 297 (1.08 mg, 5 mmol) and 
pyridine (400 µL, 5 mmol) in THF (30 mL) under argon at rt was slowly added 
propargyl bromide (600 µL, 5 mmol). The cloudy suspension was stirred for 30 min. 
Benzaldehyde (295) (250 µL, 2.5 mmol) was added dropwise at -78 °C and the 
reaction was stirred for 24 h, then 5 h during a slow warming to rt. The reaction 
mixture was then quenched with aqueous HCl (1 M). The aqueous layer was extracted 
with EtOAc/hexanes (1:1) (X 3) and the combined organic layers were dried 
(MgSO4), filtered and concentrated under reduced pressure. 1H NMR of the crude 
material revealed 80% of conversion. The crude oil was purified by silica flash 
chromatography (10% EtOAc in hexanes) to afford 286 as a colourless oil. (Optical 
rotation comparison indicated ee = 83%) 
 
1H NMR (400 MHz, CDCl3) δ 7.40-7.28 (m, 5H, Ar-H), 4.84 (t, J = 6.5 Hz, 1H, 1-H), 
2.62 (dd, J = 6.5, 2.5 Hz, 2H, 2-H), 2.49 (br s, 1H, O-H), 2.05 (t, J = 2.7 Hz, 1H, 
4-H); 13C NMR (100 MHz, C6D6) δ 141.8 128.1, 127.5, 125.6, 80.5, 72.2, 69.8, 29.0; 
[α]D: -9.9 (c 1.5, MeOH) [lit30 (R)-enantiomer, [α]D: +11.18 (c 1.7, MeOH, 93% ee)]. 
Match the literature data30 
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 (4S,5R,6R,7R,9Z)-6-[(tert-Butyldimethylsilyl)oxy]-11-[(4-
methoxyphenyl)methoxy]-5,7-dimethylundec-9-en-1-yn-4-ol 
 
 
307 
 
A-To a solution of oxalyl chloride (1.5 mL, 18 mmol) in CH2Cl2 (60 mL) was added 
DMSO (2.2 mL, 32 mmol) at -78 °C. The mixture was stirred 20 min, then 279 (3.8 g, 
9 mmol) dissolved in CH2Cl2 (5 mL) was slowly added. The mixture was stirred 
45 min then NEt3 (750 µL, 4.4 mmol) was added. The mixture was slowly allowed to 
reach 0 °C then quenched by addition of a saturated solution of NaHCO3. The 
aqueous layer was extracted with CH2Cl2 (X 3) and the combined organic layers were 
washed with a saturated solution of CuSO4, brine, water, dried (MgSO4), filtered and 
concentrated under reduced pressure to afford the crude aldehyde (3.6 g, 95%), which 
was used without any further purification (the crude material was divided into 2 
batches for the next step) 
B-To a suspension of In(0) (1.5 g, 3.07 mmol) in THF (25 mL), were added chiral 
auxiliary 297 (2.8 mg, 13 mmol), pyridine (1.0 mL, 13 mmol) and propargyl bromide 
(80 wt. % in PhMe, 1.4 mL, 13 mmol) at -20 °C. The mixture was stirred for 45 min 
then the crude aldehyde (1.8 g, 4.3 mmol) was added. The reaction mixture was 
stirred for 16 h. The mixture was then slowly allowed to reach rt and quenched with 
an aqueous HCl (1 M). The aqueous layer was extracted with 1:1 EtOAc/hexanes 
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(X 2) and the combined organic layers were dried (MgSO4), filtered and concentrated 
under reduced pressure. The crude material was purified by silica flash 
chromatography (10% EtOAc in hexanes) to afford a mixture of 307 and 308 (1:10, 
1.5 g, 75%) as a colourless oil. 1H NMR and mosher ester analysis showed the 
presence of one diastereoisomer (dr ≥ 97:3). Two batches = 3g. 
 
IR (neat): 3450, 3304, 2955, 2930, 2856, 1686, 1613, 1513, 1463, 1302, 1249, 1173, 
1086, 1034, 836, 774 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.6 Hz, 2H, 
Ar-H), 6.88 (d, J = 8.6 Hz, 2H, Ar-H), 5.68-5.54 (m, 2H), 4.44 (s, 2H, 12-H2), 4.04 
(d, J = 6.0 Hz, 2H, 11-H2), 3.81-3.76 (s, 4H, 4-H, O-CH3), 3.66 (dd, J = 4.6, 2.6 Hz, 
1H, 6-H), 2.38 (dd, J = 6.5, 2.6 Hz, 2H, 3-H2), 2.19 2.12 (m, 1H, 8-Ha), 2.01 (t, 
J = 2.62 Hz, 1H, 1-H), 1.89 1.87 (m, 2H, 8-Hb, 5-H), 1.78 1.71 (m, 1H, 7-H), 
0.94-0.89 (m, 15H, 5-CH3, 7-CH3, TBS-H), 0.08 (s, 3H, TBS-H), 0.06 (s, 3H, 
TBS-H), (Allene 10%, characteristic peaks δ 5.20-5.18 (m, 2H), 4.86 (dt, J = 6.5, 2.2 
Hz, 1H)); 13C NMR (100 MHz, CDCl3) δ 159.2 (CAr), 132.3 (CH), 130.4 (CAr), 
129.4 (2 X CAr), 127.2 (CH), 113.8 (2 X CAr), 81.2 (C-2), 77.9 (C-6), 72.9 (C-4), 
71.9 (C-12), 70.5 (C-1), 65.6 (C-11), 55.3 (O-CH3), 38.2 (C-7), 38.1 (C-5), 31.0 (C-
8), 26.0 (CTBS), 25.0 (C-3), 18.3 (CTBS), 16.0 (CH3), 8.81 (CH3), -3.5 (CTBS), -4.2 
(CTBS); MS (ESI) m/z 461 [M+H]+, 483 [M+Na]+, 499 [M+K]+; HRMS (ESI) m/z 
calculated for C27H45O4Si [M+H]+ 461.3087, found 461.3085; [α]D: -8.5 (c 0.8, 
CH2Cl2); Elem. Anal. Calculated for C27H44O4Si C 70.39, H 9.63, found C 72.46, H 
9.57. 
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Preparation of the (S)- and (R)-MTPA-esters of 307130 
To a solution of 307 (50 mg, 0.11 mmol) in CH2Cl2 (1 mL) were added EDC (65 mg, 
0.34 mmol), (S)-MTPA-OH (80 mg, 0.34 mmol) and DMAP (42 mg, 0.34 mmol). 
The reaction was stirred for 48 h and quenched by addition of water. The aqueous 
layer was extracted with Et2O (X 2) and the combined organic layers were dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude mixture was 
purified by silica flash chromatography (5% Et2O in hexanes) to give the 
(S)-MPTA-ester of 307 (30 mg, 40%) as a white solid. 
 
1H NMR (400 MHz, CDCl3) δ 7.54-7.53 (m, 2H), 7.42-7.40 (m, 3H), 7.26 (d, J = 8.6 
Hz, 2 H), 6.87 (d, J = 8.6 Hz, 2 H), 5.68-5.61 (m, 1H), 5.59-5.53 (m, 1H), 5.16 (dd, 
J = 5.8 Hz, 1H), 4.43 (s, 2H), 4.04 (d, J = 6.2 Hz, 1H), 3.80 (s, 3H), 3.50 (s, 3H), 3.40 
(t, J = 4.7 Hz, 1H), 2.65-2.54 (m, 2H), 2.23-2.14 (m, 2H), 1.91 (t, J = 2.6 Hz, 1H), 
1.88-1.82 (m, 1H), 1.74-1.67 (m, 1H), 0.93 (d, J = 6.9 Hz, 3H), 0.90 (s, 9H), 0.85 (d, 
J = 6.8 Hz, 3H), 0.04 (s, 3H), 0.03 (s, 3H). 
 
In an entirely analogous fashion, the (R)-MPTA-ester of 307 was prepared using 
(R)-MPTA-OH. 
 
1H NMR (400 MHz, CDCl3) δ 7.60-7.58 (m, 2H), 7.42-7.40 (m, 3H), 7.28 (d, 
J = 8.6 Hz, 2 H), 6.89 (d, J = 8.6 Hz, 2 H), 5.69-5.63 (m, 1H), 5.59-5.52 (m, 1H), 
5.19-5.15 (m, 1H), 4.45 (s, 2H), 4.05 (d, J = 6.2 Hz, 1H), 3.81 (s, 3H), 3.63 (s, 3H), 
3.35 (t, J = 4.7 Hz, 1H), 2.70 (ddd, J = 7.5, 2.5, 2.5 Hz, 1H), 2.62 (ddd, J = 7.5, 2.7, 
2.7 Hz, 1H), 2.20-2.13 (m, 2H), 2.02 (t, J = 2.4 Hz, 1H), 1.84-1.78 (m, 1H), 1.68-1.65 
 225 
(m, 1H), 0.90 (s, 9H), 0.82 (d, J = 6.9 Hz, 3H), 0.78 (d, J = 6.9 Hz, 3H), 0.02 (s, 3H), 
0.01 (s, 3H). 
 
 
 (4R,6Z)-8-[(4-Methoxyphenyl)methoxy]-2,4-dimethylocta-2,6-dienal 
 
 
309 
 
IR (neat): 3466, 2952, 2929, 2866, 1727, 1659, 1616, 1512, 1464, 1381, 1252, 1039, 
885, 834, 773, 680 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.37 (s, 1H 1-H), 7.26 (d, 
J = 8.6 Hz, 2H, Ar-H), 6.88 (d, J = 8.6 Hz, 2H, Ar-H), 6.24 (dd, J = 9.9, 1.3 Hz, 1H, 
3-H), 5.70-5.54 (m, 1H), 5.55-5.48 (m, 1H), 4.44 (s, 2H, 9-H2), 4.02 (d, J = 6.4 Hz, 
2H, 8-H2), 3.81 (s, 4H, O-CH3), 2.81-2.71 (m, 1H, 4-H), 2.24-2.09 (m, 2H, 5-H), 1.74 
(d, J = 1.3 Hz, 3H, 2-CH3), 1.08 (d, J = 6.6 Hz, 4-CH3); 13C NMR (100 MHz, CDCl3) 
δ 195.4 (C-1), 159.2 (CAr), 158.9 (C-2), 138.3 (CH), 130.3 (CH), 130.1 (CAr), 129.4 
(2 X CAr), 128.2 (CAr), 113.8 (2 X CAr), 71.9 (C-8), 65.3 (C-9), 55.3 (O-CH3), 34.2 
(C-4), 33.7 (C-5), 19.3 (2-CH3), 9.4 (4-CH3). 
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 (5R,6R,7S)-9,9-Diethyl-5-[(2R,4Z)-6-[(4-methoxyphenyl)methoxy]hex-4-en-2-yl]-
2,2,3,3,6-pentamethyl-7-(prop-2-yn-1-yl)-4,8-dioxa-3,9-disilaundecane 
 
 
310 
 
To a solution of 307 (110 mg, 0.24 mmol) in CH2Cl2 (3 mL) was added i-Pr2NEt 
(170 µL, 0.96 mmol) followed by TESOTf (75 µL, 0.5 mmol) at 0 °C. The reaction 
was stirred for 2 h then was quenched by addition of a saturated solution of NaHCO3. 
The aqueous layer was extracted with CH2Cl2 (X 2) and the combined organic layers 
were washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The crude material was purified by silica flash chromatography (10% Et2O 
in hexanes) to afford 310 (108 mg, 79%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.6 Hz, 2H, Ar-H), 6.88 (d, J = 8.6 Hz, 
2H, Ar-H), 5.67-5.55 (m, 2H), 4.44 (s, 2H, 12-H2), 4.06 (d, J = 5.8 Hz, 2H, 11-H2), 
3.81-3.76 (m, 4H, 4-H, O-CH3), 3.54 (dd, J = 5.3, 4.0 Hz, 1H, 6-H), 2.40 (ddd, 
J = 17.0, 6.5, 2.7 Hz, 2H, 3-Ha), 2.37 (ddd, J = 17.0, 5.0, 2.7 Hz, 2H, 3b-H), 
2.23-2.18 (m, 1H, 8-Ha), 2.00-1.85 (m, 3H, 8-Hb, 5-H, 1-H), 1.73-1.65 (m, 1H, 7-H), 
0.99-0.89 (m, 25H, 5-CH3, 7-CH3, TES-H, TBS-H), 0.65-0.59 (m, 6H, TES-H), 0.05 
(s, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 159.2 (CAr), 132.6 (CH), 
130.5(CAr), 129.3 (2 X CAr), 127.1 (CH), 113.8 (2 X CAr), 81.4 (C-2), 76.5 (C-6), 
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72.0 (C-4), 71.9 (C-12), 70.4 (C-1), 65.6 (C-11), 55.2 (O-CH3), 40.4 (C-7), 38.0 
(C-5), 29.7 (C-8), 26.2 (CTBS), 25.5 (C-3), 18.5 (CTBS), 16.9 (7-CH3), 10.3 (5-CH3), 
6.9 (CTES), 5.1 (CTES), -3.5 (CTBS); MS (ESI) m/z 575 [M+H]+, 592 [M+H2O]+, 
597 [M+Na]+, 613 [M+K]+; HRMS (ESI) m/z calculated for C33H59O4Si2 [M+H]+ 
575.3952, found 575.3962; [α]D: -8.5 (c 0.5, CHCl3). 
 
 
(5S,6R,7R,8R,10Z)-7-[(tert-Butyldimethylsilyl)oxy]-12-[(4-
methoxyphenyl)methoxy]-6,8-dimethyldodec-10-en-2-yn-5-ol 
 
 
312 
 
Procedure A 
To a solution of 310 (100 mg, 0.17 mmol) dissolved in THF (2 mL) was added n-
BuLi (2.5 M in hexanes, 83 µL,) followed by MeI (32 µL, 0.5 mmol) at -78 °C. The 
solution was stirred at rt for 2 h, then poured into a saturated solution of NH4Cl. The 
aqueous layer was extracted with CH2Cl2 and the combined organic layers were 
washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. 
The crude material was then redissolved in i-PrOH (2 mL) and H2SiF6 (25 wt. % in 
water, 32 µL) was added at 0 °C. The reaction was slowly allowed to reach rt and 
stirred for 30 min. Then the reaction was poured into water. The organic layer was 
6
8
OTBS
11 O
12
OMe
OH
3
1
13
 228 
dried (MgSO4), filtered and concentrated under reduced pressure. The crude material 
was purified by silica flash chromatography (10% EtOAc in hexane) to afford 312 
(35 mg, 42%) as a colourless oil. 
 
Procedure B 
To a solution of 307 (1.7 g, 3.7 mmol) dissolved in THF (3 mL) at -78 °C was added 
n-BuLi (2.5 M in hexanes, 3.0 mL) followed by MeI (1.2 mL, 18.5 mmol). The 
solution was stirred at rt for 2 h, then poured into a saturated solution of NH4Cl. The 
aqueous layer was extracted with CH2Cl2 (X 2). The combined organic layers were 
washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. 
The crude material was purified by silica flash chromatography (10% Et2O in 
hexanes) to afford 312 (1.0 g, 60%) as a colourless oil. 
 
IR (neat): 3450, 2956, 2928, 2855, 1613, 1513, 1463, 1302, 1249, 1173, 1086, 1034, 
836, 774 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.6 Hz, 2H, Ar-H), 6.88 (d, 
J = 8.6 Hz, 2H, Ar-H), 5.68  5.55 (m, 2H), 4.44 (s, 2H, 12-H2), 4.04 (d, J = 5.8 Hz, 
2H, 11-H2), 3.81 (s, 3H, O-CH3), 3.70 (m, 1H, 4-H), 3.63 (dd, J = 4.6, 3.4 Hz, 1H, 
6-H), 2.34-2.31 (m, 2H, 3-H2), 2.20-2.14 (m, 1H, 8-Ha), 1.91-1.81 (m, 2H, 8-Hb, 
5-H), 1.75-1.70 (m, 4H, 7-H, 1-CH3), 0.94-0.88 (m, 15H, 5-CH3, 7-CH3, TBS-H), 
0.07 (s, 3H, TBS-H), 0.06 (s, 3H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 159.2 
(CAr), 132.4 (CH), 130.4 (CAr), 129.4 (2 X CAr), 127.2 (CH), 113.8 (2 X CAr), 78.1 
(C-2), 77.8 (C-6), 75.6 (C-1), 72.9 (C-4), 71.9 (C-12), 65.6 (C-11), 55.3 (O-CH3), 
39.3 (C-7), 38.7 (C-5), 30.8 (C-8), 26.1 (CTBS), 25.5 (C-3), 18.4 (CTBS), 16.2 
(CH3), 9.1 (CH3), 3.5 (1-CH3), -3.5 (CTBS), -4.1 (CTBS); MS (ESI) m/z 475 [M+H]+, 
497 [M+Na]+, 513 [M+K]+; HRMS (ESI) m/z calculated for C28H47O4Si [M+H]+ 
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475.3244, found 475.3245; [α]D: -9.5 (0.4, CHCl3); Elem. Anal. Calculated for 
C27H44O4Si C 70.84, H 9.77, found C 70.96, H 9.69. 
 
 
Pent-3-yn-1-yl 2,4-dihydroxy-6-[(2R,3S)-3-methyl-2-{[tris(propan-2-
yl)silyl]oxy}hept-5-yn-1-yl]benzoate 
 
 
314 
 
To a solution of 215 (180 mg, 0.3 mmol) in PhMe (3.5 mL) was added 3-pentyn-1-ol 
(313) (55 µL, 0.3 mmol). The mixture was stirred at reflux for 30 min and was then 
concentrated under reduced pressure. The resulting yellow oil was dissolved in 
MeOH (3.5 mL) and treated with Cs2CO3 (200 mg, 0.6 mmol). The resulting mixture 
was stirred for 1 h then AcOH (63 µL, 1.1 mmol) was added and was stirred for 
further 10 min. Water and EtOAc were added and the aqueous layer was extracted 
with EtOAc (X 2). The combined organic layers were dried (MgSO4), filtered, 
concentrated under reduced pressure and purified by silica flash chromatography to 
afford 314 (105 mg, 67%) as a yellow oil. 
 
1H NMR (400 MHz, CDCl3) δ 11.39 (s, 1H, 8-OH), 6.32-6.30 (m, 2H, Ar-H), 5.20 (s, 
1H, 10-OH), 4.54 (dt, J = 10.6, 6.7 Hz, 1H, 5-Ha), 4.38 (dt, J = 10.6, 7.1 Hz, 1H, 
5-Hb) 4.20 (dt, J = 9.5, 2.8, 1H, 14-H), 3.27 (dd, J = 13.2, 2.8 Hz, 1H, 13-Ha), 2.73 
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(dd, J = 13.2, 9.5 Hz, 1H, 13-Hb), 2.62-2.47 (m, 2H, 4-H2), 2.22-2.08 (m, 2H, 16-H2), 
2.00-1.94 (m, 1H, 15-H), 1.78-1.76 (m, 6H, 1-H3, 19-H3), 1.04 (d, J = 6.8 Hz, 3H, 
15-CH3), 0.96-0.88 (s, 21H, TIPS-H); 13C NMR (100 MHz, CDCl3) δ 170.9 (C-6), 
164.9, 159.8, 145.5, 113.4, 106.1, 101.6, 78.2, 77.9, 75.5, 74.8 (2 X C) 63.5, 39.9, 
37.6, 22.6, 19.4, 18.1 (CTIPS), 14.4, 13.1 (CTIPS), 3.4 (2 X C); MS (ESI) m/z 501 
[M+H]+; HRMS (ESI) m/z calculated for C29H45O5Si [M+H]+ 501.3036, found 
501.3029; [α]D: +4.5 (c 0.5, CHCl3). 
 
 
Pent-3-yn-1-yl 2,4-dimethoxy-6-[(2R,3S)-3-methyl-2-{[tris(propan-2-
yl)silyl]oxy}hept-5-yn-1-yl]benzoate 
 
 
326 
 
To a solution of 314 (100 mg, 0.2 mmol) in acetone (15 mL) was added K2CO3 
(672 mg, 4.8 mmol) followed by MeI (500 µL, 8 mmol). The resulting mixture was 
stirred for 6 h. The reaction was quenched by addition of water and the aqueous layer 
was extracted with EtOAc (X 2). The combined organic layers were dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude product was purified by 
silica flash chromatography (10% Et2O in hexanes) to afford 326 (70 mg, 67%) as a 
colourless oil. 
 
10
8
OMe
MeO
6
O
4
1
13 16
19
TIPSO
O
 231 
IR (neat): 2940, 2922, 2865, 1724, 1599, 1459, 1422, 1327, 1267, 1203, 1157, 1091, 
1047, 883, 830, 678 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.46 (d, J = 2.1 Hz, 1H, Ar-
H ), 6.34 (d, J = 2.1 Hz, 1H, Ar-H), 4.44-4.31 (m, 2H, 5-H2), 4.19 (ddd, J = 7.5, 4.6, 
3.2 Hz, 1H, 14-H), 3.82 (s, 3H, O-CH3), 3.80 (s, 3H, O-CH3), 2.84 (dd, J = 13.8, 
4.6 Hz, 1H, 13-Ha), 2.64-2.54 (m, 3H, 13-Hb, 4-H2), 2.21-2.03 (m, 2H, 16-H2), 
1.94-1.84 (m, 1H, 15-H), 1.82-1.80 (m, 6H, 1-H3, 19-H3), 1.03-0.99 (m, 24H, 
TIPS-H, 14-CH3); 13C NMR (100 MHz, CDCl3) δ 167.8, 160.9, 158.2, 139.7, 117.0, 
107.5, 96.9, 78.2, 77.3, 76.4, 75.6, 74.8, 63.4, 56.0, 55.3, 38.7, 36.6, 21.8, 19.2, 18.1 
(CTIPS), 14.7, 12.9 (CTIPS), 3.4 (2 X C); MS (ESI) m/z 529 [M+H]+ 551 [M+Na]+ 
567 [M+K]+; HRMS (ESI) m/z calculated for C31H49O5Si [M+H]+ 529.3349, found 
529.3343; [α]D: +3.7 (c 0.8, CHCl3). 
 
 
5,5-Dimethyl-1,1,1-triphenyl-4-(trimethylsilyl)-3-[(triphenylsilyl)oxy]-2-oxa-4-
aza-1,5-disila-3-molybdaoctan-4-amine 
 
 
98 
 
To a suspension of Na2MoO4 (3.3 g, 16 mmol) in DME (100 mL) under Ar was added 
Me3SiCl (8 mL, 64 mmol). The reaction mixture was vigorously stirred under reflux 
for 16 h and was then concentrated under reduced pressure. The light blue residue was 
suspended in hexanes (70 mL). A solution of freshly prepared LiHMDS (31.7 mmol) 
in hexanes (27 mL) was added to a suspension of the resulting fine powder and the 
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mixture was stirred at rt for 2 h. Then the suspension was filtered through a canula 
under Ar, the filtrate was evaporated and the residue purified by high vacuum 
distillation to give 98 (4.0 g, 57%) as a pale yellow oil. This air-sensitive product was 
not characterized. 
 
 
1,1,1,5,5,5-Hexaphenyl-3-[(triphenylsilyl)oxy]-2,4-dioxa-1,5-disila-3-
molbdapenta-3-amine, pyridine adduct 
 
 
100 
 
To a solution of complex 98 (2.6 g, 5.7 mmol) in PhMe (80 mL) was added Ph3SiOH 
(4.7 g, 17.1 mmol) and the resulting mixture was stirred at 80 °C for 30 min. After 
reaching rt, pyridine (2.3 mL, 28.5 mmol) was introduced and the resulting solution 
was stirred for 18 h. The solvent was evaporated and the resulting foam was 
recrystallized twice from PhMe to give complex 100 (yield not recorded) as a yellow 
powder. Single crystals could be obtained and X-Ray proved the structure (Appendix 
1). 
 
IR (neat): 3065, 3049, 3025, 3010, 2999, 1609, 1588, 1484, 1449, 1427, 1113, 989, 
890, 738, 708, 697 cm-1; 1H NMR (400 MHz, CD2Cl2) δ 8.04 (br s, 2H), 7.60-7.36 
(m, 17H), 7.34-6.98 (m, 29H), 6.60 (br s, 2H). Match the literature data.33 
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 (8S,9R)-12,14-Dimethoxy-8-methyl-9-{[tris(propan-2-yl)silyl]oxy}-3,4,7,8,9,10-
hexahydro-1H-2-benzocyclodecan-1-one 
 
 
315 
 
To a solution of 326(15 mg, 0.03 mmol), dissolved in PhMe (1.5 mL) and heated at 
110 °C under a closed Ar atmosphere, was added catalyst 10 (7 mg, 20 mol %). After 
4 h, the reaction mixture was cooled to rt, filtered on a short pad of silica and the 
resulting filtrate was concentrated under reduced pressure. The crude material was 
purified by silica flash chromatography (10% Et2O in hexanes) to afford 315 as 
colourless oil (11 mg). The product could not be obtained pure but contaminated with 
Ph3SiOH therefore no yield was recorded. 
 
IR (neat): 2965, 2947, 2943, 2921, 2865, 1728, 1608; 1465, 1376, 1160, 1100, 1047, 
884, 713 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.44 (d, J = 2.3 Hz, 1H, Ar-H), 6.34 (d, 
J = 2.3 Hz, 1H, Ar-H), 5.25-5.19 (m, 1H, 15-Ha), 4.50-4.47 (m, 1H, 9-H), 4.01-3.97 
(m, 1H, 15-Hb), 3.81 (s, 3H, O-CH3), 3.79 (s, 3H, OCH3), 3.05 (dd, J = 13.1, 1.5 Hz, 
1H, 8-Ha), 2.65-2.56 (m, 1H, 14-Ha), 2.43-2.22 (m, 3H, 8-Hb, 10-H, 14-Hb), 
2.09-2.00 (m, 2H, 11-H2), 1.00-0.89 (m, 24H, TIPS-H, 10-CH3); 13C NMR (100 MHz, 
CDCl3) δ 168.3, 160.5, 158.8, 140.3, 115.3, 109.4, 96.9, 80.1, 79.5, 74.8, 61.4, 56.2, 
55.1, 37.8, 34.1, 23.5, 20.3, 18.1 (CTIPS), 13.8, 12.9 (CTIPS); MS (ESI) m/z 475 
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[M+H]+; HRMS (ESI) m/z calculated for C27H43O5Si [M+H]+ 475.2880, found 
475.2878; [α]D: not relevant. 
 
 
(5S,6R,7R,8R,10Z)-7-[(tert-Butyldimethylsilyl)oxy]-12-[4-
methoxyphenyl)methoxy]6,8-dimethyldodec-10-en-2-yn-5-yl 2,4-dihydroxy-6-
[(2R,3S)-3-methyl-2-{[tris(propan-2-yl)silyl]oxy}hept-5-yn-1-yl]benzoate 
and 
(5S,6R,7R,8R,10Z)-7-[(tert-Butyldimethylsilyl)oxy]-12-[4-
methoxyphenyl)methoxy]6,8-dimethyldodec-10-en-2-yn-5-yl 2-dihydroxy-4-
methoxy-6-[(2R,3S)-3-methyl-2-{[tris(propan-2-yl)silyl]oxy}hept-5-yn-1-yl]-4-
methoxybenzoate 
 
 
                                  330                                                                    331 
 
A solution of diketo-dioxinone 215 (1.26 g, 2.55 mmol) and alcohol 312 (1.15 g, 
2.42 mmol) in CH2Cl2 (20 mL) were heated to 110 ºC in a sealed tube. After 2 h, the 
solvent was concentrated under reduced pressure. The resulting mixture was dissolved 
in MeOH (20 mL) and Cs2CO3 (2.4 g, 7.0 mmol) was added. After 20 min, HCl 
(1.25 M in MeOH, 30 mL) was added and the reaction was stirred for 30 min. The 
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mixture was dissolved with EtOAc (X 3) and the combined organic layers were 
washed with aqueous HCl (1 M) followed by brine, dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude material was purified by silica flash 
chromatography (5% Et2O in hexanes) to afford 330 (0.68 g) and 331 (0.52 mg) with 
a combined yield of 55%. Furthermore by-product 332 or 333 (0.13 mg, 6%) was 
isolated. 
 
330 
 
IR (neat): 3372, 2929, 2867, 1614, 1515, 1466, 1248, 1086, 1035, 834, 772, 675 cm-1; 
1H NMR (400 MHz, CDCl3) δ 11.17 (s, 1H, 3-OH), 7.27 (d, J = 8.6 Hz, 2H, Ar-H), 
6.87 (d, J = 8.6 Hz, 2H, Ar-H), 6.34 (d, J = 2.6 Hz, 1H, Ar-H), 6.28 (d, J = 2.6 Hz, 
1H, Ar-H), 5.68-5.52 (m, 2H, 20-H, 21-H), 5.33-5.26 (m, 1H, 15-H), 5.10 (s, 1H, 
5-OH), 4.44 (s, 2H, 23-H2), 4.22 (dt, J = 8.2, 4.0 Hz, 1H, 9-H), 4.06-4.03 (m, 2H, 
22-H2), 3.80 (s, 3H, O-CH3), 3.50 (dd, J = 5.7, 2.8 Hz, 1H, 17-H), 3.30 (dd, J = 14.1, 
4.0 Hz, 1H, 8-Ha), 2.90 (dd, J = 14.1, 8.2 Hz, 1H, 8-Hb), 2.65-2.60 (m, 2H, 14-H2), 
2.39-1.97 (m, 7H, 10-H, 11-H2, 18-H, 16-H, 19-H2), 1.79-1.76 (m, 6H, 12’-CH3, 
13’-CH3), 1.06-0.86 (m, 39H, TBS-H, TIPS-H, 10-CH3, 16-CH3, 18-CH3), 0.08-0.04 
(m, 6H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 169.8 (C-1), 164.6 (CAr), 160.0 
(CAr), 159.6 (CAr), 145.5 (CAr), 132.1 (CH), 130.5 (CAr), 129.4 (2 X CAr), 127.5 
(CH), 113.8 (2 X CAr), 112.2 (CAr), 106.5 (CAr), 101.7 (CAr), 78.3 (C), 77.7 (C), 
75.9 (C-17), 75.7 (C-15, C-9), 74.2 (2C), 71.9 (C-23), 65.7 (C-22), 55.3 (O-CH3), 
39.4 (CH), 38.5 (CH), 38.2 (CH), 37.6 (C-8), 30.1 (CH2), 26.1 (CTBS), 22.7 (CH2), 
22.0 (CH2), 18.2 + 18.1 (CTBS, CTIPS), 16.1 (CH3), 14.7 (CH3), 13.0 (CTIPS), 10.8 
(CH3), 3.5 (12’-CH3, 13’-CH3), -3.7 (CTBS); MS (ESI) m/z 891 [M+H]+, 913 
 236 
[M+Na]+; HRMS (ESI) m/z calculated for C52H83O8Si2 [M+H]+ 891.5681, found 
891.5654; [α]D: +12.0 (0.4, CHCl3). 
 
331 
 
IR (neat): 3475, 2944, 2869, 1618, 1462, 1248, 1086, 1039, 834, 773, 673 cm-1; 
1H NMR (400 MHz, CDCl3) δ 11.30 (s, 1H, 3-OH), 7.27 (d, J = 8.6 Hz, 2H, Ar-H), 
6.88 (d, J = 8.6 Hz, 2H, Ar-H), 6.41 (d, J = 2.5 Hz, 1H, Ar-H), 6.31 (d, J = 2.5 Hz, 
1H, Ar-H), 5.68-5.51 (m, 2H, 20-H, 21-H), 5.31-5.27 (m, 1H, 15-H), 4.44 (s, 2H, 
23-H2), 4.26-4.22 (m, 1H, 9-H), 4.05 (d, J = 6.1 Hz, 2H, 22-H2), 3.80 (s, 3H, O-CH3), 
3.79 (s, 3H, O-CH3), 3.50 (dd, J = 5.7, 2.8 Hz, 1H, 17-H), 3.30 (dd, J = 14.1, 4.3 Hz, 
1H, 8-Ha), 2.90 (dd, J = 14.1, 8.6 Hz, 1H, 8-Hb), 2.69-2.66 (m, 2H, 14-H2), 2.32-1.81 
(m, 7H, 10-H, 11-H2, 18-H, 16-H, 19-H2), 1.76 (s, 6H, 12’-CH3, 13’-CH3), 1.07-0.86 
(m, 39H, TBS-H, TIPS-H, 10-CH3, 16-CH3, 18-CH3), 0.08-0.03 (m, 6H, TBS-H); 
13C NMR (100 MHz, CDCl3) δ 169.9 (C-1), 164.7 (CAr), 163.5 (CAr), 159.2 (CAr), 
144.6 (CAr), 132.1 (CH), 130.5 (CAr), 129.4 (2 X CAr), 127.5 (CH), 113.8 
(2 X CAr), 111.9 (CAr), 106.1 (CAr), 99.3 (CAr), 78.8 (C), 78.3 (C), 75.9 (CH), 75.8 
(CH), 75.5 (CH), 74.2 (2C), 71.9 (C-23), 65.7 (C-22), 55.3 (2 O-CH3), 39.4 (CH), 
38.5 (CH), 38.4 (CH), 37.7 (C-8), 30.9 (CH2), 26.1 (CTBS), 22.7 (CH2), 22.0 (CH2), 
18.2 + 18.1 (CTBS, CTIPS), 16.1 (CH3), 14.8 (CH3), 13.0 (CTIPS), 10.8 (CH3), 3.5 
(12’-CH3, 13’-CH3), -3.7 (CTBS). MS (ESI) m/z 905 [M+H]+, 927 [M+Na]+; HRMS 
(ESI) m/z calculated for C53H85O8Si2 [M+H]+ 905.5783, found 905.5786; [α]D: +14.0 
(c 0.4, CHCl3). 
 
 
 237 
(6S,7S,8S,10Z)-7-[(tert-Butyldimethylsilyl)oxy]-12-[(4-methoxyphenyl)methoxy]-
6,8-dimethyldodec-10-en-2-yn-5-yl 2-{2-methoxy-6-[(2R,3S)-3-methyl-2-
{[tris(propan-2-yl)silyl]oxy}hept-5-yn-1-yl]-4-oxo-3,4-dihydro-2H-pyran-2-
yl)acetate 
or 
(6S,7S,8S,10Z)-7-[(tert-Butyldimethylsilyl)oxy]-12-[(4-methoxyphenyl)methoxy]-
6,8-dimethyldodec-10-en-2-yn-5-yl 2-{2-methoxy-2-[(2R,3S)-3-methyl-2-
{[tris(propan-2-yl)silyl]oxy}hept-5-yn-1-yl]-4-oxo-3,4-dihydro-2H-pyran-6-
yl)acetate 
 
 
                              332                                                                             333 
 
IR (neat): 3466, 2952, 2929, 2866, 1727, 1659, 1616, 1512, 1464, 1381, 1252, 1229, 
1161, 1039, 885, 834, 773, 680 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.26, (d, 
J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 5.66-5.56 (m, 2H), 5.39 (s, 1H), 5.05 (td, 
J = 5.5, 5.5 Hz, 1H), 4.48 (dt, J = 8.3, 2.8 Hz, 1H), 4.43 (s, 2H), 4.29 (s, 1H), 4.07 (d, 
J = 5.3 Hz, 2H), 3.80 (s, 3H), 3.71 (s, 3H), 3.60 (s, 1H), 3.54 (dd, J = 5.5, 4.2 Hz, 1H), 
3.04 (d, J = 17.8 Hz, 1H), 2.53 (m, 3H), 2.24 (m, 2H), 2.08-2.05 (m, 4H), 1.78-1.71 
(m, 9H), 1.14 (s, 21H, TIPS-H), 0.98 (d, J = 7.0 Hz, 3H), 0.93 (d, J = 6.6 Hz, 3H), 
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0.91 (s, 9H, TBS-H), 0.89 (d, J = 6.9 Hz, 3H), 0.08 (s, 3H, TBS-H), 0.07 (s, 3H, 
TBS-H); 13C NMR (100 MHz, CDCl3) 191.8, 176.5, 169.7, 159.1, 132.7, 130.5, 129.3 
(2 X C), 127.1, 113.7 (2 X C), 100.2, 78.2, 77.5, 76.9, 76.3, 74.7, 74.0, 73.0, 71.8, 
71.6, 65.8, 62.4, 56.0, 55.2, 40.3, 40.2, 38.7, 38.1, 37.4, 29.6, 26.2 (CTBS), 22.5, 
22.4, 18.5 + 18.3 (CTBS, CTIPS), 17.0, 14.2, 13.3 (CTISP), 10.4, 3.5, 3.4, -3.6 
(CTBS), -3.7 (CTBS); MS (ESI) m/z 923 [M+H]+, 945 [M+Na]+; HRMS (ESI) m/z 
calculated for C53H87O9Si2 [M+H]+ 923.5889, found 923.5873. 
 
 
(5S,6R,7R,8R,10Z)-7-[(tert-Butyldimethylsilyl)oxy]-12-[4-
methoxyphenyl)methoxy]6,8-dimethyldodec-10-en-2-yn-5-yl 2,4-dimethoxy-6-
[(2R,3S)-3-methyl-2-{[tris(propan-2-yl)silyl]oxy}hept-5-yn-1-yl]benzoate 
 
 
328 
 
To a solution of 330 and 331 (0.9 g, 1.06 mmol) in acetone (40 mL) was added 
K2CO3 (1.5 mg, 21.1 mmol) followed by MeI (1.3 mL, 21.1 mmol). The reaction was 
heated at 60 ºC. After 2 h, the reaction was quenched by addition of a saturated 
solution of NH4Cl and the aqueous layer was extracted with EtOAc (X 2). The 
combined organic layers were dried (MgSO4), filtered and concentrated under 
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reduced pressure. The crude material was purified by silica flash chromatography (5% 
Et2O in hexanes) to afford 328 (0.80 mg, 82%) as a colourless oil. 
 
IR (neat): 2932, 2864, 1721, 1605, 1513, 1463, 1249, 1159, 1087, 1044, 835, 
773 cm-1, 1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.6 Hz, 2H, Ar-H), 6.88 (d, 
J = 8.6 Hz, 2H, Ar-H), 6.50 (d, J = 2.6 Hz, 1H, Ar-H), 6.31 (d, J = 2.6 Hz, 1H, 
Ar-H), 5.68-5.56 (m, 2H, 20-H, 21-H), 5.09-5.03 (m, 1H, 15-H), 4.44 (s, 2H, 23-H2), 
4.31-4.27 (m, 1H, 9-H), 4.05 (d, J = 6.1 Hz, 2H, 22-H2), 3.80 (s, 6H, 2 O-CH3), 3.79 
(s, 3H, O-CH3), 3.57-3.55 (m, 1H, 17-H), 2.75-2.58 (m, 4H, 8-H2, 14-H2), 2.32-1.74 
(m, 7H, 10-H, 11-H2, 18-H, 16-H, 19-H2), 1.77 (s, 3H), 1.76 (s, 3H), 1.07-0.86 (m, 
39H, TBS-H, TIPS-H, 10-CH3, 16-CH3, 18-CH3), 0.08-0.03 (m, 6H, TBS-H); 
13C NMR (100 MHz, CDCl3) δ 167.7 (C-1), 160.7 (CAr), 159.1 (CAr), 157.8 (CAr), 
139.1 (CAr), 132.6 (CH), 130.5 (CAr), 129.3 (2 X CAr), 127.2 (CH), 117.8 (CAr), 
113.8 (2 X CAr), 107.0 (CAr), 96.7 (CAr), 78.1 (2 X C), 78.0 (2 X C), 76.2 (C-17), 
75.2 (C-9), 74.6 (C-15), 71.8 (C-23), 65.7 (C-22), 55.6 (O-CH3), 55.2 (2 O-CH3), 
38.8 (CH), 37.9 (CH), 37.8 (CH), 36.1 (C-8), 30.1 (CH2), 26.1 (CTBS), 22.7 (CH2), 
22.0 (CH2), 18.2 + 18.1 (CTBS, CTIPS), 16.7 (CH3), 14.6 (CH3), 13.0 (CTIPS), 10.4 
(CH3), 3.6 + 3.5 (12’-CH3, 13’-CH3), -3.7 (CTBS); MS (ESI) m/z 919 [M+H]+, 941 
[M+Na]+; HRMS (ESI) m/z calculated for C54H87O8Si2 [M+H]+ 919.5940, found 
919.5960; [α]D: +14.0 (c 0.6, CHCl3). 
 
 
 
 
 
 240 
 (3S,8S,9R)-3-[(2R,3R,4R,6Z)-3-[(tert-Butyldimethylsilyl)oxy]-8-[4-
methoxyphenyl)methoxy]-4-methyloct-6-en-2-yl]-12,14-dimethoxy-8-methyl-9-
{[tris(propan-2-yl)silyl]oxy}-3,4,7,8,9,10-hexahydro-1H-2-benzoxacyclododecan-
1-one 
 
 
327 
 
To a solution of 328 (300 mg, 0.33 mmol) dissolved in PhMe (20 mL) and heated at 
110 °C under a closed Ar atmosphere was added catalyst 100 (130 mg, 40 mol %). 
After 8 h, the reaction mixture was filtered on a short pad of silica and the resulting 
filtrate was concentrated under reduced pressure. The crude oil was purified by silica 
flash chromatography (10% Et2O in hexanes) to afford 327 (215 mg 75%) as a 
colourless oil.  
 
IR (neat): 2940, 2865, 1739, 1604, 1514, 1466, 1258, 1157, 1087, 1055, 837, 772, 
751 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 8.6 Hz, 2H, Ar-H), 6.87 (d, 
J = 8.6 Hz, 2H, Ar-H), 6.42 (d, J = 2.5 Hz, 1H, 4-H), 6.32 (d, J = 2.5 Hz, 1H, 6-H), 
5.66-5.53 (m, 2H, 20-H, 21-H), 5.47 (br s, 1H, 15-H), 4.43 (s, 2H, 23-H2), 4.06-4.01 
(m, 3H, 9-H, 22-H2), 3.80-3.72 (m, 10H, 8-Ha, 3 OCH3), 3.49 (dd, J = 4.2, 4.2 Hz, 
1H, 17-H), 2.51-2.39 (m, 4H, 8-Hb, 11-Hb, 14-H2), 2.18-2.14 (m, 2H, 11-H, 19-Ha), 
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1.99-1.92 (m, 1H, 18-H) 1.88-1.78 (m, 3H, 10-H, 16-H, 19-Hb), 1.05 (d, J = 6.9 Hz, 
3H, 16-CH3), 0.97-0.91 (m, 33H, TIPS-H, TBS-H, 18-CH3), 0.88 (d, J = 6,3 Hz, 3H, 
10-CH3), 0.72 (s, 3H, TBS-H), 0.48 (s, 3H, TBS-H); 13C NMR (100 MHz, CDCl3) δ 
167.4 (C-1), 160.3 (CAr) 159.2 (CAr), 157.3 (CAr), 139.5 (CAr), 132.4 (C-20), 130.5 
(CAr), 129.3 (2 X CAr), 127.2 (C-21), 118.2 (CAr), 113.8 (2 X CAr), 108.3 (C-6), 
96.7 (C-4), 81.3 (C) 79.6 (C), 77.2 (C-9), 76.4 (C-17), 74.8 (C-15), 71.9 (C-23), 65.7 
(C-22), 55.8 (O-CH3), 55.2 (O-CH3 X 2), 40.8 (C-10), 38.6 (C-8), 37.7 (C-16), 37.6 
(C-18), 30.1 (C-19), 26.1 (CTBS), 23.8 + 23.3 (C-14, C-11), 18.4 (10-CH3), 18.1 + 
17.9 (CTBS, CTIPS) 17.0 (16-CH3), 13.0 (CTIPS), 11.4 (18- CH3), -3.6 (CTBS), -3.5 
(CTBS); MS (ESI) m/z 865 [M+H]+, 882 [M+H2O]+, 887 [M+Na]+, 903 [M+K]+; 
HRMS (ESI) m/z calculated for C50H80O8Si2 [M+H]+ 865.5470, found 865.5468; [α]D: 
-14,4 (c 0.6, CHCl3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 242 
(3S,8S,9R)-3-[(2R,3R,4R,6Z)-3-[(tert-Butyldimethylsilyl)oxy]-8-hydroxy-4-
methyloct-6-en-2-yl]-12,14-dimethoxy-8-methyl-9-{[tris(propan-2-yl)silyl]oxy}-
3,4,7,8,9,10-hexahydro-1H-2-benzoxacyclododecan-1-one 
 
  
334 
 
To a solution of 327 (200 mg, 0.23 mmol) dissolved in CH2Cl2/water (2 mL, 1:1) was 
added DDQ (100 mg, 0.3 mmol). The resulting mixture was vigorously stirred at rt 
for 20 min. The solution was then poured into a saturated solution of NaHCO3. The 
aqueous layer was extracted with CH2Cl2, and the organic layers was dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude material was purified by 
silica flash chromatography (5 to 20% Et2O in hexanes) to afford 334 (150 mg, 87%) 
as a colourless oil. 
 
IR (neat): 3427, 2941, 2860, 1732, 1603, 1461, 1265, 1158, 1083, 1051, 832, 769, 
674 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.50 (d, J = 2.5 Hz, 1H, 4-H), 6.31 (d, 
J = 2.5 Hz, 1H, 6-H), 5.65 (dtt, J = 12.1, 6.6, 1.2 Hz, 1H, 21-H), 5.65 (dtt, J = 12.1, 
5.7, 1.3 Hz, 1H, 20-H), 5.48 (s, 1H, 15-H), 4.22 (dd, J = 12.6, 6.6 Hz, 1H, 22-Ha), 
4.14 (dd, J = 12.6, 6.6 Hz, 1H, 22-Hb), 4.0 (dt, J = 8.8, 2.1 Hz, 1H, 9-H), 3.80-3.74 
(m, 7H, 8-Ha, 3-OCH3, 5-OCH3), 3.50 (dd, J = 4.4, 4.4 Hz, 1H, 17-H), 2.56-2.40 (m, 
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4H, 8-Hb, 11-Ha, 14-H2), 2.28-2.15 (m, 2H, 11-Hb, 19-Ha), 1.99-1.91 (m, 1H, 18-H), 
1.89-1.77 (m, 3H, 10-H, 16-H, 19-Hb), 1.05 (d, J = 6.9 Hz, 3H, 17-CH3), 0.91-0.98 
(m, 36H, TIPS-H, TBS-H, 10-CH3, 19-CH3), 0.65 (s, 3H, TBS-H), 0.59 (s, 3H, 
TBS-H); 13C NMR (100 MHz, CDCl3) δ 167.5 (C-1), 160.3 (CAr), 157.3 (CAr), 
139.5 (CAr), 131.8 (C-20), 129.5 (C-21), 118.1 (CAr), 108.4 (C-6), 96.7 (C-4), 81.3 
(C), 79.6 (C), 77.2 (C-9), 76.7(C-17), 74.8 (C-15), 58.7 (C-22), 55.8 + 55.2 (2 X 
O-CH3), 41.0 (C-10), 38.6 (C-8), 37.6 (C-18), 37.5 (C-16), 29.9 (C-19), 26.2 (CTBS), 
23.9 (C-14), 23.3 (C-11), 18.4 (10-CH3), 18.1 + 17.9 (CTBS, CTIPS), 17.3 (16-CH3), 
13.0 (CTIPS), 11.6 (18-CH3), -3.6 (CTBS); MS (ESI) m/z 745 [M+H]+, 767 [M+Na]+, 
783 [M+K]+; HRMS (ESI) m/z calculated for C42H73O7Si2 [M+H]+ 745.4895, found 
745.4921; [α]D: -16.0 (c 0.9, CHCl3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 244 
(3S,8S,9R)-3-[(2R,3R,4R,6Z)-8-Azido-3-[(tert-butyldimethylsilyl)oxy]- 4-
methyloct-6-en-2-yl]-12,14-dimethoxy-8-methyl-9-{[tris(propan-2-yl)silyl]oxy}-
3,4,7,8,9,10-hexahydro-1H-2-benzoxacyclododecan-1-one 
 
 
336 
 
To a solution of 334 (130 mg, mmol) in PhMe (20 mL) was added 
Zn(N3)2•(pyridine)2 (213 mg, 0.7 mmol) and PPh3 (190 mg, 0.7 mmol). The mixture 
was cooled to 0 ºC and DIAD (140 µL, 0.7 mmol) was added. The reaction mixture 
was stirred for 4 h at rt and then filtered. The resulting filtrate was concentrated under 
reduced pressure. The crude mixture was purified by silica flash chromatography 
(10% Et2O in hexanes) to afford the desired product 336 (115 mg, 85%) as an 
amorphous solid. 
 
IR (neat): 2960, 2944, 2867, 2099, 1739, 1608, 1461, 1263, 1161, 1091, 1057, 833, 
774 cm-1; 1H NMR (400 MHz, CD2Cl2) δ 6.43 (d, J = 2.2 Hz, 1H, 4-H), 6.34 (d, 
J = 2.2 Hz, 1H, 6-H), 5.74 (m, 1H, 20-H), 5.57 (m, 1H, 21-H), 5.47-5.40 (m, 1H, 
15-H), 4.00 (d, J = 8.9 Hz, 1H, 9-H), 3.81-3.69 (m, 9H, 2 X O-CH3, 8-Ha, 22-H2), 
3.52 (dd, J = 4.6, 4.6 Hz, 1H, 17-H), 2.48-2.38 (m, 4H, 8-Hb, 11-Ha, 14-H2), 
2.26-2.14 (m, 2H, 11-Hb, 19-Ha), 1.98-1.79 (m, 4H, 10-H, 16-H, 18-H, 19-Hb), 1.05 
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(d, J = 7.1 Hz, 3H), 0.98-0.91 (m, 36 H), 0.09 (s, 6H, TBS-H); 13C NMR (100 MHz, 
CD2Cl2) δ 167.8 (C-1), 161.0 (CAr), 157.8 (CAr), 140.0 (CAr), 135.6 (C-20), 123.7 
(C-21), 118.7 (CAr), 109.1 (CAr), 97.1 (CAr), 81.7 (C-13), 80.2 (C-12), 77.9 (C-9), 
77.0 (C-17), 75.1 (C-15), 56.3 + 55.8 (2 X O-CH3), 44.9 (C-22), 41.5 (C-10), 39.1 
(C-8), 38.2 (C-18), 38.1 (C-16), 30.4 (C-19), 26.5 (CTIPS), 23.6 (C-14), 23.6 (C-11), 
18.9 (10-CH3), 18.5 + 18.2 (CTBS, CTIPS), 17.5 (16-CH3), 13.6 (CTIPS), 11.7 
(18-CH3), -3.3 + -3.4 (CTBS); MS (ESI) m/z 770 [M+H]+, 792 [M+Na]+, 808 
[M+K]+; HRMS (ESI) m/z calculated for C42H73O7Si2 [M+H]+ 770.4960, found 
770.4966; [α]D: -24.1 (c 0.8, CH2Cl2). 
 
 
(3S,8S,9R)-3-[(2R,3R,4R,6Z)-8-Amino-3-[(tert-butyldimethylsilyl)oxy]-4-
methyloct-6-en-2-yl]-12,14-dimethoxy-8-methyl-9-{[tris(propan-2-yl)silyl]oxy}-
3,4,7,8,9,10-hexahydro-1H-2-benzoxacyclododecan-1-one 
 
 
337 
 
To a solution of 336 (105 mg, 0.14 mmol) in THF/water (1.5mL, 10:1) was added 
PPh3 (360 mg, 13.7 mmol). The reaction mixture was stirred at 50 ºC for 4 h and was 
then concentrated under reduced pressure. The crude material was purified by silica 
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flash chromatography CH2Cl2/MeOH/NH4OH. (9:1:0.1) to afford 337 (90 mg, 91%) 
as an amorphous solid. Due to its unstability, amine 337 was not characterised. 
 
 
 (2R,3S)-N-[(2Z,5R,6R,7R)-6-[(tert-Butyldimethylsilyl)oxy]-7-[(3S,8S,9R)-12-14-
dimethoxy-8-methyl-1-oxo-9-{[tris(propan-2-yl)silyl]oxy}-3,4,7,8,9,10-
hexahydro-1H-2-benzoxacyclododeca-3-yl]-5-methyloct-2-en-1-yl]-2-methyl-3-
{[tris(propan-2-yl)silyl]oxy}hexanamide 
 
 
338 
 
Procedure A  
To a solution of 247 (40 mg, 0.13 mmol) in THF were added NEt3 (20 µL, 0.13 
mmol) and Yamaguchi reagent 249 (20 µL, 0.13 mmol). The mixture was stirred for 
2 h and was then diluted with Et2O and filtered over celite. The resulting filtrate was 
concentrated under reduced pressure and purified by silica flash chromatography 
(10% Et2O in hexanes) to afford the desired mixed anhydride 347 (20 mg). To a 
solution of 337 (10 mg, 0.014 mmol) and the previous mixed anhydride 347 (20 mg, 
0.042) in THF (1 mL) were added NEt3  (6 µL, 0.042 mmol) and DMAP (5 mg, 
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0.042 mmol). The reaction mixture was stirred for 1 h then dissolved in EtOAc and 
quenched by addition of water. The organic layer was dried (MgSO4), filtered and 
evaporated under reduced pressure. The crude material was purified by flash 
chromatography (20% of EtOAc in hexanes) but no desired product was isolated. 
Instead, amide 349 (8 mg, 60%) was isolated. 
 
 
N-[(2Z,5R,6R,7R)-6-[(tert-Butyldimethylsilyl)oxy]-7-[(3S,8S,9R)-12,14-
Dimethoxy-8-methyl-1-oxo-9-{[tris(propan-2-yl)silyl]oxy}-3,4,7,8,9,10-
hexahydro-1H-2-benzoxacyclododecan-3-yl]-5-methyloct-2-en-1-yl]-2,4,6-
trichlorobenzamide 
 
 
349 
 
1H NMR (400 MHz, CD2Cl2) δ 7.42 (s, 2H, Ar-H), 6.50 (d, J = 2.5 Hz, 1H, Ar-H), 
6.31 (d, J = 2.5 Hz, 1H, Ar-H), 5.65-5.50 (m, 3H, 21-H, 22-H, 15-H), 4.24-4.13 (m, 
2H), 4.03-4.01 (m, 1H), 3.80 (s, 3H, O-CH3), 3.76-3.74 (s, 4H), 3.52 (m, 1H), 
2.56-2.40 (m, 4H), 2.28-2.15 (m, 2H), 1.99-1.89 (m, 4H), 1.07-0.86 (m, 39H), 
0.08-0.03 (m, 6H, TBS-H); 13C NMR (100 MHz, CD2Cl2) δ 167.5, 162.3, 160.8, 
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157.9, 139.7, 135.7 (2 X CAr), 135.2, 133.2, 132.4, 129.5 (2 X CAr), 119.4, 109.0, 
97.3, 81.5 (C), 80.5 (C), 77.6, 77.2, 74.5, 55.8 + 55.2 (2 X O-CH3), 41.1, 39.2, 38.2, 
38.1, 37.1, 30.1, 26.2 (CTBS), 24.2, 23.8, 18.4, 18.1 + 17.9 (CTBS, CTIPS), 17.3, 
13.0 (CTIPS), 11.6, -3.6 (CTBS), C-23 missing; MS (ESI) m/z 950 [M+H]+, 972 
[M+Na]+; HRMS (ESI) m/z calculated for C49H75NO7Si2Cl3 [M+H]+ 950.4170, found 
950.4148. 
 
Procedure B 
To a solution of 247 (100 mg, 0.33 mmol) dissolved in DMF (5 mL) were added 
HBTU (80 mg, 0.33 mmol), HOBt (30 mg, 0.33 mmol) and i-Pr2NEt (0.1 mL, 0.62 
mmol). The mixture was stirred for 30 min before 337 (75 mg, 0.1 mmol) was added. 
The resulting mixture was stirred for an additional 30 min. The reaction was then 
quenched by addition of water. The aqueous layer was extracted with Et2O (X 2) and 
the combined organic layers were dried (MgSO4), filtered and concentrated under 
reduced pressure. The crude material was purified by silica flash chromatography 
(20% of EtOAc in hexanes) to afford 338 (85 mg, 67%) as a white gum. 
 
IR (neat): 3347, 2960, 2944, 2865, 1735, 1660, 1611, 1464, 1260, 1224, 1163, 1091, 
1062, 883, 838, 779 cm-1; 1H NMR (500 MHz, CD2Cl2) δ 6.44 (t, J = 5.3 Hz, 1H, 
N-H), 6.42 (d, J = 2.2 Hz, 1H, 4-H), 6.34 (d, J = 2.2 Hz, 1H, 6-H), 5.54-5.49 (m, 1H, 
20-H), 5.46-5.41 (m, 2H, 15-H, 21-H), 4.00-3.96 (m, 2H, 9-H, 25-H), 3.90-3.78 (m, 
22-H2), 3.79 (s, 3H, O-CH3), 3.76 (s, 3H, O-CH3), 3.72 (d, J = 13.0 Hz, 1H, 8-Ha), 
3.51 (dd, J = 4.6, 4.6 Hz, 1H, 17-H), 2.53-2.549 (m, 5H, 8-Hb, 11-Ha, 14-H2, 24-H), 
2.23-2.14 (m, 2H, 11-Hb, 19-Ha), 1.97-1.76 (m, 4H, 10-H, 16-H, 18-H, 19-Hb), 
1.53-1.27 (m, 4H, 26-Ha, 26-Hb, 27-H2), 1.10-0.88 (m, 66H, 28-H3, 10-CH3, 16-CH3, 
 249 
18-CH3, 24-CH3, TIPS-H, TBS-H), 0.04 (s, 6H, TBS-H); 13C NMR (125 MHz, 
CD2Cl2) δ 173.7 (C-23), 165.5 (C-1), 160.6 (C-3), 157.4 (C-5), 139.6 (C-7), 132.0 
(C-20), 126.7 (C-21), 118.4 (C-2), 108.7 (C-6), 96.7 (C-4), 81.3 (C-13), 79.9 (C-12), 
77.5 (C-17), 76.7 (C-9), 75.4 (C-25), 74.9 (C-15), 56.0 (O-CH3), C55.4 (O-CH3), 46.0 
(C-24), 41.4 (C-16), 39.1 (C-8), 38.2 (C-18), 38.1 (C-10), 36.9 (C-22), 35.8 (C-26), 
30.3 (C-19), 26.5 (CTIPS), 24.3 (C-14), 23.8 (C-11), 19.8 (C-27), 18.9 (18-CH3), 18.6 
+ 18.4 + 18.2 (2 X CTIPS, CTBS), 17.4 (10-CH3), 14.7 (C-28), 13.6 + 13.3 
(2 X CTIPS), 12.9 (24-CH3), 11.6 (16-CH3), -3.3 (CTBS), -3.4 (CTBS); MS (ESI) m/z 
1028 [M+H]+, 1050 [M+Na]+; HRMS (ESI) m/z calculated for C58H106NO8Si3 [M+H]+ 
1028.7226, found 1028.7209; [α]D: -17.5 (c 0.4, CH2Cl2). 
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 (2R,3S)-N-[(2Z,5R,6R,7R)-6-[(tert-Butyldimethylsilyl)oxy]-7-[(3S,8S,9R)-14-
hydroxy-12-methoxy-8-methyl-1-oxo-9-{[tris(propan-2-yl)silyl]oxy}-3,4,7,8,9,10-
hexahydro-1H-2-benzoxacyclododeca-3-yl]-5-methyloct-2-en-1-yl]-2-methyl-3-
{[tris(propan-2-yl)silyl]oxy}hexanamide 
 
 
350 
 
To a solution of 338 (35 mg, 0.034 mmol) in CH2Cl2 at -78 ºC was added BCl3 (1 M 
in CH2Cl2, 75 µL). The reaction mixture was stirred for 1 h at -78 ºC and quenched by 
addition of MeOH. The resulting solution was concentrated under reduced pressure. 
The residue was dissolved again in MeOH and the solution concentrated under 
reduced pressure. The crude oil was purified by silica flash chromatography (5% 
MeOH in CH2Cl2) to afford 350 (26 mg, 75%) as an amorphous solid. 
 
IR (neat): 3347, 2946, 2869, 1649, 1620, 1469, 1276, 1260, 1163, 1100, 1041, 765, 
750 cm-1; 1H NMR (500 MHz, CD2Cl2) δ 11.48 (s, 1H 3-OH), 6.43 (t, J = 5.4 Hz, 1H, 
N-H), 6.37 (d, J = 2.2 Hz, 1H, 4-H), 6.34 (d, J = 2.2 Hz, 1H, 6-H), 5.50-5.41 (m, 2H, 
20-H, 21-H), 5.22 (br s, 1H, 15-H,), 4.23 (m, 2H, 9-H, 25-H), 3.98 (ddd, J = 5.7, 5.6, 
3.6 Hz, 1H, 8-Ha), 3.87 (ddd, J = 14.6, 5.9, 5.5 Hz, 1H, 22-Ha), 3.81 (ddd, J = 14.6, 
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5.9, 5.5 Hz, 1H, 22-Hb), 3.79 (s, 3H, 5-OCH3), 3.53 (dd, J = 5.8, 2.1 Hz, 1H, 17-H), 
2.9 (m, 1H, 14-Ha), 2.64-2.58 (m, 1H, 8-Hb), 2.50 (dq, J = 7.3, 3.6 Hz, 1H, 24-H), 
2.47 (d, J = 7.0 Hz, 1H, 14-Hb), 2.36-2.26 (m, 1H, 18-H), 2.23-2.18 (m, 2H, 16-H, 
19-Ha), 2.08-2.05 (m, 1H, 11-Ha), 1.92-1.85 (m, 2H, 10-H, 19-Hb), 1.72-1.67 (m, 
1H, 11-Hb), 1.54-1.27 (m, 4H, 26-H2, 27-H2), 1.10-0.86 (m, 66H, 28-H3, 10-CH3, 16-
CH3, 18-CH3, 24-CH3, TIPS-H, TBS-H), 0.08 (s, 3H, TBS-H), 0.07 (s, 3H, TBS); 
13C NMR (125 MHz, CD2Cl2) δ 174.1 (C-23), 171.6 (C-1), 164.9 (C-3), 164.0 (C-5), 
144.2 (C-7), 132.0 (C-20), 127.6 (C-21), 107.4 (C-6, C-2), 99.4 (C-4), 76.6 (C-15, 
C-9), 76.2 (C-17), 75.8 (C-25), 55.8 (O-CH3), 46.1 (C-24), 39.5 (C-16), 39.4 (C-18, 
C-10), 38.2 (C-8), 37.0 (C-22), 36.5 (C-26), 31.3 (C-19), 26.4 (CTIPS), 22.4 (C-14, 
C-11), 19.8 (C-27), 18.9 (18-CH3), 18.6 + 18.3 (CTIPS, CTBS), 16.2 (10-CH3), 14.7 
(C-28), 13.7 + 13.4 (2 X CTIPS), 12.9 (24-CH3), 11.6 (16-CH3), -3.3 (CTBS), -3.4 
(CTBS), C-12 and C-13 missing; MS (ESI) m/z 1014 [M+H]+, 1036 [M+Na]+; HRMS 
(ESI) m/z calculated for C57H104NO8Si3 [M+H]+ 1014.7070, found 1014.7049; [α]D: 
-17.5 (c 0.4, CH2Cl2). 
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 (2R,3S)-N-[(2Z,5R,6R,7S)-7-[(3S,8S,9R)-9,14-Dihydroxy-12-methoxy-8-methyl-1-
oxo-3,4,7,8,9,10-hexahydro-1H-2-benzoxacyclododecan-3-yl]-6-hydroxy-5-
methyloct-2-en-1-yl]-3-hydroxy-2-methylhexanamide 
 
 
351 
 
To a solution of 350 (20 mg, 0.02 mmol), in MeCN (0.5 mL), was added H2SiF6 
(25 wt. % in water, 0.5 mL) at rt. The resulting mixture was stirred at 40 ºC for 8 h. 
The reaction mixture was then cooled to 0 ºC before the reaction was diluted with 
CH2Cl2 and poured into a saturated solution of NaHCO3. The aqueous layer was 
extracted with CH2Cl2 (X 3) and the combined organic layers were dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude material was purified by 
silica flash chromatography (5% MeOH in CH2Cl2) to afford 351 (9 mg, 76%) as an 
amorphous solid. 
IR (neat): 3355, 2958, 2924, 2855, 1712, 1616, 1460, 1260, 1162, 1097, 1019, 803 
cm-1; 1H NMR (500 MHz, CDCl3) δ 10.93 (s, 1H, 3-OH), 6.40 (d, J = 2.5 Hz, 1H, 
4-H), 6.37 (d, J =-2.5 Hz, 1H, 6-H), 6.25 (s, 1H, N-H), 5.65-5.59 (m, 1H, 20-H), 
5.445.39 (m, 1H, 21-H), 5.36 (ddd, J = 8.2, 4.1, 4.1 Hz, 1H, 15-H), 4.00 (dddd, 
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J = 14.9, 7.6, 6.5, 1.2 Hz, 1H, 22-Ha), 3.94 (ddd, J = 10.3, 3.0, 3.0 Hz, 1H, 9-H), 3.81 
(s, 3H, O-CH3), 3.80-3.70 (m, 3H, 8-Ha, 22-Hb, 25-H), 3.46-3.40 (m, 2H, 17-H, 
O-H), 3.05 (br s, 1H, O-H), 2.80-2.76 (m, 2H, 8-Hb, 14-Ha), 2.63-2.58 (m, 1H, 
14-Hb), 2.42-2.36 (m, 1H, 19-Ha), 2.31-2.22 (m, 3H, 11-Ha, 19-Hb, 24-H), 2.18-2.12 
(m, 2H, 11-Hb, 16-H), 2.05-2.00 (m, 1H, 18-H), 1.75-1.67 (m, 2H, 10-H, O-H), 
1.471.38 (m, 2H, 26-Ha, 27-Ha), 1.34-1.26 (m, 2H, 26-Hb, 27-Hb), 1.11 (d, 
J = 7.1 Hz, 3H, 24-CH3), 1.01 (d, J = 7.0 Hz, 3H, 18-CH3), 0.93-0.87 (m, 9H, 28-H3, 
10-CH3, 16-CH3); 13C NMR (125 MHz, CDCl3) δ 176.5 (C-23), 170.7 (C-1), 164.0 
(C-3), 163.4 (C-5), 143.4 (C-7), 130.0 (C-20), 127.0 (C-21), 111.3 (C-6), 107.0 (C-2), 
99.3 (C-4), 82.7 (C), 79.4 (C), 77.6 (C-17), 74.9 (C-9), 73.6 (C-25), 71.8 (C-15), 55.4 
(O-CH3), 44.9 (C-24), 38.1 (C-16), 37.3 (C-10), 36.8 (C-18), 36.6 (C-8), 36.5 (C-22), 
35.8 (C-26), 30.6 (C-19), 22.6 (C-14), 21.3 (C-11), 19.2 (C-27), 15.8 (18-CH3), 15.1 
(C-10), 13.9 (C-28), 11.0 (24-CH3), 8.2 (16-CH3); MS (ESI) m/z 588 [M+H]+, 610 
[M+Na]+; HRMS (ESI) m/z calculated for C33H50NO8 [M+H]+ 588.3536, found 
588.3522; [α]D: +1.5 (c 0.2, CH2Cl2). 
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 (2R,3S)-N-[(2Z,5R,6R,7S)-7-[(3S,8S,9R)-9,14-Dihydroxy-12-methoxy-8-methyl-1-
oxo-3,4,7,8,9,10-hexahydro-1H-2-benzoxacyclododecin-3-yl]-6-hydroxy-5-
methyloct-2-en-1-yl]-3-hydroxy-2-methylhexanamide 
 
 
Cruentaren A 
(6) 
 
To a solution of 351 (6 mg, 0.015 mmol) in EtOAc (2 mL) was added quinoline 
(2.5 µL, mmol) followed by Lindlar’s catalyst (5 wt. % Pd on CaCO3, poisoned with 
lead, 6 mg, 100 wt. %). The reaction was placed under a H2 atmosphere and stirred 
for 20 min. The reaction mixture was filtered through celite and concentrated under 
reduced pressure. The crude oil was purified by silica flash chromatography (5% 
MeOH in CH2Cl2) to afford cruentaren A (6) (5 mg, 83%) as a colourless oil. (15 mg 
in two batches).  
 
IR (neat): 3345, 2962, 2934, 2878, 1643, 1616, 1580, 1542, 1460, 1444, 1380, 1317, 
1253, 1224, 1204, 1141, 1104, 1055, 1041, 1017, 990, 955 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 11.48 (br s, 1H, 3-OH), 6.37 (d, J = 2.7 Hz, 1H, 4-H), 6.31 (d, J = 2.7 Hz, 
1H, 6-H), 6.14 (t, J = 5.7 Hz, 1H, N-H), 5.56 (m, 1H, 20-H), 5.48 (ddd, J = 11.0, 2.9, 
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1.0 Hz, 1H, 12-H), 5.44 (ddd, J = 11.0, 4.5, 1.9 Hz, 1H, 13-H), 5.42-5.39 (m, 1H, 
21-H), 5.30 (ddd, J = 11.6, 5.6, 1.8 Hz, 1H, 15-H), 3.92 (dddd, J = 14.9, 7.5, 5.7, 1.2 
Hz, 1H, 22-Ha), 3.86-3.82 (m, 2H, 22-Hb, 25-H), 3.81 (s, 3H, 5-OCH3), 3.76 (dd, 
J = 12.8, 1.4 Hz, 1H, 8-Ha), 3.65 (ddd, J = 10.8, 2.3, 1.4 Hz, 1H, 9-H), 3.46 (d, 
J = 8.9 Hz, 1H, 17-H), 3.15 (br s, 1H, 9-OH), 2.83 (dt, J = 14.3, 11.6 Hz, 1H, 14-Ha), 
2.76 (br s, 1H, 17-OH), 2.33 (dt, J = 14.2, 11.8 Hz, 1H, 11-Ha), 2.29 (qd, J = 7.2, 
2.8 Hz, 1H, 24-H), 2.30-2.20 (m, 4H, 8-Hb, 14-Hb, 19-H2), 2.05-1.95 (m, 3H, 10-H, 
11-Hb, 16-H), 1.70 (qddd, J = 6.8, 6.8, 2.3, 2.0 Hz, 1H, 18-H), 1.52-1.42 (m, 2H, 
26-Ha, 27-Ha), 1.38 (br s, 1H, 9-OH), 1.28-1.36 (m, 2H, 26-Hb, 27-Hb), 1.15 (d, 
J = 7.2 Hz, 3H, 24-CH3), 1.02 (d, J = 6.8 Hz, 3H, 10-CH3), 0.93 (t, J = 7.1 Hz, 3H, 
28-H3), 0.90 (d, J = 7.0 Hz, 3H, 16-CH3), 0.80 (d, J = 6.8 Hz, 3H, 18-CH3); 13C NMR 
(100 MHz, CDCl3) δ 176.4 (C-23), 171.5 (C-1), 165.7 (C-3), 163.5 (C-5), 143.7 
(C-7), 132.1 (C-12), 130.9 (C-20), 126.7 (C-21), 125.8 (C-13), 112.3 (C-6), 104.9 
(C-2), 99.7 (C-4), 78.0 (C-15), 74.7 (C-17), 73.1 (C-9), 71.8 (C-25), 55.4 (O-CH3), 
44.8 (C-24), 39.2 (C-16), 38.2 (C-10), 36.8 (C-18), 36.6 (C-8), 36.5 (C-22), 35.8 
(C-26), 31.6 (C-11), 30.7 (C-19), 29.8 (C-14), 19.2 (C-27), 16.1 (18-CH3), 14.2 
(10-CH3), 14.0 (C-28), 11.2 (24-CH3), 8.6 (16-CH3); MS (ESI) m/z 590 [M+H]+, 497 
[M+Na]+; HRMS (ESI) m/z calculated for C33H52NO8 [M+H]+ 590,3693, found 
590.3701; [α]D: -3,0 (c 0.4, CH2Cl2). Match the literature data (Appendix 2, Appendix 
3).12 
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5 Appendices 
 
Appendix 1 - Crystal structure for compound 100 
 
 
 
Empirical formula C59 H50 Mo N2 O3 Si3. C7 H8 
Formula weight 1107.35 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Triclinic, P-1 
Unit cell dimensions a = 13.1793(2) Å, a = 87.0373(14)° 
 b = 13.6503(2) Å, b = 77.3013(14)° 
 c = 18.2684(3) Å, g = 64.0513(16)° 
Volume, Z 2879.19(9) Å3, 2 
Density (calculated) 1.277 Mg/m3 
Absorption coefficient 0.338 mm-1 
F(000) 1152 
Crystal colour / morphology Yellow blocks 
Crystal size 0.56 x 0.33 x 0.20 mm3 
q range for data collection 3.13 to 32.73° 
Index ranges -18<=h<=19, -19<=k<=16, -27<=l<=26 
Reflns collected / unique 36984 / 18846 [R(int) = 0.0182] 
Reflns observed [F>4s(F)] 14630 
Absorption correction Analytical 
Max. and min. transmission 0.951 and 0.908 
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Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 18846 / 123 / 712 
Goodness-of-fit on F2 1.054 
Final R indices [F>4s(F)] R1 = 0.0394, wR2 = 0.1189 
R indices (all data) R1 = 0.0551, wR2 = 0.1230 
Largest diff. peak, hole 0.926, -0.718 eÅ-3 
Mean and maximum shift/error 0.000 and 0.002 
 
Table 1 - Bond lengths [Å] 
Bond                                    Lenghts [Å] Bond                                    Lenghts [Å] 
Mo(1)-N(1) 1.6532(16) 
Mo(1)-O(4) 1.9017(12) 
Mo(1)-O(3) 1.9026(13) 
Mo(1)-O(2) 1.9074(13) 
Mo(1)-N(5) 2.2743(15) 
O(2)-Si(2) 1.6315(14) 
Si(2)-C(17) 1.865(2) 
Si(2)-C(23) 1.868(2) 
Si(2)-C(11) 1.880(2) 
O(3)-Si(3) 1.6273(13) 
Si(3)-C(41) 1.8654(19) 
Si(3)-C(35) 1.8679(18) 
Si(3)-C(29) 1.8740(18) 
O(4)-Si(4) 1.6270(12) 
Si(4)-C(47) 1.8677(18) 
Si(4)-C(53) 1.8731(19) 
Si(4)-C(59) 1.8898(13) 
Si(4)-C(59') 1.926(6) 
N(5)-C(6) 1.327(2) 
N(5)-C(10) 1.339(2) 
C(6)-C(7) 1.381(3) 
C(7)-C(8) 1.368(3) 
C(8)-C(9) 1.376(3) 
C(9)-C(10) 1.372(3) 
C(11)-C(12) 1.391(3) 
C(11)-C(16) 1.402(3) 
C(12)-C(13) 1.390(4) 
C(13)-C(14) 1.396(4) 
C(14)-C(15) 1.413(5) 
C(15)-C(16) 1.384(4) 
C(17)-C(18) 1.397(3) 
C(17)-C(22) 1.397(3) 
C(18)-C(19) 1.395(3) 
C(19)-C(20) 1.371(4) 
C(20)-C(21) 1.375(4) 
C(21)-C(22) 1.377(3) 
C(23)-C(24) 1.392(3) 
C(23)-C(28) 1.405(3) 
C(24)-C(25) 1.388(4) 
C(25)-C(26) 1.392(5) 
C(26)-C(27) 1.371(5) 
C(27)-C(28) 1.381(4) 
 
C(29)-C(34) 1.388(3) 
C(29)-C(30) 1.403(3) 
C(30)-C(31) 1.403(3) 
C(31)-C(32) 1.368(4) 
C(32)-C(33) 1.384(4) 
C(33)-C(34) 1.390(3) 
C(35)-C(36) 1.395(3) 
C(35)-C(40) 1.401(3) 
C(36)-C(37) 1.392(3) 
C(37)-C(38) 1.360(4) 
C(38)-C(39) 1.364(4) 
C(39)-C(40) 1.390(3) 
C(41)-C(46) 1.395(3) 
C(41)-C(42) 1.408(3) 
C(42)-C(43) 1.395(3) 
C(43)-C(44) 1.367(4) 
C(44)-C(45) 1.370(3) 
C(45)-C(46) 1.404(3) 
C(47)-C(48) 1.389(3) 
C(47)-C(52) 1.408(2) 
C(48)-C(49) 1.386(3) 
C(49)-C(50) 1.400(3) 
C(50)-C(51) 1.372(3) 
C(51)-C(52) 1.380(3) 
C(53)-C(58) 1.393(3) 
C(53)-C(54) 1.395(2) 
C(54)-C(55) 1.389(3) 
C(55)-C(56) 1.386(3) 
C(56)-C(57) 1.388(4) 
C(57)-C(58) 1.383(3) 
C(59)-C(60) 1.3900 
C(59)-C(64) 1.3900 
C(60)-C(61) 1.3900 
C(61)-C(62) 1.3900 
C(62)-C(63) 1.3900 
C(63)-C(64) 1.3900 
C(59')-C(60') 1.3900 
C(59')-C(64') 1.3900 
C(60')-C(61') 1.3900 
C(61')-C(62') 1.3900 
C(62')-C(63') 1.3900 
C(63')-C(64') 1.3900 
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Table 2- Bond Angles [º] 
Bond                             Angles [º] Bond                             Angles [º] 
N(1)-Mo(1)-O(4) 107.78(8) 
N(1)-Mo(1)-O(3) 102.78(7) 
O(4)-Mo(1)-O(3) 93.43(5) 
N(1)-Mo(1)-O(2) 105.40(8) 
O(4)-Mo(1)-O(2) 141.98(6) 
O(3)-Mo(1)-O(2) 96.89(6) 
N(1)-Mo(1)-N(5) 92.00(7) 
O(4)-Mo(1)-N(5) 78.86(5) 
O(3)-Mo(1)-N(5) 164.89(6) 
O(2)-Mo(1)-N(5) 81.97(6) 
Si(2)-O(2)-Mo(1) 147.70(9) 
O(2)-Si(2)-C(17) 108.56(8) 
O(2)-Si(2)-C(23) 109.07(9) 
C(17)-Si(2)-C(23) 110.07(10) 
O(2)-Si(2)-C(11) 108.47(9) 
C(17)-Si(2)-C(11) 110.13(9) 
C(23)-Si(2)-C(11) 110.50(11) 
Si(3)-O(3)-Mo(1) 148.62(9) 
O(3)-Si(3)-C(41) 111.19(8) 
O(3)-Si(3)-C(35) 107.34(8) 
C(41)-Si(3)-C(35) 108.98(8) 
O(3)-Si(3)-C(29) 109.86(8) 
C(41)-Si(3)-C(29) 108.53(8) 
C(35)-Si(3)-C(29) 110.94(8) 
Si(4)-O(4)-Mo(1) 170.81(10) 
O(4)-Si(4)-C(47) 106.38(7) 
O(4)-Si(4)-C(53) 110.41(8) 
C(47)-Si(4)-C(53) 111.90(8) 
O(4)-Si(4)-C(59) 109.57(8) 
C(47)-Si(4)-C(59) 111.95(9) 
C(53)-Si(4)-C(59) 106.65(9) 
O(4)-Si(4)-C(59') 108.0(2) 
C(47)-Si(4)-C(59') 99.6(3) 
C(53)-Si(4)-C(59') 119.4(2) 
C(6)-N(5)-C(10) 117.92(17) 
C(6)-N(5)-Mo(1) 121.35(13) 
C(10)-N(5)-Mo(1) 120.60(13) 
N(5)-C(6)-C(7) 122.03(19) 
C(8)-C(7)-C(6) 119.8(2) 
C(7)-C(8)-C(9) 118.5(2) 
C(10)-C(9)-C(8) 118.67(19) 
N(5)-C(10)-C(9) 123.08(18) 
C(12)-C(11)-C(16) 117.3(2) 
C(12)-C(11)-Si(2) 121.06(18) 
C(16)-C(11)-Si(2) 121.7(2) 
C(13)-C(12)-C(11) 123.1(3) 
C(12)-C(13)-C(14) 118.9(3) 
C(13)-C(14)-C(15) 119.1(3) 
C(16)-C(15)-C(14) 120.5(3) 
C(15)-C(16)-C(11) 121.1(3) 
C(18)-C(17)-C(22) 117.08(19) 
C(18)-C(17)-Si(2) 122.95(17) 
C(22)-C(17)-Si(2) 119.97(16) 
C(19)-C(18)-C(17) 121.2(2) 
C(20)-C(19)-C(18) 120.1(2) 
C(19)-C(20)-C(21) 119.7(2) 
C(20)-C(21)-C(22) 120.6(3) 
C(21)-C(22)-C(17) 121.4(2) 
C(24)-C(23)-C(28) 116.6(2) 
C(24)-C(23)-Si(2) 122.47(18) 
C(28)-C(23)-Si(2) 120.9(2) 
C(25)-C(24)-C(23) 121.9(3) 
C(24)-C(25)-C(26) 119.5(3) 
C(27)-C(26)-C(25) 120.1(3) 
C(26)-C(27)-C(28) 119.8(3) 
C(27)-C(28)-C(23) 122.1(3) 
C(34)-C(29)-C(30) 117.99(17) 
C(34)-C(29)-Si(3) 122.69(14) 
C(30)-C(29)-Si(3) 119.32(14) 
C(29)-C(30)-C(31) 120.0(2) 
C(32)-C(31)-C(30) 120.6(2) 
C(31)-C(32)-C(33) 120.2(2) 
C(32)-C(33)-C(34) 119.4(2) 
C(29)-C(34)-C(33) 121.8(2) 
C(36)-C(35)-C(40) 117.34(19) 
C(36)-C(35)-Si(3) 120.16(16) 
C(40)-C(35)-Si(3) 122.48(15) 
C(37)-C(36)-C(35) 120.3(2) 
C(38)-C(37)-C(36) 121.4(3) 
C(37)-C(38)-C(39) 119.6(2) 
C(38)-C(39)-C(40) 120.5(2) 
C(39)-C(40)-C(35) 120.9(2) 
C(46)-C(41)-C(42) 116.95(17) 
C(46)-C(41)-Si(3) 122.80(14) 
C(42)-C(41)-Si(3) 120.22(14) 
C(43)-C(42)-C(41) 121.02(19) 
C(44)-C(43)-C(42) 120.3(2) 
C(43)-C(44)-C(45) 120.6(2) 
C(44)-C(45)-C(46) 119.6(2) 
C(41)-C(46)-C(45) 121.51(19) 
C(48)-C(47)-C(52) 117.58(17) 
C(48)-C(47)-Si(4) 120.21(13) 
C(52)-C(47)-Si(4) 122.21(14) 
C(49)-C(48)-C(47) 121.49(18) 
C(48)-C(49)-C(50) 119.4(2) 
C(51)-C(50)-C(49) 120.1(2) 
C(50)-C(51)-C(52) 120.04(19) 
C(51)-C(52)-C(47) 121.33(18) 
C(58)-C(53)-C(54) 117.79(18) 
C(58)-C(53)-Si(4) 120.61(15) 
C(54)-C(53)-Si(4) 121.56(14) 
C(55)-C(54)-C(53) 120.89(18) 
C(56)-C(55)-C(54) 120.3(2) 
C(55)-C(56)-C(57) 119.5(2) 
C(58)-C(57)-C(56) 119.9(2) 
C(57)-C(58)-C(53) 121.6(2) 
C(60)-C(59)-C(64) 120.0 
C(60)-C(59)-Si(4) 121.48(11) 
C(64)-C(59)-Si(4) 118.49(11) 
C(59)-C(60)-C(61) 120.0 
C(62)-C(61)-C(60) 120.0 
C(61)-C(62)-C(63) 120.0 
C(62)-C(63)-C(64) 120.0 
C(63)-C(64)-C(59) 120.0 
C(60')-C(59')-C(64') 120.0 
C(60')-C(59')-Si(4) 118.6(4) 
C(64')-C(59')-Si(4) 121.4(4) 
C(59')-C(60')-C(61') 120.0 
C(62')-C(61')-C(60') 120.0 
C(61')-C(62')-C(63') 120.0 
C(64')-C(63')-C(62') 120.0 
C(63')-C(64')-C(59') 120.0 
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Appendix 2 – NMR spectra of isolated cruentaren A (Höfle et al.)‡ 
1H NMR (600 MHz, CDCl3) 
 
                                                
‡ NMR spectra of isolated cruentaren A were obtained from Professor Gerhard Höfle. 
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13C NMR (150 MHz, CDCl3) 
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Appendix 3 – NMR spectra of synthesized cruentaren A (MF822) 
1H NMR (500 MHz, CDCl3) 
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13C NMR (125 MHz, CDCl3) 
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